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Abstract 
Two conserved protein kinases, Chk1 and Chk2, are activated in response to genotoxic 
stress and mediate multiple cell cycle checkpoint mechanisms that ensure genomic 
integrity. The establishment of mitotic checkpoint delay in response to DNA damage or 
incompletely replicated DNA is conventionally thought to be accomplished through 
inhibition of the cyclin-dependent kinase, Cdc2. Both Chk1 and Chk2 have the potential to 
operate in this pathway. Therefore, the initial aim of this study was to investigate the 
relative requirement of Chk1 and Chk2 for mitotic delay mechanisms triggered by DNA 
damage and DNA replication arrest in avian and human cells. 
These studies demonstrated that Chk1 is the principal regulator of the G2/M checkpoint 
with a direct role in the establishment and maintenance of the mitotic delay in response to 
DNA damage. Chk1 was also found to be required for the S/M checkpoint in response to 
DNA replication arrest; however, detailed analysis indicated that its role is to maintain 
rather than initiate this checkpoint, as cells lacking functional Chk1 can initially delay 
mitosis for many hours before they enter a premature mitosis with unreplicated DNA.  
In avian cells, mitotic phosphorylation of cyclinB2 was found to be mediated by cyclin 
dependent kinases and suppressed by checkpoint signalling. However, accumulation of 
potentially active phospho-cyclinB2/Cdc2 complexes was observed during the initial 
mitotic delay in the absence of functional Chk1, suggesting that other factors apart from 
the conventionally known mechanisms can restrain mitotic Cdc2 activity. In addition, 
avian cells were able to delay mitosis effectively during replication arrest in the presence 
of the ATM/ATR inhibitor caffeine, further emphasizing the possibility of mitotic delay 
mechanisms that operate independently of ATM/ATR and Chk1. 
Furthermore, this study revealed that endogenous Cdc6 accumulates in a Chk1-dependent 
manner during replication arrest. To test whether Cdc6 might function upstream or 
downstream of Chk1 in the replication checkpoint pathway, Cdc6 was ectopically 
expressed in both checkpoint-proficient and checkpoint-deficient Chk1-depleted cells. The 
results from these intervention experiments give preliminary evidence that places Cdc6 
downstream of Chk1 in the S/M checkpoint response. 
The ability of cells to delay the onset of mitosis while DNA replication is stalled 
independently of ATM/ATR/Chk1 is consistent with the general idea of an inherent 
relationship between the process of DNA replication and mitosis. The replication 3 
machinery might be able to signal either normal DNA replication in progress or the 
presence of stalled replication structures and thereby intrinsically link the successful 
completion of DNA synthesis to progression into mitosis. 
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1  Introduction 
The progression of normal cells into cancer cells is accompanied by a series of genetic 
changes. The deregulation of cell cycle components has been implicated in tumorigenesis. 
One of the major aims during development is to ensure the fidelity of cell division without 
any damage to the integrity of the genome (Nyberg et al., 2002). To preserve genomic 
stability, cells have developed a variety of mechanisms that enable them to deal with any 
endogenous and exogenous assaults. These surveillance mechanisms ensure the correct 
sequence of cell cycle events and also coordinate repair mechanism; they are commonly 
known as cell cycle checkpoints (Hartwell and Weinert, 1989). 
1.1  DNA Damage and replication checkpoints  
In response to genotoxic stress, cells can activate various checkpoint responses which will 
delay the progression of the cell cycle until any lesions have been resolved. Depending on 
the type of stress as well as the position in the cell cycle, several checkpoints can be 
triggered, that can halt cell cycle progression, induce repair processes, or activate cell death 
mechanisms. The eukaryotic cell cycle can be divided into interphase, in which cells grow, 
accumulate nutrients and replicate their DNA, and mitosis, the process of cell division 
which results in the production of two daughter cells. Interphase consists of three stages: 
the first gap or growth phase G1, which is followed by S-phase in which DNA synthesis 
takes place and another gap or growth phase G2. Multiple cell cycle checkpoints have been 
identified throughout the cell cycle, during each of these phases and also at transition 
stages in between (Elledge, 1996; Hartwell and Weinert, 1989). 
Both exogenous and endogenous factors can lead to DNA damage, for example ionising 
radiation (IR) can result in DNA single- and double-strand breaks whereas metabolic 
processes can lead to oxidation of the DNA. In general, checkpoint proficient cells will 
attempt to repair the damage before cells progress any further through the cell cycle. If the 
damage is un-repairable, other potential responses include the initiation of programmed 
cell death or even adaptation and re-entry into the cell cycle. DNA damage checkpoints are 
thought to constantly monitor the DNA for lesions and are presumably active at all times. 
The simple model in Figure 1.1 illustrates three of the best characterized DNA damage 
checkpoint responses that act at the G1/S transition, but also throughout S phase, and at the 
G2/M transition. Relevant in particular for this study of mitotic checkpoint mechanisms is Verena Oehler, 2007     Chapter 1, 15 
the G2/M checkpoint which can arrest cells in G2 phase and thereby prevent cell division 
in the presence of damaged DNA.  
Replication forks will slow down or halt their progress if they encounter any obstacles, 
such as DNA adducts or when DNA precursor pools are limiting. Drugs such as 
hydroxyurea or aphidicolin are commonly used to block DNA replication in experimental 
systems. In general, blocks to the replication machinery can activate at least three 
checkpoint responses: the stabilisation of stalled replication forks and the suppression of 
futile origin firing which can be grouped into the replication recovery functions (Figure 
1.1). The third response, which is very much relevant for this study, the S/M checkpoint, 
delays the onset of mitosis in the presence of unreplicated DNA. 
The known checkpoint proteins that are involved in the execution of cell cycle checkpoint 
mechanisms can be broadly divided into sensors, transducers, mediators and effectors, 
although some proteins fit in more then one category. Initially, sensor proteins detect 
damaged DNA or stalled replication structures and set a signalling cascade in motion that 
includes transducer proteins which transmit and amplify the checkpoint signal to 
downstream effector proteins which are directly involved in cell cycle progression, repair 
mechanisms or apoptosis (Nyberg et al., 2002; Sancar et al., 2004). The majority of 
checkpoint proteins and signalling pathways have initially been identified and 
characterised in budding and fission yeast. As many checkpoint proteins are conserved 
from yeast to higher organisms, it was assumed that most of these observations could be 
extrapolated, however, although many general checkpoint properties are indeed similar, 
significant differences were also identified. Therefore, general checkpoint mechanisms will 
be introduced first with a focus on the model organisms Schizosaccharomyces pombe 
(fission yeast) and Saccharomyces cerevisiae (budding yeast). After that, the current 
knowledge of these mechanisms in higher eukaryotes will be discussed. 
1.2  Checkpoint pathways in fission yeast 
Fission yeast has been a powerful model organism for cell cycle research in general and for 
the investigation of cell cycle checkpoint mechanisms in particular as they are easy to grow 
and manipulate. There are basically two major checkpoint responses in fission yeast: 
during S phase, replication stress can create structures such as stalled replication forks 
which result in the activation of the replication recovery functions and lead to mitotic delay 
(S/M checkpoint), whereas the DNA damage checkpoint response delays cells in G2 phase 
from entering mitosis with damaged DNA (G2/M checkpoint).   Verena Oehler, 2007     Chapter 1, 16 
 
           
G1 S G2 M G1 S G2 M
S/M
DNA REPLICATION BLOCK
Suppression of
futile origin firing
Replication
fork stabilisation
DNA DAMAGE
G1/S  S      G2/M 
 
Figure 1.1: DNA damage and replication checkpoints 
Schematic overview of the phases of the cell cycle and the most relevant cell cycle checkpoints 
activated in response to either DNA damage (i.e. through Irradiation) or DNA replication block (i.e. 
with the DNA polymerase inhibitor aphidicolin) throughout the cell cycle. In response to DNA 
damage, cell cycle checkpoints can be induced at the G1/S transition, throughout S phase, and at 
the G2/M transition. In response to DNA replication block, cells can activate the replication 
recovery functions, such as the suppression of futile origin firing and the stabilisation of stalled 
replication forks. In addition, the S/M checkpoint ensures that cells do not enter mitosis in the 
presence of unreplicated DNA.    
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1.2.1 Outline of the checkpoint signalling cascade in fission yeast 
Several proteins responsible for monitoring aberrant DNA structures have been identified 
in fission yeast, most notably the Rad9, Hus1, Rad1, and Rad17 proteins. These four 
proteins are structurally related to replication proteins. The 9-1-1 complex consists of the 
three proteins: Rad9-Hus1-Rad1 which were found to share sequence similarity with the 
proliferating cell nuclear antigen (PCNA), a DNA polymerase processivity factor, and 
form a trimeric complex that structurally resembles a PCNA trimer (Thelen et al., 1999). 
The Rad17 protein contains five domains with sequence similarity to the subunits of 
replication factor C (RFC) and was shown to interact with four RFC subunits and form a 
pentameric complex Rad17-RFC (Griffiths et al., 1995). In analogy to the replication 
proteins, it is possible that the 9-1-1 complex might slide along the DNA scanning for sites 
of DNA damage or stalled replication forks. A model has been proposed where the Rad17-
RFC complex can load the 9-1-1 complex onto the DNA as a checkpoint sliding clamp. 
Upon ATP-binding the clamp loading complex can undergo conformational changes that 
result in the opening of the complex allowing DNA binding (Venclovas et al., 2002).  
In addition to these two sensory complexes there are two more Rad-proteins, Rad3 and 
Rad26, which are homologues of vertebrate ATR and ATRIP and are also involved in 
sensing DNA lesions. Importantly, Rad3 is the phosphoinositide 3-kinase related kinase 
(PIKK) that becomes activated in response to genotoxic stress and transduces the 
checkpoint signal to downstream effector kinases Chk1 and Cds1 (the fission yeast 
homologue of vertebrate Chk2). Thus, Rad3 has both sensor and transducer properties. 
Most parts of the signalling pathway, including Chk1 and Cds1 activation, are dependent 
on the Rad17-RFC and 9-1-1 complexes, but the phosphorylation of Rad26 by Rad3 in 
response to ionising radiation does not require the two sensor complexes, suggesting that 
Rad3 and Rad26 may bind damage independently (Edwards et al., 1999). 
In general, the checkpoint signal leads to the activation of either of the two downstream 
checkpoint kinases: Whereas Chk1 is selectively activated in response to DNA damage, 
Cds1 becomes mainly activated in response to replication stress (Murakami and Okayama, 
1995; Walworth et al., 1993). It is known that Rad3 relays the checkpoint signal to its 
downstream kinases via mediator or adaptor proteins. The adaptor protein Crb2 plays a 
crucial role in the establishment of the DNA damage checkpoint. Crb2 is a BRCT-domain 
protein similar to vertebrate 53BP1 and mediates the checkpoint response through 
interactions with both Rad3 and Chk1 (Mochida et al., 2004). In contrast, in response to 
replication stress, Rad3 transduces the checkpoint signal via Mrc1, the mediator of Verena Oehler, 2007     Chapter 1, 18 
replication checkpoint comparable to vertebrate Claspin, which is required for the initial 
phosphorylation of Cds1 by Rad3 (Tanaka and Russell, 2001; Tanaka and Russell, 2004). 
In addition, the Rad3-related kinase Tel1, which is involved in telomere maintenance, has 
been shown to regulate Mrc1 in combination with Rad3 by differential phosphorylation 
(Zhao et al., 2003). Aside from Tel1, recently the closely related Tel2 has also been 
implicated in the activation of the Mrc1-mediated replication checkpoint (Shikata et al., 
2007).   
Once the checkpoint signal reaches the effector kinases Chk1 and Cds1, they can 
subsequently phosphorylate a wide variety of downstream targets that will lead to the 
implementation of appropriate checkpoint responses. The cyclin dependent kinase Cdc2, 
which executes the transition into mitosis, is the major downstream target of mitotic 
checkpoints in response to DNA damage or replication block. A simplified diagram for the 
checkpoint signalling cascades in fission yeast is shown in Figure 1.2.   
1.2.2 Chk1 and Cds1 kinases in fission yeast 
In general, the two checkpoint kinases are thought to operate in two different pathways 
according to the type of genotoxic stress that leads to their activation. However, there is 
evidence for some kind of overlap or interplay between the two kinases as demonstrated 
with the checkpoint pathway in response to replication stress: early studies demonstrated 
that the S/M checkpoint in fission yeast prevents the onset of mitosis if DNA replication is 
blocked by hydroxyurea (Enoch and Nurse, 1990). The checkpoint response is thought to 
be accomplished by Cds1, which is primarily activated by hydroxyurea in these cells.  
However, in the absence of Cds1, fission yeast mutants still retain the capacity to delay 
mitosis, probably due to Chk1 which becomes strongly activated in these cells. Moreover, 
mutants deficient for both Chk1 and Cds1 completely lack mitotic delay, further 
confirming this model of compensatory activation of the two kinases in S/M checkpoint 
control (Boddy et al., 1998). It has been suggested that failure to stabilize protein 
complexes at stalled replication forks in Cds1-deficient yeast cells might cause DNA 
damage and therefore activation of Chk1 (Lindsay et al., 1998).  
Interestingly however, this study by Lindsay et al. proposed two models for Cds1 function 
in response to S phase perturbations. The first model implied that Cds1 has two separate 
targets: on one side it can stabilise components of the replication machinery and on the 
other side it can additionally target proteins that regulate Cdc2 activity, as described in the 
diagram in Figure 1.2 (Lindsay et al., 1998). This model is the generally accepted one but  Verena Oehler, 2007     Chapter 1, 19 
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Figure 1.2: Outline of the checkpoint signalling cascade in fission yeast 
DNA damage induced lesions can be detected by the 9-1-1 and Rad17-RFC complex and also by 
Rad3-Rad26. The signal is transduced by Rad3 to the effector kinase Chk1 via the mediator 
protein Crb2. Chk1 activation leads to downstream responses that result in the execution of mitotic 
delay via inhibition of Cdc2.  
In response to replication stress, stalled replication structures can be detected by 9-1-1 and Rad17-
RFC and the signal is transduced by Rad3. Mediator proteins such as Mrc1 are also directly 
involved in sensing and transmitting the checkpoint signal to the effector kinase Cds1 which in turn 
will activate downstream responses that result in the execution of mitotic delay via inhibition of 
Cdc2 and the replication recovery functions: suppression of origin firing and stabilisation of stalled 
replication forks. 
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interestingly, another alternative model was also proposed. This second model suggested 
that Cds1 has only one single target, the replication machinery. Accordingly, Cds1 would 
stabilise the replication structures during S phase and they could themselves generate a 
signal leading to the inhibition of Cdc2 and mitotic delay in a manner that would be 
independent of the action of the checkpoint Rad proteins (Lindsay et al., 1998). 
1.2.3 Targets of the mitotic checkpoint mechanisms 
The ultimate target of the mitotic checkpoint mechanisms is to block the onset of mitosis in 
the presence of damaged or incompletely replicated DNA. During a normal cell cycle the 
transition to mitosis requires the activation of the cyclin dependent kinase Cdc2 which is 
stimulated through its association with a regulatory mitotic B-type cyclin subunit and an 
activatory phosphorylation on Threonine 167 (T167). Cdc2 activity is also regulated 
through inhibitory phosphorylation on a Tyrosine 15 (Y15) residue. The phosphorylation 
status of the critical Cdc2-residue Y15 is controlled by the Wee1 and Mik1 kinases, which 
are responsible for the phosphorylation, and the Cdc25 phosphatase which is able to 
remove it (Lundgren et al., 1991; Millar et al., 1991).  
The inhibition of mitosis during checkpoint responses is generally thought to be achieved 
by preventing the activation of Cdc2. The checkpoint kinases Chk1 and Cds1 were both 
implicated in the regulation of the Wee1 and Mik1 kinases and the Cdc25 phosphatase. In 
response to DNA damage, Chk1 was shown to be able to activate Wee1 which can in turn 
contribute to the maintenance of inhibitory Y15 phosphorylation on Cdc2 (O'Connell et al., 
1997). In a similar manner, Cds1 appears to be able to bind and phosphorylate Wee1 in 
response to hydroxyurea (Boddy et al., 1998). In addition to Wee1, the other Y15-kinase 
Mik1 was found to be important for both the establishment and the maintenance of the 
DNA damage and replication checkpoints (Rhind and Russell, 2001). Thus, the activation 
of Wee1 and Mik1 by Chk1 and Cds1 during checkpoint activation in fission yeast is 
associated with the maintenance of the inhibitory Cdc2-Y15 phosphorylation. 
Another study identified the phosphatase Cdc25 as target of the DNA damage checkpoint 
in fission yeast by demonstrating that Chk1 can associate with Cdc25 in vivo and 
furthermore phosphorylate Cdc25 in vitro (Furnari et al., 1997). In addition to that, it was 
established that Cds1 can phosphorylate Cdc25 in response to replication stress. In the 
absence of Cds1 in fission yeast, the other checkpoint kinase Chk1 can be activated and 
phosphorylate Cdc25 in a similar manner (Zeng et al., 1998). In either case, Cdc25 
phosphatase activity is inhibited, either directly or by association with another protein of Verena Oehler, 2007     Chapter 1, 21 
the 14-3-3 family. The phosphorylation of Cdc25 on several specific sites (Serines 99, 192, 
359) leads to its association with Rad24 and Rad25, two fission yeast homologues of 14-3-
3 proteins (Ford et al., 1994; Zeng et al., 1998). In this complex Cdc25 is unable to remove 
the inhibitory Y15 phosphorylation on Cdc2 and thus maintains the inactive kinase form. 
In summary, Chk1 and Cds1 can execute mitotic checkpoint responses by targeting the 
downstream kinases Wee1 and Mik1 as well as the Cdc25 phosphatase. As shown in the 
model in Figure 1.3, Chk1 mainly becomes activated in response to DNA damage and 
leads to Cdc2 inhibition through Wee1 and Mik1 induced inhibitory Y15 phosphorylation 
and inhibition of the Cdc25 phosphatase. In response to replication stress, Cds1 is mainly 
activated and can inhibit Cdc2 in the same manner as Chk1 by targeting Wee1, Mik1, and 
Cdc25. In addition to that, the replication recovery functions of Cds1 ensure the 
stabilisation of stalled replication structures by suppressing any futile firing of origins and 
furthermore by stabilising stalled replication forks. However, in the absence of Cds1, Chk1 
activation is responsible for the checkpoint response, presumably because the stalled 
replication structures collapse and can then be detected by the DNA damage sensors.  
1.2.4 DNA replication and checkpoint signalling 
As mentioned above, one study has previously suggested a model where the stalled 
replication machinery itself could potentially contribute to the checkpoint signal leading to 
the inhibition of mitosis. There has been some speculation about whether proteins involved 
in DNA replication might be able to sequester Cdc2 on stalled replication structures and 
thereby inhibit the onset of mitosis (Lindsay et al., 1998; Russell, 1998).  
For example, it has been proposed that the presence of replication proteins Cdc18 (also 
known as Cdc6) and Orp1 (an ORC subunit homologue) in combination with stalled 
replication structures is important for Cds1 activation during replication checkpoint 
responses (Murakami et al., 2002). Cdc18 is an essential factor for the initiation of DNA 
synthesis in fission yeast. It has been shown to interact with Cdc2, and it is thought that the 
Cdc2-dependent phosphorylation of Cdc18 is involved in preventing the re-activation of 
replication origins once DNA synthesis has finished (Lopez-Girona et al., 1998). These 
findings make Cdc18 a prime candidate to be involved in replication checkpoint signalling. 
Only recently Rad26 has been shown to physically interact with Cdc18 and it was also 
demonstrated that this interaction allows a more stable recruitment of Rad3 to the 
chromatin when DNA replication is stalled thereby enforcing long-term maintenance of the 
checkpoint (Hermand and Nurse, 2007).Verena Oehler, 2007     Chapter 1, 22 
 
Cdc2
P P T167
14-3-3 Wee1 Wee1
active
inactive
Chk1
DNA damage  Replication stress
Cds1
Y15 P P
Cdc2
Replication 
recovery 
Stalled 
replication
structures
Collapsed
replication
structures
Mik1 Mik1
Cdc25 Cdc25
Y15
Cdc25 Cdc25
Cdc2
P P T167
14-3-3 Wee1 Wee1
active
inactive
Y15 P P
Cdc2
Cdc25 Cdc25
Y15
Cdc25 Cdc25
Mik1 Mik1
MITOSIS MITOSIS
cyclinB cyclinB
 
Figure 1.3: Targets of the mitotic checkpoint mechanisms in fission yeast 
In response to DNA damage, Chk1 becomes activated and phosphorylates downstream targets 
Cdc25, Wee1, and Mik1. Phosphorylation of Cdc25 creates a binding site for 14-3-3 proteins and 
inhibits the phosphatase activity of Cdc25. Phosphorylation of Wee1 and Mik1 further induces their 
kinase activity towards Cdc2 and ensures the maintenance of the inhibitory Y15 phosphorylation 
which keeps Cdc2 in an inactive state and blocks the onset of mitosis.  
In response to replication stress, Cds1 becomes activated and can phosphorylate downstream 
targets Cdc25, Wee1, and Mik1, which results in mitotic delay in a similar fashion as Chk1 
activation described above. Additionally, the replication recovery functions of Cds1 are responsible 
for stabilising stalled replication structures. In the absence of Cds1, Chk1 becomes activated 
presumably because stalled replication structures would collapse and then be detected by the DNA 
damage sensors. In this scenario, in the absence of Cds1, Chk1 would be responsible for the block 
to mitosis in response to replication block. Verena Oehler, 2007     Chapter 1, 23 
1.3  Checkpoint pathways in budding yeast 
Checkpoint proteins and signalling pathways have also been identified and extensively 
studied in the budding yeast model organism. Similar to fission yeast, the budding yeast 
proteins involved in checkpoint signalling can be roughly grouped into sensors, mediators, 
transducers, and effectors, although very often one protein can be assigned to more than 
one of these categories.  
To briefly summarize budding yeast checkpoint control, the monitoring and detection of 
aberrant DNA structures is thought to be mainly accomplished by Rad-family protein 
complexes, whereby the Rad24 protein complex can function as a clamp-loader similar to 
fission yeast Rad17-RFC. Accordingly, the budding yeast Rad17 complex, consisting of 
Rad17, Mec3 and Ddc1, can be viewed as the sliding clamp that is  loaded onto the DNA 
by the clamp loader Rad24 complex (Green et al., 2000; Thelen et al., 1999). Several other 
proteins have been implicated in detecting checkpoint-activating structures and mediating 
checkpoint signalling, including the Rad9 protein, the Mrc1 protein, as well as various 
repair proteins, such as for example the double strand recognition and repair proteins 
Mre11, Rad50, Xrs2 (D'Amours and Jackson, 2002).  
The major transducer kinase in budding yeast is called Mec1, the homologue of fission 
yeast Rad3, and the main effector kinases responsible for budding yeast checkpoint 
signalling are Chk1 and Rad53, the latter being the homologue of fission yeast Cds1. In 
response to both DNA damage and replication arrest, Rad53 has been identified as the 
major effector kinase that is phosphorylated in a Mec1-dependent manner (Pellicioli et al., 
1999; Santocanale and Diffley, 1998). The other effector kinase Chk1 has been shown to 
be mainly activated in response to DNA damage, and as for Rad53, this is accomplished in 
a Mec1-dependent fashion. In response to DNA damage, it is thought that Chk1 and Rad53 
function in parallel pathways, preventing progression through mitosis by maintaining the 
anaphase inhibitor Pds1 and by regulating the Polo kinase Cdc5, respectively (Sanchez et 
al., 1999). Another important component of checkpoint signalling in budding yeast is 
Dun1, a downstream kinase of Mec1/Rad53, which leads to the transcriptional activation 
of repair genes and has been shown to regulate the abundance of the ribonucleotide 
reductase inhibitor Sml1 in response to DNA damage (Zhao and Rothstein, 2002).  As for 
the checkpoint response to replication arrest or DNA damage in S phase, Rad53 alone has 
emerged as main effector kinase responsible for preventing the firing of late origins 
(Santocanale and Diffley, 1998). Verena Oehler, 2007     Chapter 1, 24 
1.4  Checkpoint pathways in vertebrate cells 
Many of the basic principles of cell cycle checkpoint mechanisms were first described in 
the yeast model organisms. As many checkpoint proteins have homologues in higher 
eukaryotes, the question of whether the findings in budding and fission yeast could be 
extrapolated to vertebrate cells was raised. The cell cycle checkpoint research has rapidly 
progressed using various cell lines and several animal model systems, most notably work 
on Xenopus oocytes, knock-out mice models, and avian DT40 knock-out cell lines. 
Similar to fission yeast, the components of the checkpoint pathways in vertebrate cells can 
be broadly divided into sensor proteins, adaptor/mediator proteins, transducers and 
effectors, although some proteins fit into more than one category. The next sections will 
first examine how DNA damage and replication stress are thought to be sensed in 
vertebrate cells, and then the actual details of the checkpoint signalling cascades will be 
discussed with a focus on mitotic checkpoint responses.  
1.4.1 Sensing checkpoint-activating DNA structures   
In general, cells are constantly exposed to endogenous and exogenous forms of DNA 
damage. In order to study individual cell cycle checkpoint responses, cells are often 
exposed to DNA damage by ionising radiation (IR) or ultra-violet (UV) radiation. These 
two types of radiation induce quite different types of DNA damage; IR treatment induces 
DNA single- and double-strand breaks whereas UV light has cross-linking properties and 
frequently creates pyrimidine dimers. Apart from radiation, DNA damage can also be 
induced by various genotoxic chemotherapeutic agents, for example cisplatin or etoposide. 
During S phase, when cells replicate their DNA, they are susceptible to lesions that 
compromise replication fork progression and ultimately endanger genomic integrity. In 
general, drugs that interfere with the process of DNA replication directly are used to study 
replication checkpoint responses in experimental systems. Hydroxyurea (HU) is a 
ribonucleotide reductase inhibitor that causes the depletion of dNTP pools and thus inhibits 
DNA synthesis. Another drug that is frequently used for checkpoint analysis is aphidicolin, 
which inhibits the DNA polymerases α (also δ and ε) and therefore blocks DNA 
replication (Liu et al., 2003). 
As in fission yeast, the vertebrate Rad17-RFC complex and the 9-1-1 complex have been 
identified as ‘sensors’ of DNA lesions in vertebrate cells. Correspondingly, the hetero-Verena Oehler, 2007     Chapter 1, 25 
pentameric Rad17-RFC complex can bind to the hetero-trimeric 9-1-1 complex in an ATP-
dependent manner but binding to DNA is independent of ATP. Also in vertebrates, it is 
thought that the Rad17-RFC complex can act as a clamp loader that loads the 9-1-1 
checkpoint clamp onto DNA in a manner reminiscent to RFC and PCNA during DNA 
replication (Bermudez et al., 2003; Lindsey-Boltz et al., 2001).   
Apart from the Rad17-RFC and 9-1-1 complex, several other proteins have been identified 
that are in some way involved in sensing DNA damage or stalled replication structures. 
Protein kinases such as ATM and ATR provide not only sensory functions; they also 
transduce the checkpoint signal and are generally thought to be essential components of the 
cell cycle checkpoint machinery. 
1.4.1.1  PI3-kinase related protein kinases: ATM, ATR, DNA-PK 
Two members of the PIKK family are primarily required for the cell cycle checkpoint 
mechanisms in vertebrate cells: ATM (Ataxia-Telangiectasia-mutated) and ATR (ATM 
and Rad3-related). Whereas ATM appears to be mainly activated by DNA damage, such as 
double-strand breaks, ATR responds mainly to stalled replication structures and single-
stranded DNA, however this distinction is not completely clean-cut as their activatory 
patterns sometimes overlap (Yang et al., 2003).   
Another member of the PIKK family is DNA-PK (DNA-dependent protein kinase), a 
serine/threonine protein kinase involved in the repair of DNA double-strand breaks by the 
process of non-homologous end joining (NHEJ). This repair mechanism accomplishes the 
ligation of the ends of DNA strand breaks without the need for a homologous template. 
DNA-PK functions in this response as a hetero-trimeric complex in association with two 
Ku subunits, Ku70 and Ku80, which form a DNA end binding complex and recruit and 
activate the DNA-PK catalytic subunit (Doherty and Jackson, 2001).  
The ATM protein kinase received its name Ataxia-telangiectasia-mutated because 
mutations in the gene cause the condition Ataxia-telangiectasia in humans. This disease is 
characterised by neurological defects, radiation sensitivity, genome instability, and cancer 
predisposition, amongst other symptoms (Savitsky et al., 1995). ATM knock-out mice are 
viable and recreate much of the phenotype of Ataxia-telangiectasia (Xu et al., 1996). ATM 
is mainly involved in the recognition of DNA double-strand breaks and even a very small 
number of DNA double-strand breaks are already sufficient to induce ATM activation in 
cells (Bakkenist and Kastan, 2003). The intra-molecular auto-phosphorylation of ATM on Verena Oehler, 2007     Chapter 1, 26 
a specific serine residue (S1981) converts the dimeric ATM protein into monomers. 
Activated ATM rapidly phosphorylates histone H2AX on S319 (γ-H2AX), thereby 
marking sites of DNA damage, particularly DNA double-strand breaks, and initiating the 
recruitment of various checkpoint proteins, including mediator proteins which further 
contribute to the activation of several ATM downstream targets to transduce and amplify 
the checkpoint signal (Burma et al., 2001; Paull et al., 2000; Rogakou et al., 1998). The 
major downstream target of ATM in vertebrate cells is thought to be the checkpoint kinase 
Chk2 which will be discussed in more detail at a later point. 
ATR and ATRIP (ATR-interacting protein) are the vertebrate homologues of Rad3 and 
Rad26, and as with their fission yeast counterparts they are involved in sensing DNA 
lesions. ATR is another member of the PIKK family and has essential functions during 
early embryonic development as ATR knock-out mice are embryonically lethal and 
furthermore display high levels of chromosome fragmentation (Brown and Baltimore, 
2000). A mutation that alters splicing of the ATR gene and affects the expression of ATR 
has been associated with Seckel syndrome, an autosomal recessive disorder. The disease is 
characterised by growth retardation and mental retardation and also presents symptoms 
indicating impaired DNA damage responses (O'Driscoll et al., 2003).  
ATR and ATRIP are thought to be mainly involved in sensing single-stranded DNA 
stretches, which are generated for example when a replication fork stalls. The replication 
protein A (RPA) can bind to the single-stranded DNA and it is thought that RPA-coated 
DNA preferentially recruits the ATR-ATRIP complex, although it has been shown that 
ATR can also bind directly to DNA. The ATR-ATRIP complex is able to induce the 
phosphorylation of the Rad17 sensor protein in the presence of RPA-coated DNA. 
However, the loading of Rad17, the 9-1-1 complex and other checkpoint mediator factors 
appears to be independent of ATR (Unsal-Kacmaz et al., 2002; Zou and Elledge, 2003).  
Similar to ATM, ATR can trigger the phosphorylation of histone H2AX, for example in 
response to UV light when DNA repair intermediates trigger the response (Hanasoge and 
Ljungman, 2007). In addition, when UV light-induced bulky DNA adducts collide with 
replication forks, resulting DNA double-strand breaks can also lead to histone H2AX 
phosphorylation by ATM (Rogakou et al., 1998). Furthermore activated DNA-PK has been 
shown to induce H2AX phosphorylation (Park et al., 2003). Overall, ATM, ATR and 
DNA-PK can be involved in the phosphorylation of histone H2AX, which can be used as a 
marker for DNA lesions and sites to which several checkpoint proteins are recruited. These Verena Oehler, 2007     Chapter 1, 27 
sites are detectable within one minute of IR treatment and can be visualised as distinct 
nuclear foci using antibodies specific for γ-H2AX (Sedelnikova et al., 2002).  
Interestingly, ATR seems to play an important role during normal S phase progression, as 
it is recruited to the chromatin in the absence of DNA damage (Dart et al., 2004). 
Moreover, both ATM and ATR have been shown to contribute to the regulation of the 
timing of origin firing during an unperturbed S phase (Shechter et al., 2004). Thus, ATM 
and ATR are thought to contribute to the regulation of a normal unperturbed cell cycle as 
well as to checkpoint signalling in response to DNA damage and replication stress. 
In any case, all three PIKK family members possibly will associate with a variety of 
adaptor/mediator proteins in order to transduce and amplify the checkpoint signal to their 
respective downstream targets.  
1.4.1.2  Adaptor and mediator proteins involved in checkpoint signalling 
Checkpoint mediator proteins can transiently associate with sensor proteins and transducer 
proteins and thereby help to specifically transmit checkpoint signals. In response to DNA 
damage or replication stress, at least five mediator proteins are involved in checkpoint 
signalling in vertebrate cells: the mediator of DNA damage checkpoint 1 (MDC1), the 
topoisomerase binding protein 1 (TopBP1), the p53 binding protein 1 (53BP1), breast 
cancer gene 1 (BRCA1), and Claspin. Some of these proteins do not only act as mediators 
but also as sensor proteins, and many of these mediator proteins contain one or more 
BRCT domains, of which the first was identified in the C-terminal part of BRCA1. The 
BRCT domain is an evolutionary conserved interaction motif that is found in many 
proteins involved in cell cycle checkpoint function (Bork et al., 1997).  
The BRCT domain containing protein MDC1 is one of the first proteins to localise to sites 
of DNA damage. Following H2AX-phosphorylation by ATM, MDC1 can directly 
associate with γ-H2AX via its BRCT domain and subsequently recruit further checkpoint 
proteins, such as the MRN repair complex, 53BP1, and BRCA1 (Stucki et al., 2005). The 
MRN complex consists of three proteins which are called meiotic recombination 11 
(MRE11), Rad50, and Nijmegen breakage syndrome 1 (NBS1). The mediator protein 
MDC1 can furthermore interact with the ATM downstream target Chk2 and is also 
phosphorylated in an ATM/Chk2-dependent manner in response to DNA damage 
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The multiple BRCT domain-containing protein TopBP1 is phosphorylated in response to 
DNA damage and replication blocks. TopBP1 has a crucial role in ATR-dependent 
checkpoint signalling and has been shown to activate the ATR-ATRIP complex in Xenopus 
(Kumagai et al., 2006). This interaction as well as ATR activation appears to be dependent 
on the checkpoint clamp 9-1-1 complex (Lee et al., 2007). Furthermore, ATM can also 
regulate TopBP1 by phosphorylation and thereby enhance the TopBP1-ATR association 
(Yoo et al., 2007). 
The p53 binding protein 53BP1 is another BRCT domain containing protein involved in 
checkpoint signalling. 53BP1 is phosphorylated in response to DNA damage and forms 
nuclear foci that co-localize with γ-H2AX, mainly to DNA double-strand breaks (Rappold 
et al., 2001). However, depending on the type of damage, both ATM and ATR have been 
associated with 53BP1 phosphorylation (Jowsey et al., 2007). Apart from stimulating p53-
dependent transcription, 53BP1 has been shown to function in the process of non-
homologous end joining of DNA double-strand breaks (Nakamura et al., 2006).  
BRCA1 is a breast cancer susceptibility gene that is involved in DNA damage repair. It 
contains a C-terminal BRCT domain and as previously mentioned, BRCA1 is recruited to 
sites of damage, such as DNA double-strand breaks. It has also been proposed that a direct 
interaction between ATRIP and BRCA1 is required for the checkpoint function of ATR 
(Bork et al., 1997; Venere et al., 2007). 
Another adaptor protein, Claspin, has been identified in Xenopus as a protein that is 
required for Chk1 activation during the replication checkpoint response (Kumagai and 
Dunphy, 2000). Claspin also acts as a sensor protein and can bind to chromatin in the 
absence or presence of DNA damage. It is involved in the ATR-dependent activation of 
Chk1 and the stabilisation of Claspin is thought to be part of the checkpoint in response to 
replication arrest (Bennett and Clarke, 2006). 
The mechanistical details of the functions and interactions of these mediator proteins are 
rather complex. Depending on the type of DNA damage, different lesions such as DNA 
double-strand breaks or sections of single-stranded DNA, result in the recruitment of the 
appropriate mediator proteins. Figure 1.4 shows a simplified model for the checkpoint 
signalling components that participate in the recognition of DNA lesions in response to 
DNA damage. For example, UV-light-induced DNA lesions may result in the generation of 
single-stranded DNA and thus activate mainly ATR with the possible participation of 
mediator proteins like TopBP1, BRCA1, 53BP1, and Claspin. Verena Oehler, 2007     Chapter 1, 29 
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Figure 1.4: Sensing and transducing DNA damage in vertebrate cells 
UV light induced DNA damage DNA lesions, including single-stranded DNA. ATR can directly bind 
to these lesions or ATR-ATRIP is recruited to stretches of RPA-coated single-stranded DNA. 
Rad17-RFC and 9-1-1 are also involved in sensing DNA damage. ATR can phosphorylate histone 
H2AX at the sites of damage. The complete activation of ATR is achieved through the involvement 
of several mediator proteins, such as TopBP1, BRCA1, 53BP1, and Claspin. These mediator 
proteins may also bind directly to the DNA and they communicate the checkpoint signal from ATR 
to the effector kinase Chk1.   
DNA damage, such as DNA double-strand breaks induced by IR, lead to the recruitment of ATM. 
The intra-molecular phosphorylation of ATM converts the dimer into active monomers which can 
phosphorylate histone H2AX. Damage can also be sensed by the Rad17-RFC and 9-1-1 
complexes. Mediator proteins such as MDC1 and 53BP1 communicate the checkpoint signal to the 
effector kinase Chk2. Verena Oehler, 2007     Chapter 1, 30 
Other types of DNA damage, such as DNA double-strand breaks induced by IR, may lead 
mainly to the activation of ATM in cooperation with mediator proteins such as MDC1 and 
53BP1. Besides, the DNA double-strand breaks may additionally lead to the generation of 
other structures, such as DNA repair intermediates and single stranded DNA which could 
subsequently lead to the activation of ATR (Figure 1.4). 
Figure 1.5 illustrates the structures and proteins involved in sensing and transducing the 
checkpoint signal in response to DNA replication block. Inhibitors of DNA replication, 
such as aphidicolin or hydroxyurea, stall the replication machinery and can generate 
stretches of single-stranded DNA which will mainly result in the activation of ATR in 
association with appropriate mediator proteins, such as TopBP1, Claspin, BRCA1, and 
53BP1.  
Ultimately, in response to either DNA damage or replication arrest, the activation of 
ATM/ATR ensures that the specific checkpoint signal is transduced to the two major 
checkpoint effector kinases: Chk1 and/or Chk2.  
1.4.2 Checkpoint kinases Chk1 and Chk2  
The two checkpoint kinases Chk1 and Chk2 are serine/threonine protein kinases and were 
initially identified in yeast as has been described above. Whereas fission yeast Chk1 is 
mainly activated in response to DNA damage, Cds1 becomes mainly activated in response 
to DNA replication arrest (Murakami and Okayama, 1995; Walworth et al., 1993) . In 
contrast to fission yeast however, the vertebrate homologue of Cds1 is called Chk2 and 
becomes mainly activated in response to DNA damage (Chaturvedi et al., 1999), whereas 
Chk1 can be active even during an unperturbed cell cycle and is further activated in 
response to both DNA damage and replication arrest in vertebrate cells (Jiang et al., 2003; 
Sanchez et al., 1997). The main function of Chk1 and Chk2 is to transduce the checkpoint 
signal from their upstream kinases ATM and ATR to downstream targets of the checkpoint 
signalling cascade. Originally, it was thought that Chk1 does exclusively depend on ATR, 
and Chk2 on ATM, but there appears to be some cross talk between the two pathways as 
will be addressed where appropriate in the following sections.  Verena Oehler, 2007     Chapter 1, 31 
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Figure 1.5: Sensing and transducing the checkpoint signal from DNA lesions induced by 
DNA replication arrest 
DNA replication inhibitors such as aphidicolin or hydroxyurea which block DNA polymerase or 
deplete nucleotide pools generate single-stranded DNA structures. RPA-coated single-stranded 
DNA may result in the recruitment of the ATR-ATRIP complex. Other sensor proteins are Rad17-
RFC and 9-1-1. Mediator proteins such as TopBP1, Claspin, BRCA1, and 53BP1 communicate the 
checkpoint signal to the effector kinase Chk1 and may also have roles in the sensing and effector 
steps. 53BP1 and BRCA1 also have roles in double-strand break repair.  
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1.4.2.1  Chk1 and Chk2 knock-out models  
In mammals, Chk1 function is essential for embryonic development as Chk1 knock-out 
mice die before embryonic day 7. Chk1-deficient blastocysts and embryonic stem cells 
show severe proliferation defects and impaired cell cycle checkpoint responses. These cells 
fail to arrest in response to DNA damage and replication block, demonstrating the essential 
function of Chk1 in cell cycle checkpoint control (Liu et al., 2000; Takai et al., 2000).  
Interestingly however, Chk1-deficient tumour cells can be viable, as was shown with the 
generation of a somatic avian B-lymphoma DT40 cell line deficient for Chk1 (Zachos et 
al., 2003). These knock-out cells demonstrated that Chk1 has essential functions during 
many cell cycle checkpoint responses as the Chk1-/- cells exhibit an impaired G2/M arrest 
and are hypersensitive to killing by IR. Furthermore, Chk1 function is required for 
replication checkpoint responses, such as the replication recovery functions including the 
stabilisation of stalled replication forks and the suppression of futile origin firing (Zachos 
et al., 2005). Only recently it has been shown that Chk1 is also involved in the spindle 
checkpoint functions (Zachos et al., 2007). 
In humans, very few Chk1 mutations have been associated with cancer so far, examples are 
frame-shift mutations in sporadic and hereditary colorectal cancers and sporadic stomach 
tumours (Bertoni et al., 1999; Menoyo et al., 2001). Furthermore, a study using conditional 
Chk1-heterozygous mice has demonstrated that Chk1 is haploinsufficient for many 
functions that are critical for tumour suppression (Lam et al., 2004). 
In contrast to Chk1, Chk2 function is not essential for embryonic development as Chk2 
knock-out mice are viable, fertile and only display minor defects in cell cycle checkpoint 
control (Hirao et al., 2000; Takai et al., 2002). There is evidence from these studies that 
Chk2 plays a role in p53-mediated apoptosis. Furthermore, Chk2 has been identified as a 
putative tumour suppressor; a specific deletion mutation (CHEK2 1100delC) has been 
associated with an increased risk for breast cancer (Meijers-Heijboer et al., 2003). In 
addition to that, Chk2 mutations have been found in a particular subset of the multi-cancer 
phenotype Li Fraumeni-syndrome (Lee et al., 2001b). 
As for Chk1, the avian B-lymphoma DT40 cell line has also been used to generate a Chk2-
deficient cell line (Rainey et al., 2007). The Chk2-/- cells are perhaps not surprisingly 
viable and display only subtle cell cycle checkpoint impairments. Importantly, it was 
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treatment. Furthermore, it was shown that in the DT40 cells, Chk2 is activated in response 
to DNA damage but not replication arrest (Rainey, 2003; Rainey et al., 2007).  
Viable knock-out models for the simultaneous deletion of both Chk1 and Chk2 do not yet 
exist. However, the generation of Chk1/Chk2 double knock-out thymocytes has been 
reported recently (Zaugg et al., 2007). In this specific study it was shown that Chk1 is 
essential for the T-lineage development and that the cross-talk between Chk1 and Chk2 is 
involved in the regulation of normal thymocyte development. Also, under some 
circumstances, Chk2 appeared to be at least partially able to compensate for the loss of 
Chk1 in these cells (Zaugg et al., 2007). These Chk1/Chk2 double knock-out thymocytes 
have not yet been analysed with respect to their response to genotoxic stress, such as DNA 
damage or replication arrest.   
1.4.3 Targets of cell cycle checkpoint signalling  
The effector kinases Chk1 and Chk2 can phosphorylate several known downstream targets, 
yet many more potential targets still remain to be identified. Overall, a number of cell 
cycle checkpoints are responsible for the establishment of cell cycle delay and thus target 
regulators of the cell cycle transitions, the cyclin dependent kinases. Some of the key 
targets for the negative regulation of Cdks are members of the Cdc25 phosphatase family, 
which consists of Cdc25A, Cdc25B, and Cdc25C in vertebrate cells. All of these 
phosphatases are involved in the regulation of Cdks at various stages of the cell cycle. 
Cdc25A can de-phosphorylate and activate Cdk2 in complex with cyclinE or cyclinA and 
the Cdk1 (Cdc2)-cyclinB complex, whereas Cdc25B and Cdc25C mainly act on Cdc2-
cyclinB and thus control mitotic entry. Both Chk1 and Chk2 are able to phosphorylate 
Cdc25,  and thereby inhibit the Cdc25 phosphatase activity through various mechanisms, 
which ultimately lead to the inhibition of the relevant Cdk and thus cell cycle arrest 
(Chaturvedi et al., 1999; Peng et al., 1997; Sanchez et al., 1997). 
Another major downstream target of cell cycle checkpoint activation is the tumour 
suppressor p53, which has been shown to accumulate in response to DNA damage and can 
subsequently induce cell cycle arrest, for example at the G1/S transition by activation of 
the Cdk inhibitor p21 (Agarwal et al., 1995). Furthermore, p53 can induce apoptosis by up-
regulating the expression of apoptosis-promoting genes, such as Bax, Puma or Fas (Haupt 
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The tumour suppressor p53 is mutated or lost in a high percentage of human cancers. The 
avian B-lymphoma DT40 cell lines and the human colon carcinoma BE cells that have 
been used in the experimental section of this project are both cancer cell lines. As many 
transformed cell lines, the DT40 cells do not express p53 (Takao et al., 1999) and the BE 
cells appear to express a non-functional mutated version of p53. Therefore, these cells are 
not susceptible to any p53-mediated checkpoint responses but they are suitable for the 
investigation of mitotic checkpoint responses in a p53-deficient background.    
1.5  Mitotic checkpoint signalling pathways 
This study focuses on mitotic checkpoint pathways in response to either DNA damage or 
DNA replication block in vertebrate cells. The following section will discuss how these 
checkpoint signalling cascades are thought to function according to current knowledge.   
1.5.1 The G2/M checkpoint in response to DNA damage  
The G2/M arrest ensures that cells with damaged DNA do not enter mitosis and undergo 
cell division. For example, IR-induced DNA double-strand breaks or UV-induced bulky 
DNA adducts and resulting single-stranded stretches of DNA can be detected by various 
sensors and adaptor proteins, such as Rad17-RFC, 9-1-1, ATR and ATRIP, MDC1, 
BRCA1, TopBP1, Claspin and 53BP1 as described in Figure 1.4. and 1.5. The cooperative 
action of these proteins consequently leads to the activation of the transducer kinases ATM 
and ATR.   
In response to DNA double-strand breaks, ATM becomes activated as it undergoes an 
intra-molecular auto-phosphorylation on S1981 which converts the dimeric ATM protein 
into active monomers (Bakkenist and Kastan, 2003). In addition, ATR can be activated in 
response to DNA damage and it is thought that the resection of the double-strand break is 
required. In this way generated single-stranded stretches of DNA may then be coated by 
RPA and signal to recruit the ATR-ATRIP complex (Zou and Elledge, 2003).  
More recently, several studies have discussed the relatively new role for ATR in the DNA 
damage response to double-strand breaks as previously mainly ATM has been implicated 
in this type of response. It has been shown that ATR activation in response to DNA 
double-strand breaks requires both ATM and the nuclease activity of the MRE11 protein 
(Jazayeri et al., 2006; Myers and Cortez, 2006).  Verena Oehler, 2007     Chapter 1, 35 
The major downstream target of ATM is thought to be Chk2, whereas ATR mainly targets 
Chk1 for phosphorylation (Matsuoka et al., 2000; Zhao and Piwnica-Worms, 2001). 
However, as with ATM and ATR activation in response to DNA damage, also at the level 
of their downstream targets appears to be some cross-talk between the ATM-Chk2 and 
ATR-Chk1 signalling pathways. For example, the phosphorylation of Chk1 in response to 
IR-induced DNA damage appears to be dependent on ATM and NBS1 (Gatei et al., 2003). 
Furthermore, a recent study has suggested that ATR can phosphorylate Chk2 in response to 
DNA damage, at least in the absence of ATM (Wang et al., 2006). 
In either case, activated ATM/ATR can subsequently phosphorylate the effector kinases 
Chk1 and Chk2. Two C-terminal serine residues, S317 and S345 of Chk1, were identified 
as the major ATR phosphorylation sites, although other putative sites have also been 
suggested (Zhao and Piwnica-Worms, 2001). The identification of an auto-inhibitory 
domain has led to the proposal that Chk1 activation is associated with conformational 
changes promoted at least partly by ATR-phosphorylation that disrupt an interaction 
between the kinase domain and the auto-inhibitory domain of Chk1 (Katsuragi and Sagata, 
2004). In general, the phosphorylation of Chk1 on the two serine residues (S317 and S345) 
can be used as an indicator of Chk1 activation (Zhao and Piwnica-Worms, 2001). 
The major phosphorylation site on Chk2 is a threonine residue, T68, which is 
phosphorylated by ATM in response to IR and required for the activation of Chk2 (Ahn et 
al., 2000). The multi-step activation process of Chk2 involves the initial phosphorylation 
on T68, which can then bind in trans to the FHA (fork-head associated) domain of another 
Chk2 molecule (Ahn et al., 2002). This step is thought to promote the oligomerisation of 
Chk2 which in turn enhances kinases activity (Xu et al., 2002b). Recent analyses of the 
crystal structure of Chk2 led to the proposal that once two Chk2 kinases are dimerized, an 
activation segment exchange can occur between the two adjacent kinase domains and 
promote the trans-autophosphorylation of two threonine residues (T383 and T387) in the 
catalytic domain in the T-loop region (Oliver et al., 2006). 
Activated Chk1 and/or Chk2 can then relay the checkpoint signal to their downstream 
targets. For the G2/M checkpoint the ultimate target is the cyclin dependent kinase Cdc2.  
1.5.1.1  Regulation of Cdc2 throughout the cell cycle 
The kinase activity of Cdc2 is regulated through various changes in the phosphorylation 
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cycle. Cdc2 is able to bind to cyclins A and B and in particular the gradual accumulation of 
the latter and its association with Cdc2 are important for the mitotic kinase activity 
(Solomon et al., 1990). It has been proposed that cyclin binding is required for stabilising 
the catalytic subunit and also induces changes in the conformation which then allows 
threonine 161 (T161) to be phosphorylated (Draetta, 1993). This activatory T161 
phosphorylation is absolutely required for Cdc2 kinase activity and is thought to be 
catalysed by the CAK (Cdc2-activating kinase) complex. There is some speculation about 
the actual nature of this CAK kinase(s), but in general it is believed that CAK is a trimer 
containing cdk7, cyclinH, and Mat1 which are all subunits of the transcription factor IIH 
(Kaldis and Solomon, 2000). 
During interphase, the Cdc2 kinase is kept inactive through the inhibitory phosphorylation 
on two specific residues, T14 and Y15. There are two kinases that catalyse this inhibitory 
phosphorylation in vertebrate cells: Wee1, which specifically phosphorylates Y15, and 
Myt1, which is a dual-specificity kinase and has been shown to phosphorylate both T14 
and Y15 (McGowan and Russell, 1993; Mueller et al., 1995). Active Cdc2 is generated by 
the reversal of the inhibitory phosphorylation by the phosphatase activity of Cdc25(C) 
(Gautier et al., 1991).  
The polo-like kinase Plk1 appears to be involved in the regulation of several components 
of the mitosis promoting complex. It has been implicated in both the activation of Cdc25C 
and the targeting of cyclinB to the nucleus by phosphorylation. Moreover, Myt1 has been 
identified as a substrate for Plk1 during mitosis (Nakajima et al., 2003; Toyoshima-
Morimoto et al., 2002; Toyoshima-Morimoto et al., 2001).  
For illustration purpose, Figure 1.6 shows the generally accepted model for Cdc2/cyclinB 
regulation throughout the cell cycle. Cdc2 can complex with cyclinB, subsequently 
undergo phosphorylation on T14, Y15, and T161. The phosphatase activity of Cdc25C 
leads to the removal of the inhibitory phosphorylation on Cdc2 and in concert with the 
mitosis-promoting functions of Plk1 the Cdc2/cyclinB becomes abruptly activated at the 
G2/M transition (Figure 1.6). 
The major B-type cyclin in the vast majority of vertebrate cells is cyclinB1; however in 
chicken cells the major B-type cyclin is cyclinB2 which in general fulfils the same 
functions as cyclinB1 (Gallant and Nigg, 1992). Although both vertebrate cyclins are 
regulated at the level of sub-cellular localisation, there are some differences in respect to 
their phosphorylation status which will be addressed in the results section of this thesis. Verena Oehler, 2007     Chapter 1, 37 
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Figure 1.6: Model for Cdc2 regulation in vertebrate cells 
In G1 phase, Cdc2 exists as an inactive monomer. Upon cyclinB binding during S-phase, 
vertebrate Cdc2 gets phosphorylated on T14, Y15, and T161 by Wee1, Myt1, and CAK. The 
Cdc2/cyclinB complex is kept inactive through the inhibitory phosphorylation on residues T14 and 
Y15 until the end of G2 phase. De-phosphorylation of T14 and Y15 by the Cdc25C phosphatase 
activates the complex and mitosis can be initiated. Complete Cdc2/cyclinB activation possibly 
involves Plk1-mediated phosphorylation of cyclinB. Verena Oehler, 2007     Chapter 1, 38 
In general, it is thought that the activation of Cdc2 occurs very abruptly with a peak in the 
Cdc2 kinase activity at the G2/M transition resulting in the onset of mitosis. Originally, it 
was believed that the individual vertebrate Cdks are indispensable, for example Cdc2 has 
always been assigned the role of the mitotic Cdk, whereas for example Cdk2 was thought 
to be the major Cdk responsible for the G1/S transition and S-phase. Recently however, the 
strictness of these assignments has been questioned.  
The generation of Cdk2 knock-out mice revealed that Cdk2 is not an essential gene as 
these animals, although infertile, were found to be viable (Berthet et al., 2003; Ortega et 
al., 2003). Interestingly, it was proposed that in the absence of Cdk2, Cdc2 might be able 
to substitute for loss of Cdk2 (Aleem et al., 2005). This study suggested that Cdc2 could  
complex with cyclinE to perform the G1/S transition and S phase functions and further on 
in the cell cycle complex with cyclinB to perform the usual mitotic Cdc2 functions (Aleem 
et al., 2005). Importantly, the recent generation of Cdk2-deficient avian DT40 cells 
supported these ideas and furthermore demonstrated that Cdc2 is indeed essential for the 
initiation of replication as well as mitotic events in these Cdk2 knock-out cells (Hochegger 
et al., 2007). This study made use of Cdk2 knock-out cells and an analog-sensitive mutant 
of Cdc2 and the results led to the proposal that the functions of these two Cdks can 
completely overlap during S phase control. Interestingly, the results from this particular 
study also indicate that the presence of active Cdc2 is possible early on in the cell cycle, 
independently of mitotic events. 
1.5.1.2  Mitosis and cytokinesis  
During a normal unperturbed cell cycle and in the absence of any lesions that may result in 
checkpoint activation, cells are able to undergo the process of cell division which starts 
with the segregation of sister chromatids (mitosis) and ends with the division of the 
cytoplasm and organelles onto the two daughter cells (cytokinesis). 
It has been well established that the process of cell division can be grouped into several 
distinct phases, beginning with prophase, in which the chromatin visibly condenses and the 
two centrosomes start to nucleate microtubules. In prometaphase, the nuclear envelope 
breaks down and microtubules can attach to kinetochores at the centrosome. The next 
stage, metaphase, is the alignment of the chromosomes at the metaphase plate. During the 
subsequent stages of anaphase, the two sister chromatids are pulled apart towards opposite 
poles of the cell and the poles themselves further separate. During the next phase, 
telophase, the two new nuclear envelopes form and chromatin de-condensation begins.  Verena Oehler, 2007     Chapter 1, 39 
Around the same time, cytokinesis starts which eventually completes the process of cell 
division (Nigg, 2001).     
Cdc2 is thought to be involved in many aspects of the cell division process, including 
centrosome assembly, mitotic spindle assembly, and nuclear envelope breakdown. Apart 
from Cdc2, other important mitotic kinases include Plk1 and members of the Aurora kinase 
family, for example Aurora A, B and C (Nigg, 2001). 
1.5.1.3  Mitotic delay mechanisms induced by Chk1/Chk2 
In general, the onset of mitosis is blocked or delayed in the presence of any DNA lesions 
that lead to the activation of checkpoint responses, such as the G2/M checkpoint in 
response to DNA damage. The effector kinases Chk1 and Chk2 can both phosphorylate 
Cdc25 and in this way negatively regulate the kinase activity of Cdc2. The N-terminal 
phosphorylation of serine 216 (S216) on Cdc25C by Chk1 and Chk2 creates a binding site 
for 14-3-3 proteins (Chaturvedi et al., 1999; Peng et al., 1997; Sanchez et al., 1997). This 
interaction results in the nuclear export and subsequent degradation of Cdc25C. In 
addition, the N-terminal phosphorylation of Cdc25C can also directly inhibit the 
phosphatase activity (Blasina et al., 1999). Chk1 has also been shown to phosphorylate 
several Cdc25 family members on specific C-terminal sites, which as a result inhibits the 
interaction of the relevant Cdc25 phosphatase with its respective Cdk/cyclin substrates 
(Uto et al., 2004). As a consequence of these inhibitory mechanisms in response to DNA 
damage, the Cdc25C phosphatase cannot de-phosphorylate Cdc2 on residues T14 and Y15 
and the Cdk is kept in an inactive state and blocks the G2/M transition.  
Apart from preventing Cdc25 phosphatase activity, Chk1 can phosphorylate and thereby 
further activate Wee1 which in turn promotes the inhibitory phosphorylation of Cdc2 
(O'Connell et al., 1997). In addition to that, Chk1-phosphorylation of Wee1 can also 
promote 14-3-3 protein binding and further enhance the inhibitory Wee1 kinase activity 
(Lee et al., 2001a).  
An illustration of the DNA damage-induced mitotic delay mechanisms is shown in Figure 
1.7. In general, it is believed that mitotic delay is always imposed through these two 
conventional delay mechanisms: the inhibition of Cdc25 phosphatase and the promotion of 
Wee1 kinase activity which ensure the maintenance of inhibitory Cdc2 phosphorylation, 
keeping the Cdc2/cyclinB complex inactive and hence preventing the onset of mitosis. Verena Oehler, 2007     Chapter 1, 40 
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Figure 1.7: Model for the establishment of mitotic delay in response to DNA damage 
In response to DNA damage, Chk1 and Chk2 become activated via ATM/ATR. Chk1 can 
subsequently phosphorylate downstream targets Cdc25 and Wee1; Chk2 is able to phosphorylate 
Cdc25. The phosphatase activity of Cdc25 can be inhibited either directly or through association 
with 14-3-3 proteins and nuclear export or by Chk1-mediated C-terminal phosphorylation which 
inhibits Cdc25 binding to substrates. Furthermore, Chk1-mediated Wee1 phosphorylation promotes 
the inhibitory phosphorylation on Cdc2-Y15. Through maintenance of the inhibitory 
phosphorylation, Cdc2 is kept inactive and consequently mitosis is blocked. Verena Oehler, 2007     Chapter 1, 41 
1.5.2 The S/M checkpoint in response to DNA replication arrest  
The S/M checkpoint response ensures that cells do not enter mitosis and divide in the 
presence of incompletely replicated DNA. In marked contrast to fission yeast, immuno-
depletion experiments in Xenopus oocytes demonstrated that Chk1, rather than Cds1/Chk2, 
becomes activated in response to replication blocks (Kumagai et al., 1998). The same is 
true for mouse embryonic cells where Chk1-deficiency leads to premature mitotic entry of 
cells in the presence of replication inhibitors (Takai et al., 2000).  
In an experimental system DNA replication can be blocked with various drugs, for 
example aphidicolin, which inhibits DNA polymerase and stalls the replication process. 
There are several sensor proteins that are involved in the detection of stalled replication 
forks. ATR-ATRIP can bind to single-stranded RPA-coated DNA and ATR can also bind 
to DNA independently of ATRIP. The Rad17-RFC complex can interact with regions of 
DNA that have been primed by the DNA polymerase and subsequently act as a clamp 
loader for the 9-1-1 complex. Furthermore, the adaptor protein Claspin can bind to 
branched structures in the stalled replication fork independently of ATR and Rad17-RFC 
(Sar et al., 2004; Zou and Elledge, 2003).  
The activated transducer kinase ATR consequently phosphorylates and activates the 
effector kinase Chk1, which in turn phosphorylates downstream targets, such as Cdc25C 
and Wee1 in the same manner as described above. Hence, as for the mitotic G2/M delay in 
response to DNA damage, it is believed that the mitotic delay in response to DNA 
replication block is also always imposed through the two above described conventional 
delay mechanisms: the inhibition of Cdc25 phosphatase and the promotion of Wee1 kinase 
activity which ensure the maintenance of inhibitory Cdc2 phosphorylation, thereby 
keeping the Cdc2/cyclinB complex inactive and preventing the onset of mitosis as 
illustrated in the simple model in Figure 1.8. 
Thus, the S/M checkpoint is thought to operate via ATR and Chk1, ultimately targeting 
Cdc2 via maintenance of inhibitory T14/Y15-Cdc2 phosphorylation. However, in the last 
few years there have been a few reports challenging that pathway. For example, a mutant 
version of Cdc2 that cannot be phosphorylated on T14 and Y15 can still respond to the 
aphidicolin-induced replication checkpoint in Xenopus oocytes (Kumagai and Dunphy, 
1995). Furthermore, primary mouse cells with conditionally deleted ATR, and thus 
minimised Chk1 activation, still display a functional S-M checkpoint response when DNA 
replication is blocked (Brown and Baltimore, 2003). This interesting observation led to the  Verena Oehler, 2007     Chapter 1, 42 
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Figure 1.8: Model for the establishment of mitotic delay in response to replication arrest 
In response to DNA replication block, Chk1 become activated via ATR and can subsequently 
phosphorylate downstream targets Cdc25 and Wee1. The phosphatase activity of Cdc25 can be 
inhibited either directly or through association with 14-3-3 proteins and nuclear export or by 
phosphorylation of Cdc25 on the C-terminus which inhibits binding to substrates. Furthermore, 
Chk1-mediated Wee1 phosphorylation promotes the inhibitory phosphorylation on Cdc2-Y15. 
Through maintenance of the inhibitory phosphorylation, Cdc2 is kept inactive and consequently 
mitosis is blocked. Verena Oehler, 2007     Chapter 1, 43 
suggestion of the existence of an ATR-independent replication checkpoint. Another recent 
study has reported that Chk1 activation in response to hydroxyurea treatment in Hela cells 
is mediated by Claspin but independently of ATM/ATR activity as judged by caffeine 
sensitivity. This study also suggested that the block to mitosis was associated with the 
down-regulation of cyclinB (Rodriguez-Bravo et al., 2006). 
1.5.3 Replication Recovery functions 
Apart from the S/M checkpoint, blocks to DNA replication can also lead to the activation 
of another set of checkpoint functions which are often referred to as the replication 
recovery functions. These checkpoint mechanisms ensure that the replication machinery is 
kept in a stable condition so that DNA replication can resume once the respective lesions 
have been resolved. As previously described, Cds1 is the main effector kinase for these 
responses in fission yeast; however in vertebrate cells, Chk1 appears to be responsible for 
most of these recovery functions.  
Initially, studies using a selective Chk1 inhibitor were able to show that Chk1 is required 
for the suppression of late origin firing in response to replication stress (Feijoo et al., 
2001). Furthermore, the generation of the Chk1-deficient DT40 cell line allowed the 
investigation of replication recovery functions on a genetic basis (Zachos et al., 2003). 
Using a dual labelling technique to monitor replication fork progression and origin firing, it 
was shown that in response to replication arrest, a high percentage of the Chk1-deficient 
cells lost the ability to recover from replication arrest, which was furthermore associated 
with the appearance of new sites of replication. Thus, this study demonstrated that Chk1 is 
essential for the replication recovery functions, such as the stabilisation of stalled 
replication forks and the suppression of futile origin firing (Zachos et al., 2003).  
1.5.4 DNA replication and checkpoint control 
To maintain genomic integrity it is important for cells to successfully complete DNA 
synthesis before they undergo mitosis and divide and it seems only logical that at least 
some of the checkpoint-activating proteins might actually be proteins that participate in the 
process of DNA replication. As previously mentioned, several replication proteins, such as 
fission yeast Cdc18 (Cdc6) and Orp1 have been implicated to some extent in Cds1 
activation during replication checkpoint responses (Murakami et al., 2002). Especially 
Cdc6, which is an essential factor for the initiation of DNA synthesis, has emerged as a 
prime candidate to be involved in replication checkpoint signalling.  Verena Oehler, 2007     Chapter 1, 44 
1.5.4.1  DNA replication 
The major function of Cdc6 is in the establishment of the pre-replicative complex. As 
illustrated in the simple model in Figure 1.9, the process of DNA replication is initiated at 
origins of replication which are bound by the origin recognition complex (ORC). The ORC 
subsequently recruits two replication proteins, namely Cdt1 and Cdc6. Together, these 
three proteins (ORC, Cdt1 and Cdc6) enable the loading of the Mcm2-7 (minichromosome 
maintenance) hexamer onto the origin and as a consequence the pre-replicative complex is 
formed (Bell and Dutta, 2002). Once the DNA has been prepared for DNA synthesis in this 
manner, termed ‘licensing’, S phase is thought to be initiated through the action of Cdks, 
mainly Cdk2, as well as the Dbf4-dependent kinase Cdc7, which promote the loading of 
replication components, such as Cdc45, RPA, and DNA polymerase α onto the chromatin 
(Walter and Newport, 2000). The pre-replicative complexes are disassembled after the 
initiation of DNA replication until the passage through the following mitosis. The 
coordinated assembly and disassembly of these complexes is thought to control that the 
process of DNA replication only occurs once per cell cycle (Stillman, 1996). 
The exact fate of Cdc6 after S phase has not been completely clear and there has been 
some degree of discrepancy between some studies. Several studies using epitope-tagged 
versions of Cdc6 observed the translocation of the protein from the nucleus to the 
cytoplasm at the G1/S transition (Petersen et al., 2000; Saha et al., 1998). Overall however, 
it appears that in vertebrate cells, endogenous Cdc6 remains nuclear and chromatin bound 
throughout S phase, whereas exogenous, i.e. ectopically expressed, Cdc6 is able to 
translocate from the nucleus to the cytoplasm in a Cdk2-dependent manner (Alexandrow 
and Hamlin, 2004). The differences in the localisation patterns of endogenous and 
ectopically expressed Cdc6 might be attributed to the use of an epitope tag and also to 
differences in expression levels of the protein. Another study has shown that the Cdc6 
protein appears to be degraded by the anaphase promoting complex (APC) in G1 phase 
(Petersen et al., 2000).  
1.5.4.2  Cdc6 and checkpoint control 
Besides studies in both budding and fission yeast, only a very small number of studies have 
addressed any potential functions for Cdc6 in checkpoint control in vertebrate cells. One 
study showed that the over-expression of human Cdc6 in G2 phase cells resulted in a 
mitotic delay that was associated with Chk1 phosphorylation and could also be abrogated 
by chemical inhibition of Chk1 (Clay-Farrace et al., 2003). Another study showed that the  Verena Oehler, 2007     Chapter 1, 45 
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Figure 1.9: Initiation of DNA replication in vertebrates 
DNA replication is initiated at origins of replication which are bound by the origin recognition 
complex (ORC), which subsequently recruits Cdt1 and Cdc6. Together, ORC, Cdt1 and Cdc6 
enable the loading of the Mcm2-7 hexamer onto the origin and as a consequence the pre-
replicative complex is formed. Once the DNA is licensed, S phase can be initiated through the 
action of Cdk2 and the Dbf4-dependent kinase Cdc7, which promote the loading of replication 
components, such as Cdc45, RPA, and DNA polymerase α onto the chromatin.  
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presence of Cdc6 is required for Chk1 phosphorylation in response to replication block in 
the Xenopus system (Oehlmann et al., 2004). These observations predict a model in which 
Cdc6 would function upstream of Chk1 in the replication checkpoint response. 
However, as explained in an earlier section, there is also some indication that Cdc6 might 
be able to directly interact with Cdc2. At least in yeast, several studies have shown that 
Cdks can bind to Cdc6/Cdc18 in a cyclin-dependent manner, for example the mitotic Cdk 
in both fission and budding yeast can interact with an N-terminal domain in Cdc6/Cdc18 
and this process is mediated by the mitotic B-type cyclin subunit (Lopez-Girona et al., 
1998; Mimura et al., 2004). As Chk1 is generally required for the stabilisation of stalled 
replication structures, it could be predicted that in this kind of scenario Cdc6 might 
function downstream of Chk1 in the checkpoint response. Thus, there appears to be 
potential for the Cdc6 protein to function either upstream or downstream of Chk1 in 
replication checkpoint control. 
1.5.4.3  Regulation of DNA synthesis and mitosis 
Overall, the regulation of DNA replication and mitosis has been most extensively studied 
in yeast. However, some of the earliest studies addressing the regulation of these processes 
were classic cell fusion experiments performed with Hela cells (Rao and Johnson, 1970). 
As an example, the fusion of the nuclei from a G1 and an S phase cell showed that S phase 
nuclei appear to contain certain inducers of DNA synthesis, termed S phase promoting 
factors (SPF), that can transmit and rapidly initiate S phase in the G1 nucleus. Interestingly 
however, these experiments also revealed that when the nucleus from an S phase cell was 
fused with the nucleus of a G2 phase cell, the progression of the resulting heterokaryon 
into mitosis was dependent on the completion of DNA synthesis in the S phase nucleus 
(Rao and Johnson, 1970). Thus, the presence of certain S phase components was able to 
delay the onset of mitosis in the G2 nucleus until DNA synthesis in the S phase nucleus 
was complete. Under these conditions, any checkpoint kinases should have hardly been 
activated and thus, it seems likely that these observations indicate the functioning of an 
intrinsic link between DNA replication and mitosis. Alternatively, a low level of activation 
of checkpoint kinases during normal unperturbed DNA replication might be sufficient to 
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1.6  Checkpoint signalling and cancer therapy 
In general, cell cycle checkpoint mechanisms aim to ensure the integrity of the genome and 
promote the survival of the whole organism (Nyberg et al., 2002). Tumour cells very often 
display mutations in components of the checkpoint signalling machinery. One of the major 
approaches of cancer therapy is chemotherapy which involves the treatment with cytotoxic 
drugs in order to kill tumour cells. Another approach is radiotherapy which aims to 
sensitize cells to killing by radiation. As these types of therapy might often target both 
normal and tumour cells, it is of interest to improve these treatments by ensuring greater 
selectivity towards the tumour cells. By studying the molecular details of cell cycle 
checkpoint control in both normal and tumour cells, exploration of the basic aspects of 
these mechanisms should enable the development of more effective and targeted cancer 
therapies (Hartwell and Kastan, 1994; Zhou and Bartek, 2004).  
1.7  Project aims 
Chk1 and Chk2 participate in various cell cycle checkpoints, their roles have been shown 
to vary between different organisms. The initial aim of this project was to determine the 
specific requirement of Chk1 and Chk2 for mitotic checkpoint responses in vertebrate 
cells. The main focus was directed towards two checkpoints in response to two distinct 
types of genotoxic stress that both delay the onset of mitosis: the G2/M checkpoint in 
response to DNA damage and the S/M checkpoint in response to DNA replication block.  
Two different vertebrate cell lines were deployed for this purpose: avian B-lymphoma 
DT40 cells, where wild-type and Chk1 and Chk2 knock-out cell lines are available, and 
human colon carcinoma BE cell line in which Chk1 and Chk2 function can be abrogated 
by siRNA or using a selective Chk1 inhibitor. The generation of the Chk1-and Chk2-
deficient DT40 cells has been described previously (Rainey et al., 2007; Zachos et al., 
2003). The avian DT40 and human BE cell lines were used for detailed kinetic analysis of 
the two mitotic checkpoint mechanisms. In addition, it was of interest to investigate the 
mechanisms of mitotic delay by biochemical analyses with particular interest in the 
regulation of the mitotic cyclin dependent kinase Cdc2 and the mitotic B-type cyclin. 
A recent study by Zachos et al. suggested that Chk1 functions indirectly in the S/M 
checkpoint by maintaining any stalled but viable replication structures (Zachos et al., 
2005). Chk1-deficient DT40 cells were able to initially delay mitosis in response to Verena Oehler, 2007     Chapter 1, 48 
replication block but eventually entered mitosis with un-replicated DNA, suggesting a 
defect in the maintenance of the delay. As these cells still expressed functional Chk2, the 
question was raised of whether the initial mitotic delay in response to replication block 
could be executed by Chk2. Interestingly, when Chk2-deficient DT40 cells were treated 
with a selective Chk1-inhibitor, they still retained an initial mitotic delay after DNA 
replication block, however whether the kinetics of checkpoint failure were altered was not 
resolved. Building on these observations, it was of interest to attempt to generate a DT40 
Chk1/Chk2 double-knock-out cell line in order to study checkpoint function in the absence 
of both kinases. These initial observations also raised the possibility of the existence of 
intrinsic control mechanisms that might operate independently of Chk1 and Chk2 function, 
a notion that could benefit from further investigation.  
Furthermore, it was of interest to determine how cells deficient for Chk1 can execute 
normal cell cycle progression as well as checkpoint responses, such as the initial S/M delay 
after DNA replication arrest. The previous study by Zachos et al. indicated that the 
premature mitotic entry of Chk1-deficient cells appeared to be associated with the loss of 
all viable replication structures. This hypothesis was derived from the observation that the 
loss of the surrogate marker PCNA (proliferating cell nuclear antigen) appeared to precede 
the onset of premature mitosis (Zachos et al., 2005). However, this study did not document 
the exact timing of the loss of viable replication structures and the onset of premature 
mitosis in individual cells, an issue which was aimed to be addressed here in order to gain 
insight into the mitotic delay mechanism.  
In addition to that, it was of interest to further test the hypothesis of whether the replication 
protein Cdc6 functions in replication checkpoint control in vertebrate cells. Moreover, if 
this was the case, the two vertebrate systems could potentially be employed to identify the 
exact pathway in which Cdc6 functions. For example, the issue of whether Cdc6 might 
operate upstream or downstream of Chk1 could be resolved using the Chk1-proficient in 
combination with the Chk1-deficient cell systems available.49 
2  Materials and Methods 
2.1  Materials 
2.1.1 Chemicals and reagents 
Unless specified otherwise, chemicals and reagents were purchased in the highest available 
quality from Fisher Scientific UK, GE Healthcare, Invitrogen Ltd, Severn Biotech Ltd, and 
Sigma-Aldrich. 
2.1.2 Enzymes and kits 
Amaxa: Cell line nucleofector kit T 
Applied Biosystems: GeneAmp RNA PCR Core Kit, GeneAmp PCR Core Reagents 
GE Healthcare: ECL Western Blotting Detection Reagents, Rediprime II DNA labelling 
system 
Invitrogen Ltd: Restriction enzymes and reaction buffers 
New England Biolabs Ltd: Restriction enzymes and reaction buffers 
Promega: Shrimp Alkaline Phosphatase  
QIAGEN: QIAprep Spin Mini-Prep Kit, QIAGEN Plasmid Maxi Kit, QIAquick PCR 
purification Kit, QIAquick Gel Extraction Kit 
Roche: Rapid DNA Ligation Kit 
Stratagene: Herculase Enhanced DNA polymerase and 10x reaction buffer  
2.1.3 Bacteriology 
Beatson Institute Central Services: LB broth culture medium, LB plates with 100 g/ml 
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Invitrogen: E.coli DH5α competent cells, SOC medium 
Sigma-Aldrich: Ampicillin, Kanamycin 
2.1.4 Cell culture  
Beatson Institute Central Services: sterile distilled water, sterile PBS (Phosphate 
Buffered Saline), sterile PE (Phosphate Buffered Saline/EDTA) 
Beckman Coulter: JE-5.0 Elutriation System and Avanti J-20XP centrifuge with 
Masterflex L/S easy-load II pump system 
Autogen Bioclear: Blasticidin S, Foetal Bovine Serum, Zeocin 
Invitrogen: DMEM (Dulbecco’s Modified Eagle’s Medium), 200mM L-Glutamine 
(100x), Lipofectamine 2000 Reagent, Oligofectamine Reagent, OptiMEM 1 (Reduced 
Serum Medium), 2.5% Trypsin (10x) 
Fisher Scientific UK: DMSO (Dimethyl sulfoxide), HCl (Hydrochloric acid) 
Sigma-Aldrich: Amphotericin B (Fungizone), Aphidicolin, 5-Bromo-2-deoxyuridine 
(BrdU), Caffeine, Chicken Serum, Cycloheximide, 10x DMEM, MG132, Nocodazole, 
Penicillin G, Poly-L-Lysine, Puromycin, Roscovitine, Sodium bicarbonate solution 7.5%, 
Sodium pyruvate 100mM,  Streptomycin Sulphate 
Merck: Allsterpaullone, Purvalanol A, Wortmannin 
NCI (Bethesda, MD, USA): UCN-01 (7-hydroxy-staurosporine) 
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2.1.5 Antibodies  
Table 1: Primary and secondary antibodies 
Antibody  Host species  Company  Dilution 
Duration 
Monoclonal Anti-Actin, clone AC-40  
A4700 
mouse 
monoclonal 
Sigma-Aldrich  1:1000 
1h 
Bromodeoxyuridine, Bu20a  mouse 
monoclonal 
Dako Ltd. 
 
1:40 
1h 
Cdc2 p34 (17): sc-54  mouse 
monoclonal 
Santa Cruz 
Biotechnology, Inc. 
1:1000 
1h 
p-Cdc2 p34 (Thr14/Tyr15): sc-12340  rabbit 
polyclonal 
Santa Cruz 
Biotechnology, Inc. 
1:1000 
overnight 
p-Cdc2 (Tyr 15): sc-7989  rabbit 
polyclonal 
Santa Cruz 
Biotechnology, Inc. 
1:1000 
overnight 
Phospho-cdc2 (Thr161) antibody  
#9114 
rabbit 
polyclonal 
Cell Signaling 
Technology 
1:1000 
overnight 
CDC47/MCM7 Ab-2 (clone 
47DC141) 
mouse 
monoclonal 
NeoMarkers  1:1000 
1h 
Cdc6 (H-304): sc-8341  rabbit 
polyclonal 
Santa Cruz 
Biotechnology, Inc. 
1:1000 
overnight 
Chk1 (G-4): sc-8404  mouse 
monoclonal 
Santa Cruz 
Biotechnology, Inc. 
1:1000 
1h 
Phospho-Chk1 (S317) antibody #2344  rabbit 
polyclonal 
Cell Signaling 
Technology 
1:1000 
overnight 
Phospho-Chk1 (Ser345) antibody 
#2341 
rabbit 
polyclonal 
Cell Signaling 
Technology 
1:1000 
overnight 
Anti-CHK2, clone 7, Catalog #05-649  mouse 
monoclonal 
Chemicon  1:1000 
overnight 
Cyclin B2, raised against C-terminal 
peptide from chicken 
(CSQLNSKTIKDLAASLL) 
rabbit 
polyclonal 
In house: Cancer 
Research UK 
1:1000 
1h 
Anti-phospho-Histone H3 (Ser10), 
Mitosis Marker, Catalog # 06-570 
rabbit 
polyclonal 
Chemicon  1:33 
3h 
PCNA (PC10): sc-56  mouse 
monoclonal 
Santa Cruz 
Biotechnology, Inc. 
1:1000 
1h 
HRP-Linked anti Mouse antibody IgG    New England 
Biolabs 
1:5000  
1h 
HRP-Linked anti Rabbit antibody IgG    New England 
Biolabs 
1:5000  
1h 
Goat Anti-mouse FITC  goat  Stratech Scientific 
LTD 
1:100 
1h 
Goat Anti-rabbit FITC  goat  Stratech Scientific 
LTD 
1:100 
1h 
Goat Anti-mouse TRITC  goat  Stratech Scientific 
LTD 
1:100 
1h 
Goat Anti-rabbit Phycoerythrin  goat  Stratech Scientific 
LTD 
1:100 
1h 
Goat Anti-rabbit TRITC  goat  Stratech Scientific 
LTD 
1:100 
1h 
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2.1.6 Immunofluorescence 
Fisher Scientific UK: Acetone, Methanol 
Science Services Ltd: Paraformaldehyde solution 16% 
Sigma-Aldrich: Poly-L-Lysine, Propidium Iodide (PI) 
Vector Laboratories, Inc.: Vectashield mounting medium, Vectashield with DAPI (4',6-
diamidino-2-phenylindole) 
2.1.7 Plasmids, Primers, Probes 
Plasmids 
pcDNA 3.1Zeo RFP-PCNA based on pcDNA 3.1Zeo from Invitrogen   
pEGFP-C1 RFP-PCNA obtained from CG Morrison, based on pEGFP-C1 from BD 
Biosciences Clontech 
Chk2 gene targeting construct adapted from pBS-LA/Puro/RA2 designed by M. Rainey 
(Rainey, 2003): LA-left arm was based on PCR product amplified from chicken genomic 
DNA with primers LAa and LAb, the RA-right arm was based on the product obtained 
from a restriction digest with BamH1 and KpnI of a PCR product amplified from chicken 
genomic DNA with primers RAc and RAd. The selectable marker cassette Puro was 
replaced by BSR from a ploxBSR vector obtained from JM Buerstedde (Arakawa et al., 
2001). Targeting construct backbone pBluescript SK(II) was obtained from Stratagene. 
More detailed description of the generation of the original targeting vectors can be found in 
the thesis of M. Rainey (Rainey, 2003) and general chicken genome sequence information 
can be obtained from http://www.ensembl.org/Gallus_gallus. Verena Oehler, 2007     Chapter 2, 53 
Primers 
A  Forward  5’-ATG TCT CGA GAG ACG AGG AGC-3’ 
C  Reverse  5’-ACC AGT ACT CAT CAT TCA CAC-3’  
Bsr1  Reverse  5’-GAT CTG GGC TAG CCC TGA TC-3’ 
Bsr2  Forward  5’-CTC ATC AAT GTA TCT TAT CAT GTC-3’ 
F  Forward  5’-GTG GAC TGC TGG AGT TTA GGA-3’ 
H  Forward  5’-CAC TCG TGG AGA ATA CAC ATT-3’  
I  Reverse  5’-AAT GTG TAT TCT CCA CGAGTG-3’  
LA1   Forward  5’-GTG TGC GCG CTG CTC CT-3’   
R  Reverse  5’-GCC AGG GAT GCT CTA AGG CTT CCT C-3’  
RA1  Reverse  5’-GGC TGT ACT TAA TAG ACT CAA T-3’ 
RA2  Reverse  5’-CAT GTT GGA TAC GTG TTT CCA-3’ 
V  Forward  5’-TCG GCG CTC GCC ATG TCT-3’ 
 
LAa  Forward  5’-TTGCGGCCGCAAAGACGAGGAGCGACGCGC-3’ 
LAb  Reverse  5’-CGGGATCCCGAACCAGTACTCATCATTCACAC-3’ 
RAc  Forward  5’-GAAGATCTTCAGCACTTGTAATAAAGTTGCGG-3’ 
RAd  Reverse  5’-GGGGTACCCCAATGTGTATTCTCCACGAGTGA-3’ 
 
Probes 
Probe A used for Southern blotting was generated by M. Rainey as previously described 
(Rainey, 2003). 
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2.1.8 siRNA sequences 
All siRNA SMARTpool reagents were obtained from DHARMACON RNA Technologies. 
Chk1: siGENOME SMART pool reagent (of four duplexes) and individual siRNA, raised 
against Human CHEK1, NM_001274 
Chk2: siGENOME SMART pool reagent (of four duplexes) and individual siRNA, raised 
against Human CHEK2, NM_007194 
Table 2: siRNA duplex sequences 
siRNA  Sequence 
Chk1 siGENOME duplex (6) 
 
Sense sequence: 
G.C.A.A.C.A.G.U.A.U.U.U.C.G.G.U.A.U.A.U.U   
Antisense sequence: 5’-
P.U.A.U.A.C.C.G.A.A.A.U.A.C.U.G.U.U.G.C.U.U  
Chk1 siGENOME duplex (7) 
 
Sense sequence: 
G.G.A.C.U.U.C.U.C.U.C.C.A.G.U.A.A.A.C.U.U 
Antisense sequence: 5’-
P.G.U.U.U.A.C.U.G.G.A.G.A.G.A.A.G.U.C.C.U.U 
Chk1 siGENOME duplex (8)  Sense sequence: 
A.A.A.G.A.U.A.G.A.U.G.G.U.A.C.A.A.C.A.U.U 
Antisense sequence: 5’-
P.U.G.U.U.G.U.A.C.C.A.U.C.U.A.U.C.U.U.U.U.U 
Chk1 siGENOME duplex (9)  Sense sequence: 
C.C.A.C.A.U.G.U.C.C.U.G.A.U.C.A.U.A.U.U.U 
Antisense sequence: 5’-
P.A.U.A.U.G.A.U.C.A.G.G.A.C.A.U.G.U.G.G.U.U 
Chk2 siGENOME duplex (5)  Sense sequence: 
G.A.A.A.U.U.G.C.A.C.U.G.U.C.A.C.U.A.A.U.U 
Antisense sequence: 5’-
P.U.U.A.G.U.G.A.C.A.G.U.G.C.A.A.U.U.U.C.U.U 
Chk2 siGENOME duplex (13)  Sense sequence: 
C.U.C.A.G.G.A.A.C.U.C.U.A.U.U.C.U.A.U.U.U 
Antisense sequence: 5’-
P.A.U.A.G.A.A.U.A.G.A.G.U.U.C.C.U.G.A.G.U.U 
Chk2 siGENOME duplex (14)  Sense sequence: 
A.A.A.C.G.C.C.G.U.C.C.U.U.U.G.A.A.U.A.U.U 
Antisense sequence: 5’-
P.U.A.U.U.C.A.A.A.G.G.A.C.G.G.C.G.U.U.U.U.U 
Chk2 siGENOME duplex (15) 
 
Sense sequence: 
G.C.U.A.A.A.U.C.A.U.C.C.U.U.G.C.A.U.C.U.U 
Antisense sequence: 5’-
P.G.A.U.G.C.A.A.G.G.A.U.G.A.U.U.U.A.G.C.U.U 
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2.1.9 Miscellaneous 
BioRad: Bio-Spin 30 Chromatography Columns 
Fuji Photo Film: Super RX Medical X-ray film 
GE Healthcare: Redivue (γ-
32P)-ATP, Redivue (α-
32P)-dCTP, Full-Range Rainbow 
Molecular Weight Marker, Hybond N
+ Nylon membrane  
Invitrogen: 100bp DNA Ladder, 1kb DNA Ladder, λ DNA Hind III fragments 
React Scientific: GE Nitrocellulose Supported Transfer Membrane (0.45 micron) 
Sigma-Aldrich: Protein A-Sepharose 4B 
Whatman International Ltd.: Whatman 3mm filter paper Verena Oehler, 2007     Chapter 2, 56 
2.2  Methods 
2.2.1 Bacteriology 
Transformation of DNA into bacterial hosts 
E. coli DH5α competent cells were thawed on ice and a 50 l aliquot was mixed with 2 l 
of DNA solution (of varying concentrations) in a pre-chilled polypropylene tube. After 
incubation on ice for 45min, cells were subjected to heat-shock at 42
oC for 45s and then 
chilled on ice for 2 min before 180 l of SOC medium was added and the tube incubated 
for a further hour at 37
oC while shaking. The transformation mixture was spread onto LB-
agar plates containing the appropriate antibiotic and incubated overnight at 37
oC. 
Bacterial culture 
Single bacterial colonies were picked from LB-agar plates and inoculated into 5ml of LB-
medium containing the appropriate antibiotic The culture was grown overnight at 37
oC 
while shaking. For long-term storage, 500 l of bacterial culture were mixed with 500 l of 
sterile glycerol in a cyrotube and stored at -70
oC. 
Small-scale plasmid DNA preparation 
1.5ml of bacterial overnight culture was pelleted by centrifugation at 5000rpm for 5min in 
a micro-centrifuge. The pellet was resuspended and processed using the QIAprep Spin 
Mini-Prep Kit according to the manufacturer’s instructions. The eluted DNA was stored at 
-20
oC. 
Large-scale plasmid DNA preparation 
100ml of bacterial overnight culture was pelleted by centrifugation at 6000rpm for 15min 
at 4
oC in a Sorvall RC3C DuPont centrifuge. The pellet was resuspended and processed 
using the QIAGEN Plasmid Maxi Kit according to the manufacturer’s instructions. The 
concentration and purity of the eluted DNA was determined using an Eppendorf 
biophotometer. The DNA was stored at -20
oC. 
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2.2.2 DNA protocols 
Isolation of genomic DNA from cell cultures 
Phenol extraction was used to isolate genomic DNA for PCR and Southern blotting from 
up to 10
7 cells. The cells were harvested, washed, and resuspended in 100 l PBS and 
incubated overnight at 55
oC with the addition of 200 l 1.5x Lysis buffer (0.3M Tris pH 
8.0, 0.15M EDTA pH 8.0, 1.5% SDS) plus proteinase K (0.15mg/ml). After addition of 
another 200 l of 1.5x Lysis buffer, 1 volume (500 l) of phenol/chloroform/isoamyl 
alcohol was added. Samples were centrifuged at 14,000rpm in a micro-centrifuge and the 
top aqueous layer transferred to a new tube. Another extraction step was performed using 1 
volume of chloroform/isoamyl alcohol and the resulting top aqueous layer was transferred 
to a new tube again. DNA was precipitated by addition of ½ volume of 7.5M ammonium 
acetate and 2 volumes of absolute ethanol. After washing the DNA in 70% cold ethanol, 
the DNA pellet was resuspended in TE buffer (10mM Tris pH 8.0, 1mM EDTA pH 8.0) 
and stored at 4
oC. 
Polymerase chain reaction (PCR) 
PCR was performed using the GeneAmp PCR Core Reagents or the Herculase Enhanced 
DNA polymerase PCR reagents. The PCR protocol was designed according to the 
manufacturer’s instructions. In general 1 l of genomic DNA was used per reaction. 
Primers were obtained from VHBIO (for sequences see 2.1.7). The reaction was performed 
in a PTC-200 thermal cycler with a heated lid. In general, the protocol consisted of an 
initial denaturation step at 95
oC for 2min, followed by 35 amplification cycles (94
oC 
denaturation for 1min, 59
oC annealing for 1min and 72
oC elongation for 1min/1kb of 
product) and an additional elongation step at the end. PCR products were stored at 4
oC.  
Agarose gel electrophoresis 
1% (w/v) agarose gels were poured by dissolving ultra pure electrophoresis grade agarose 
in 1xTAE buffer (40mM Tris, 0.114% (v/v) glacial acetic acid, 1mM EDTA pH 8.0) and 
placed in a horizontal gel apparatus from Stratagene containing 1xTAE running buffer. 
DNA samples were diluted in 1x DNA loading buffer (for 10x: 50% (v/v) 20x TAE, 50% 
(v/v) glycerol, 1% (w/v) bromophenol blue) and loaded alongside suitable DNA ladder 
markers in the wells of the gel. Electrophoresis was performed at 80-100V and the DNA 
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Cloning protocols 
DNA restriction digests were performed using the appropriate restriction enzyme and the 
corresponding reaction buffer from Invitrogen or New England Biolabs Inc. Reactions 
were carried out according to the manufacturer’s instructions and samples generally 
incubated in a 37
oC water bath for the duration of the digest. DNA from restriction digests 
or PCR reactions was purified using the QIAquick PCR purification Kit according to the 
manufacturer’s instructions. For purification of DNA fragments from agarose gels the 
respective band was excised using a scalpel and the DNA recovered using the QIAquick 
Gel Extraction Kit according to the manufacturer’s instructions. The Rapid DNA Ligation 
Kit from Roche was used for the ligation of DNA fragments into plasmids with T4 DNA 
ligase. The plasmid DNA used in ligation reactions was pre-treated with Shrimp Alkaline 
Phosphatase according to the manufacturer’s instructions to prevent vector re-ligation. In 
general, DNA was purified by ethanol precipitation: Potassium acetate was added to a final 
concentration of 0.3M. After addition of 2 volumes of ethanol, the mixed samples were 
cooled on ice and then centrifuged at high speed. The DNA pellet was washed with 70% 
ethanol and then resuspended in an appropriate amount of TE buffer.  
Southern blotting 
Genomic DNA isolated from Chk1-/- DT40 clones transfected with the Chk2 targeting 
construct was analysed for targeted integration by Southern blotting. The DNA was 
digested in an excess of EcoRI restriction enzyme overnight and separated on a 0.8% 
agarose gel alongside a α-
32P-labelled DNA ladder. In preparation for transfer, the gel was 
subjected to an acid depurination wash in 0.25M HCl for 30min, an alkali denaturation 
wash in 1.5M NaCl/0.5M NaOH for 1h, and a neutralisation wash in 1M Tris-HCl 
pH8.0/1.5M NaCl for 1h. The transfer was set up in a large dish filled with 20xSSC (3M 
NaCl, 300mM trisodium citrate, pH7.0). Two sheets of 33mm paper with 5cm overhangs 
into the buffer solution were placed on a glass plate on top of four rubber stoppers. The 
inverted gel was positioned on the paper, removing any air bubbles, and the nylon filter 
membrane adjusted on top of the gel. A further two sheets of 33mm paper and a stack of 
paper towels and a weight were sat on top and saran wrap placed around the sides of the 
gel. This setup allowed the flow of 20xSSC buffer from the dish up through the gel and the 
nylon membrane, thereby transferring DNA fragments onto the membrane. In general, the 
transfer was left to proceed for 16-24h, and then the DNA was cross-linked to the 
membrane using 2400J/m
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Probe hybridisation 
The nylon filter membrane was placed on mesh into an Appligene hybridisation bottle 
containing 30ml of pre-warmed hybridisation buffer (0.25M Na2HPO4 pH7.2, 7% (w/v) 
SDS, 1mM EDTA pH8.0) and incubated in an Appligene rotating mini-hybridisation oven 
at 65
oC for 3-4h. After pre-hybridisation, the solution was replaced with a 30ml aliquot of 
hybridisation buffer containing the labelled probe and incubation continued at 65
oC 
overnight. The probe was generated using the Rediprime II DNA labelling system 
according to the manufacturer’s instructions. In general, 50ng diluted and denatured DNA 
was combined with the Rediprime reaction mix and 5 l (50 Ci) of α-
32P-dCTP and 
incubated at 37
oC for 10 min. The reaction was stopped by addition of 5ml 0.2M EDTA 
and the labelled DNA was passed through a Bio-Spin 30 Columns to remove any 
unincorporated nucleotides. Prior to hybridisation, the DNA was denatured for 5min. After 
probe-hybridisation, the nylon filter was washed 2x in 5% wash buffer (20mM Na2HPO4 
pH 7.2, 1mM EDTA pH8.0, 5% (w/v) SDS) and 2x in 1% wash buffer (20mM Na2HPO4 
pH 7.2, 1mM EDTA pH8.0, 1% (w/v) SDS) for 10min each at 65
oC in the rotating oven. 
The nylon filter was briefly dried, wrapped in saran wrap and exposed to X-ray film at -
70
oC. 
2.2.3 Cell Culture 
All cell culture work was performed using aseptic techniques inside a laminar flow hood. 
Growth conditions for avian DT40 cell lines 
Chicken B-lymphoma DT40 suspension cells were grown at 39
oC and 5% CO2 in a humid 
incubator. The DT40 culture medium consists of DMEM supplemented with 10% foetal 
bovine serum (FBS), 1% chicken serum (heat-inactivated at 56
o for 2 hours), 2mM L-
glutamine, 10 M β-mercaptoethanol, 30 g/ml penicillin, 50 g/ml streptomycin. DT40 
cells grow in suspension and were routinely passaged every 3-4 days by dilution (1:10) 
into fresh culture medium. For long-term storage cells were frozen in 10% DMSO in FBS 
and stored in liquid nitrogen vapour phase tanks. 
Growth conditions for human BE cell line 
Human colon carcinoma BE adherent cells were grown at 37
oC and 5% CO2 in a humid 
incubator. The BE culture medium consists of DMEM supplemented with 10% FBS, 2mM Verena Oehler, 2007     Chapter 2, 60 
L-glutamine, 30 g/ml penicillin, 50 g/ml streptomycin. BE cells were routinely passaged 
every 3-4 days. Cells were briefly exposed to 0.25% trypsin in PE buffer, loosened off the 
culture dish by agitation and then resuspended and diluted (1:10) into fresh medium. For 
long-term storage cells were frozen in 10% DMSO in FBS and stored in liquid nitrogen 
vapour phase tanks. 
Transfection of BE cells with siRNA 
For transfection of siRNA with Oligofectamine reagent, BE cells were seeded at 
2.5x10
5/ml 16-24h prior to transfection. Oligofectamine was used according to the 
manufacturer’s instructions. In general, both siRNA (e.g. 50nM of siRNA pool, individual 
duplex or negative control) and Oligofectamine were diluted in OptiMEM, incubated at RT 
for 5min, then combined and incubated for a further 20min. The mixture was added 
directly to the cells. Down regulation of protein levels was generally achieved after 48h-
72h in culture and confirmed by Western blotting.  
Transient transfection of cells with plasmid DNA 
For transient transfection with plasmid DNA, cells were set up at an appropriate density in 
a culture dish (e.g. BE at 1.2x10
5/ml). After 16-24h transfection of the DNA of choice was 
performed using Lipofectamine 2000 according to the manufacturer’s instructions. In 
general, both DNA (e.g. 5-10 g) and Lipofectamine 2000 were diluted in OptiMEM, 
incubated at RT for 5min, then combined and incubated for a further 20min, and then 
added directly to the cells. Transgene expression was in general tested after 24-48 hours.   
Stable transfection of DT40 cells with plasmid DNA 
The Amaxa nucleofector kit T was routinely used for the stable transfection of DT40 cells. 
The DNA of choice was linearised with the appropriate restriction enzyme, ethanol 
precipitated and resuspended in TE (Tris-EDTA) buffer. 1-5x10
6 cells were pelleted, 
resuspended in 100 l of solution T /DNA, transferred to a cuvette and placed in the 
Nucleofector.  Program A23 was routinely used. Cells were then returned to culture, 
allowed to recover overnight and plated into 96 well plates in the presence of the 
appropriate antibiotic. After approximately 2 weeks, when cell colonies appear visibly in 
the wells, clones were picked and expanded for subsequent analysis. Verena Oehler, 2007     Chapter 2, 61 
2.2.4 Elutriation of living cells 
This method was used to separate an asynchronous cell population into fractions enriched 
in a specific phase of the cell cycle: G1-S-G2/M. The method was also used to synchronise 
an asynchronous cell population by elutriating only cells that were in G1/S phase of the 
cell cycle and then returning them to culture to perform time course experiments. The 
principle of the elutriation method is that a cell population inside a rotating flow chamber 
is exposed to two opposing forces, the centrifugal force and the flow force. Cells can be 
eluted according to their size by changing either the flow rate or in this case by changing 
the rotation speed. Decrease of the rotation speed in small intervals will release small cells 
(such as those in G1) first, and then with further decreases in rpm larger cells at later stages 
of the cell cycle are progressively eluted.     
Elutriation of living cells was performed using the Beckman Coulter JE-5.0 Elutriation 
System in combination with an Avanti J-20XP centrifuge and Masterflex L/S easy-load II 
pump system. DT40 cells were set up at 0.3x10
6/ml in large culture flasks and after 16-24h 
cells were pelleted, and resuspended in 7ml of medium. Best results were achieved with 
approximately 2-3x10
8 cells, maximum capacity of the flow cell is 10
9cells. BE cells were 
set up to be 80% confluent, washed, trypsinised and then pelleted and resuspended in 7ml 
of medium. The cell solution was inserted into the loading chamber of the elutriator and 
then allowed to enter the flow chamber at a constant flow of 40ml/min of elutriation 
medium at 4000rpm. Once all cells were loaded, cell fractions were elutriated by gradual 
reduction of rotor speed by 200rpm increments while the medium flow rate was kept at a 
constant speed of 40ml/min. Cells were collected in 100-150ml aliquots and then either 
further analysed by FACS and Western blotting or returned into culture and treated as 
required. 
2.2.5 Protein Extraction and Analysis 
Whole cell extracts 
Cells were treated as required and then harvested by pelleting them directly (suspension 
cells) or scraping them into PBS (adherent cells) and pelleting them into an eppendorf 
tube. Cell pellets were washed in ice cold PBS and resuspended in whole cell extract lysis 
buffer (20mM Hepes, 5mM EDTA, 10mM EGTA, 5mM NaF, 50ng/ml Okadaic acid, 
1mM DTT, 0.4M KCl, 0.4% Triton X-100, 10% Glycerol, 5 g/ml Leupeptin, 50 g/ml 
PMSF, 1mM Benzamidine, 5 g/ml Aprotinin, 1mM Sodium Vanadate). Samples were Verena Oehler, 2007     Chapter 2, 62 
then incubated on ice for 20-30 min and subsequently centrifuged at 14,000rpm in a cooled 
micro-centrifuge. Supernatants were removed, analysed for protein concentration and 
stored at -80oC. 
Determination of protein concentration: Bradford Assay 
Bovine serum albumin (BSA) was used to prepare a dilution series of standard protein 
concentrations in lysis buffer ranging from 0mg/ml to 2mg/ml. Each BSA standard sample 
was diluted with a 50% Coomassie protein assay reagent solution and the absorbance 
determined at a wavelength of 595 nm using an Eppendorf biophotometer. The absorbance 
values were used to generate a standard curve. 10 l of each protein sample was measured 
in the same way and the protein concentration determined from the standard curve.  
Protein analysis: 
Protein samples were resolved on SDS-polyacrylamide gels composed of a 10% resolving 
gel solution and a stacking gel solution. 
Table 3: SDS PAGE resolving and stacking gels 
10% resolving gel  40ml 
H2O  15.8ml 
30% Acrylamide mix 
37.5:1 Bis Acrylamide ratio 
13.3ml 
1.5M Tris (pH8.8)  10.0ml 
10% SDS  0.4ml 
10% Ammonium persulfate (APS)  0.4ml 
N,N,N’,N’-Tetramethylethylenediamine 
(TEMED) 
0.016ml 
10% phosphorylation shift gel  40ml 
H2O  12.9ml 
40% Acrylamide mix 
2% Bis-Acrylamide 
10ml 
1.7ml 
1M Tris (pH8.8)  15ml 
10% SDS  0.4ml 
10% APS  0.4ml 
TEMED  0.016ml 
Stacking gel  10ml 
H2O  6.8ml 
30% Acrylamide mix 
37.5:1 Bis-Acrylamide ratio 
1.7ml 
1M Tris (pH6.8)  1.25ml 
10% SDS  0.1ml 
10% APS  0.1ml 
TEMED  0.01ml Verena Oehler, 2007     Chapter 2, 63 
 
In general, 50 g of protein in SDS sample buffer (4 volumes of 5% SDS, 25% glycerol, 
125mM Tris pH6.8, bromophenolblue and 1 volume of 1M DTT) were boiled for 5 min 
and then loaded into individual wells alongside a full-range molecular weight marker. Gels 
were run in a gel tank in SDS Running buffer (25mM Tris, 0.1% SDS, 0.19M glycine) at 
20 to 250 V until dye front migrated to the bottom of the gel tank. Gels were transferred 
onto nitrocellulose by Western blotting. 
Protein analysis: Western blotting 
Polyacrylamide gels were transferred onto a nitrocellulose filter using a semi-dry 
electroblotter. The nitrocellulose and 10 pieces of 3mm paper were soaked in transfer 
buffer (48mM Tris pH9.2, 39mM glycine, 1.3mM SDS, 20% (v/v) methanol) and 
assembled on the blotter, from anode to cathode, 5 pieces of 3mm paper, nitrocellulose, 
resolving polyacrylamide gel, and 5 pieces of 3mm paper. The transfer was performed at 
20V, 200mA, 10W for 1 hour. 
The nitrocellulose filter blot was washed briefly in TBST (10mM Tris pH7.6, 100mM 
NaCl, 0.1% (v/v) Tween 20) and then blocked in 5% (w/v) Marvel in TBST for an hour. 
Appropriate dilutions of primary antibody were prepared in 5% Marvel/TBST or for 
phospho-specific antibodies in 5% (w/v) BSA in TBST. The blot was incubated for at least 
one hour at room temperature or over night at 4
oC. Next, blots were washed 3 x 5min in 
TBST before being incubated in 5% Marvel/TBST containing a 1/500 dilution of 
appropriate horseradish-peroxidase-conjugated secondary antibody for an hour. After 
washing once for 15min in 5% Marvel/TBST and a further 3 x5 min in TBST, the blots 
were analysed by enhanced chemiluminescence with ECL detection reagent, exposed to 
film and developed with a Kodak processor. 
Measurement of Cdc2 kinase activity: IP-Kinase Assay  
Cdc2 kinase activity was measured by an immunoprecipitation (IP) kinase assay. DT40 
cells were elutriated and the G1/S population was returned to culture and treated as 
required. Cells were harvested after 14h, washed in ice-cold PBS and resuspended in the 
appropriate amount of IP lysis buffer (50 mM Hepes pH 7.5, 150mM NaCl, 1mM EDTA, 
2.5mM EGTA, 10% Glycerol, 1mM DTT, 0.1% Tween20, 10mM β-glycerophosphate, 
1mM NaF, 0.1mM NaVO3, 2 g/ml Aprotinin, 5 g/ml Leupeptin, 0.1M PMSF) and frozen Verena Oehler, 2007     Chapter 2, 64 
on dry-ice for at least 5min. Samples were thawed on ice and centrifuged at 14,000rpm in a 
cooled micro-centrifuge. The protein concentration of the supernatants was analysed by 
Bradford assay. Per IP reaction, 0.2-1mg of protein was diluted in IP lysis buffer and pre-
cleared with 40 l of a 50% Protein A Sepharose slurry by rotating for 1h at 4
oC. The 
sample was centrifuged at high speed for 1min and the supernatant transferred into a new 
tube. The appropriate amount (e.g. 2 g) of immune or pre-immune serum was added and 
the sample incubated for at least 3h or overnight at 4
oC on a rotating wheel. After addition 
of 40 l of 50% Protein A Sepharose slurry, the sample was incubated for another hour at 
4
oC while rotating and then centrifuged at high speed for 1min. The supernatant was 
discarded and the pellet washed 3x in IP lysis buffer and 3x in kinase buffer (50mM Hepes 
pH 7.5, 50mM NaCl, 10mM MgCl2, 10mM MnCl2, 1mM DTT). The kinase reaction was 
performed in a 20 l reaction mix containing 1 g Histone H1 substrate, 50 Μ ATP, 2 Ci 
γ− 
32P ATP in kinase buffer. The pellet was incubated in the reaction mixture for 30min at 
30
oC. The sample was boiled in SDS sample buffer, run on a 10% SDS PAGE gel. The gel 
was transferred to a nitrocellulose filter, which was briefly dried, wrapped in saran wrap 
and exposed to an X-ray film at -70
oC.        
2.2.6 Flow cytometry protocols 
Preparation and fixation of cells 
DT40 or BE cells were set up and treated as required. An appropriate amount (5-
10x10
5/ml) were harvested (trypsinised if adherent), washed in PBS, and fixed in 70% 
Ethanol in PBS at 4
oC for at least 30min or overnight. 
Cell Cycle Analysis: PI staining (DNA content) 
Propidium iodide is a fluorescent dye that intercalates with nucleic acids and can be used 
to analyse the DNA content of a cell population. Fixed cells were pelleted and resuspended 
in 1ml of PBS containing 25 g/ml propidium iodide and 250 g/ml RNAseA and incubated 
for 30min at RT in the dark before being analysed by flow cytometry. 
Cell Cycle Analysis: BrdU/PI staining (proliferating cells) 
Bromodeoxyuridine is a synthetic thymidine analogue which can be incorporated into 
newly synthesised DNA in replicating cells. In general, 25 M BrdU was added to the cells 
prior to harvesting for 30min. Once fixed, cells were resuspended in 1ml of PBS and the Verena Oehler, 2007     Chapter 2, 65 
DNA denatured at RT for 15min with addition of 1ml of 4N HCl. Cells were then pelleted, 
washed in PBT (PBS-0.5%BSA, 0.1%Tween20), pelleted again, and resuspended in PBT 
containing a 1/40 dilution of Anti-BrdU mouse monoclonal antibody and incubated at RT 
for 30min. Samples were washed again, pelleted, and resuspended in PBT containing a 
1/40 dilution of anti-mouse FITC conjugate and incubated for 30 min at RT in the dark. 
After an additional wash, cells were pelleted and resuspended in1ml of PBS containing 
25 g/ml propidium iodide and 250 g/ml RNAseA and incubated for 30min at RT in the 
dark before being analysed by flow cytometry. 
Cell Cycle Analysis: P-S10-H3/PI staining (mitotic cells) 
The phosphorylation of Serine 10 on Histone H3 is an early event during mitosis and can 
be used as a tool for quantification of the percentage of mitotic cells in a population. In 
general, fixed cells were pelleted and resuspended in 1ml PBS containing 0.1% Triton X-
100 and incubated on ice for 1h. Cells were pelleted and resuspended in 1% BSA/PBS 
containing a 1/33 dilution of Anti-P-S10-H3 rabbit polyclonal antibody for at least 1h at 
RT. Samples were washed and pelleted again and resuspended in 1% BSA/PBS containing 
a 1/33 dilution of anti-rabbit FITC conjugate and incubated for 30min at RT in the dark. 
After an additional wash, cells were pelleted and resuspended in 1ml of PBS containing 
25 g/ml propidium iodide and 250 g/ml RNAseA and incubated for 30min at RT in the 
dark before being analysed by flow cytometry. 
Flow cytometry 
Samples were analysed using a Becton Dickinson FACScan with a laser at 488nm and 
Macintosh CellQuest software. Data was then further analysed and quantified using PC 
WinMDI software.  
2.2.7 Immunofluorescence 
Fixing and staining cells for confocal microscopy 
Cells were set up at appropriate concentration (e.g. DT40 at 2.5x10
5/ml). Suspension cells 
were grown on poly-L-lysine coated cover slips and adherent cells were grown on 
uncoated cover slips generally in 6 well plates. After respective treatment, cells were fixed 
either in 4% paraformaldehyde for 15 min, or in 50:50 Methanol/Acetone mix for 10 min. 
Cover slips were washed and permeabilised 3x 5min in 0.1% Triton X-100 in PBS and Verena Oehler, 2007     Chapter 2, 66 
blocked for 30 min in 10% FCS, 0.5% BSA in PBS. The cover slips were transferred to a 
humid black box and the blocking solution was replaced with a 1/100 dilution of primary 
antibody/antibodies in blocking buffer. After 1-3h incubation at room temperature, the 
cells were washed 3x 5 min in blocking buffer. Then the secondary antibody/antibodies/PI 
was added in a 1-2/100 dilution in blocking buffer for 40 min in the dark at room 
temperature. Finally cover slips were washed twice in blocking buffer and once in 
permeabilising buffer and then mounted on a glass slide with vectashield (clear or with 
Dapi) and sealed with clear nail varnish. The cover slides were analysed using Leica 
confocal microscopes and windows based LCS software. 
Time-lapse microscopy 
DT40 H2B-GFP PCNA-RFP suspension cells were grown in Iwaki 35mm glass bottom 
dishes. Time-lapse microscopy was performed using an inverted Zeiss microscope system 
with temperature humidity 37
oC and CO2 control. Pictures were taken using a 40x 
objective and three channels (Bright field, GFP, RFP) at 2 min intervals over up to 20 
hours. Analysis of experimental data was performed using AndorIQ software. 
 
     67 
3  Results: Requirement for Chk1 and Chk2 
function for S/M and G2/M checkpoints  
3.1  Mitotic checkpoint responses in avian DT40 cells 
3.1.1 Analysis of mitotic delay proficiency in DT40 WT, Chk1-/-, 
and Chk2-/- knock-out cell lines in response to replication block 
and DNA damage  
The role of Chk1 and Chk2 in different checkpoint responses has been shown to vary 
between different organisms. Furthermore it has been difficult to study Chk1 function 
genetically in mammalian cells due to the lack of a viable knock-out model. In order to 
investigate and compare Chk1 and Chk2 function in vertebrate cells, this study used avian 
DT40 knock-out cell lines which are viable in the absence of either Chk1 or Chk2. The 
generation of the Chk1-deficient and Chk2-deficient DT40 cell lines has been described 
previously (Rainey et al., 2007; Zachos et al., 2003). 
This study focused on checkpoint responses to two distinct types of genotoxic stress that 
both delay the onset of mitosis: replication block and DNA damage. When DNA 
replication is blocked, for example with the DNA polymerase inhibitor aphidicolin, 
checkpoint proficient cells will arrest in S-phase and delay the onset of mitosis. This S/M 
checkpoint response ensures that cells do not enter mitosis in the presence of un-replicated 
DNA. Failure of the S/M checkpoint is characterised by an increase in the total number of 
cells entering mitosis when DNA replication is blocked and more specifically by the 
appearance of mitotic cells with a DNA content of less than 4N. Throughout this study 
mitotic checkpoint proficiency has been measured by staining for both the DNA content 
and a mitotic marker, the phosphorylation of Histone H3 on Serine 10 (P-S10-H3), and 
subsequent analysis of the samples by flow cytometry. A typical example of a functional 
mitotic delay in response to replication block as observed in DT40 WT cells can be seen in 
Figure 3.1. Cells were treated with the DNA polymerase inhibitor aphidicolin and grown in 
the presence of the spindle poison nocodazole which traps cells in mitosis and therefore 
allows an accurate measurement of both the proportion and DNA content of cells that enter 
mitosis during the course of the experiment. As shown in Figure 3.1, after prolonged 
treatment with aphidicolin and nocodazole, relatively few mitotic cells are observed and all 
of these exhibit 4N DNA content, i.e. they have completed DNA replication.  Verena Oehler, 2007     Chapter 3, 68 
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Figure 3.1: Measurement of S/M checkpoint proficiency by flow cytometry 
DT40 WT and Chk1-/- cells were treated with the DNA polymerase inhibitor aphidicolin for 16h in 
the presence of nocodazole. Samples were analysed by flow cytometry for DNA content and 
mitotic indices (P-S10-H3/PI). Gates R3 and R4 depict mitotic cells with 2N and 4N DNA content 
respectively. 
 Verena Oehler, 2007     Chapter 3, 69 
As described in more detail below, DT40 cells which are deficient for Chk1 (Chk1-/- cells) 
exhibit S/M checkpoint failure under these conditions, resulting in an increase in the total 
number of mitotic cells and the appearance of a large number of 2N mitotic cells (Figure 
3.1).  
The other mitotic checkpoint response of interest is activated when cells are subjected to 
DNA damage, such as DNA double-strand breaks induced by irradiation (IR). This G2/M 
arrest ensures that cells with damaged DNA are unable to divide and arrest in G2 until the 
DNA damage has been resolved. Failure of the G2/M checkpoint is characterised by cells 
entering mitosis without any measurable arrest, which can be detected as an increase in the 
number of 4N mitotic cells if nocodazole is present in the experiment. 
The response of DT40 WT, Chk1-/-, and Chk2-/- cells to these two distinct genotoxic 
stresses that delay mitosis was analysed by flow cytometry. Cells were subjected to either 
10Gy of IR to induce DNA damage or treated with the DNA polymerase inhibitor 
aphidicolin to block DNA replication. The cells were grown in the presence of the spindle 
poison nocodazole and an untreated control was also included in the analysis.  
As shown in Figure 3.2, after 16h in the presence of nocodazole alone, a majority (72%) of 
DT40 WT cells progressed into mitosis. In response to DNA polymerase inhibition with 
aphidicolin, a high proportion of DT40 WT cells were blocked from entering mitosis and 
no cells entering mitosis with 2N DNA content were observed, demonstrating activation of 
the S/M checkpoint. When DT40 WT cells were challenged with 10Gy of IR and then 
returned to culture, approximately two thirds of the cells arrested in G2 phase with a DNA 
content of 4N, displaying a functional G2/M checkpoint after DNA damage. It should also 
be mentioned that some cells died after both treatments, probably through apoptosis (i.e. 
less than 2N DNA content but P-S10-H3-negative). 
The cell cycle profile of control Chk1-/- cells and their progress into mitosis in the absence 
of perturbation was similar to control DT40 WT cells (Figure 3.2). In response to DNA 
replication block with aphidicolin almost half of the Chk1-/- cell population stained 
positive for P-S10- H3. Interestingly, the majority of these mitotic cells displayed a DNA 
content of only 2N. This premature mitosis of cells that have not yet completed DNA 
replication is characteristic of S/M checkpoint failure. In comparison, after exposure to IR, 
Chk1-/- cells progressed through the cell cycle without any measurable arrest and 
accumulated in mitosis with 4N DNA content comparable to un-stressed control cells (56% 
and 58% respectively, Figure 3.2). Moreover, in the absence of Chk1, hardly any non- Verena Oehler, 2007     Chapter 3, 70 
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Figure 3.2: S/M and G2/M checkpoint proficiency in DT40 WT, Chk1-/-, Chk2-/- cell lines 
Flow cytometry data for DNA content (PI profiles) and mitotic indices (P-S10-H3/PI staining) of 
DT40 WT, Chk1-/- and Chk2-/- cell lines after 16h treatments with the DNA polymerase inhibitor 
aphidicolin or 10Gy of IR in the presence of nocodazole. The percentage of total mitotic cells after 
each treatment is annotated in the mitotic indices profile. 
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mitotic cells with sub 2N DNA content were detected after either treatment. Taken together 
these results demonstrated that both S/M and G2/M checkpoint responses were severely 
compromised in the absence of Chk1.  
Unperturbed Chk2-deficient DT40 cells showed slight differences in their cell cycle profile 
as compared to control DT40 WT cells (compare DNA content histograms in Figure 3.2). 
The relative decrease in G1 and increase in G2 cells in asynchronous Chk2-/- cultures has 
been described previously and may suggest a slower rate of progression through G2/M in 
these cells (Rainey, 2003). Nevertheless, after 16h the vast majority (65%) of Chk2-/- cells 
had also progressed through the cell cycle and accumulated in mitosis in the presence of 
nocodazole. Block of DNA replication with aphidicolin resulted in mitotic delay of a high 
proportion of Chk2-/- cells and no mitotic cells with less than 4N DNA content were 
observed, demonstrating that the S/M checkpoint was still functional in the absence of 
Chk2. As for the G2/M arrest in response to DNA damage, only approximately 50% of 
Chk2-/- cells arrested in G2 in comparison to IR treated DT40 WT cells where the majority 
of cells arrested in G2 (Figure 3.2). This result indicates that the G2/M arrest is slightly 
compromised in the absence of Chk2 in these cells, consistent with the findings of Rainey 
et al. (Rainey et al., 2007). 
A graphical summary of the flow cytometry data for all DT40 cell lines is shown in Figure 
3.6, including data for the DT40 WT, Chk1-/-, and Chk2-/- cells as shown in Figure 3.2, as 
well as data from checkpoint proficiency assays shown subsequently in Figures 3.4 and 
3.5. The total percentage of P-S10-H3-positive cells in each sample with respect to the 
nocodazole treated control (designated 100%) is shown in Figure 3.6a. The percentage of 
2N mitotic cells (Figure 3.6b) provides a specific measure of S/M checkpoint failure, 
whereas the amount of 4N mitotic cells with respect to the nocodazole treated control 
allows an assessment of G2/M checkpoint failure in irradiated cells (Figure 3.6c). 
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3.1.2 Analysis of mitotic delay proficiency in Chk1 mutant cell 
lines in response to replication block and DNA damage  
These checkpoint proficiency assays performed in the DT40 WT and knock-out cell lines 
demonstrated that Chk1 is essential for normal S/M and G2/M checkpoint delays. To 
further characterize the function of Chk1, various mutant versions of Chk1 were re-
introduced into the Chk1-deficient cell line (by Mark Walker). These cell lines were then 
analysed by flow cytometry for proficiency in the S/M and G2/M checkpoint assays as 
described above. 
The Chk1 Revertant cell line was established by transfecting Chk1-/- cells with an 
expression vector encoding an avian Chk1 cDNA. To enable an optimal comparison, a 
clone was chosen that expressed similar Chk1 protein levels as the WT DT40 cells. This 
approach was used for all mutant cell lines generated as far as it was possible. The protein 
expression levels of Chk1 in all the seven cell lines that have been analysed are shown in 
Figure 3.3. The Chk1 protein levels were somewhat higher in the Chk1 mutant cell lines, 
but importantly, re-introduction of functional Chk1 was able to completely restore normal 
S/M and G2/M checkpoint function, confirming that Chk1 is essential for both of these 
responses (Figure 3.4; Chk1 Revertant). 
To establish whether Chk1 kinase activity per se is essential for checkpoint proficiency, a 
kinase dead version of the protein was generated. An expression vector encoding a mutant 
version of Chk1 where lysine 38 was replaced by an arginine (Chk1 K38R) was stably 
introduced in the Chk1-/- cells. This mutation interferes with ATP binding in the catalytic 
domain of Chk1. As shown in Figure 3.4, the Chk1 K38R cells showed high levels of 
premature mitosis (26%) after block to DNA replication and progressed into mitosis 
without any detectable arrest 16h after exposure to DNA damage. Thus, both S/M and 
G2/M checkpoints were impaired or abolished in the Chk1 K38R cell line, demonstrating 
that Chk1 kinase activity is essential for these checkpoint responses.  
The upstream kinase ATR has been shown to phosphorylate Chk1 on serines 317 and 345 
(Zhao and Piwnica-Worms, 2001). In order to investigate the requirement for 
phosphorylation of these sites during checkpoint responses, two mutant versions of Chk1 
were created. In each case the respective serine residue was mutated to an alanine residue 
that cannot be phosphorylated. As shown in Figure 3.5, in the presence of the DNA 
polymerase inhibitor aphidicolin a majority of the Chk1 S317A cells were able to delay 
mitosis, indicating that the S/M checkpoint is active in these cells. Verena Oehler, 2007     Chapter 3, 73 
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Figure 3.3: Expression levels of Chk1 and mutant derivatives in DT40 cell lines 
To determine the expression levels of Chk1 in all seven cell lines tested in the checkpoint assays 
whole cell extracts were separated on a 10% SDS PAGE gel. Chk1 protein levels were analysed 
by Western blotting for Chk1 and Actin was used as a loading control.  Verena Oehler, 2007     Chapter 3, 74 
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Figure 3.4: S/M and G2/M checkpoint proficiency in Chk1 Revertant and Kinase Dead cell 
lines 
Flow cytometry data for DNA content (PI profiles) and mitotic indices (P-S10-H3/PI staining) of 
Chk1 Revertant and Chk1 K38R cell lines after 16h treatments with the DNA polymerase inhibitor 
aphidicolin or 10Gy of IR in the presence of nocodazole. The percentage of total mitotic cells after 
each treatment is annotated in the mitotic indices profile. 
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Figure 3.5: S/M and G2/M checkpoint proficiency in Chk1 phosphorylation mutant cell lines 
Flow cytometry data for DNA content (PI profiles) and mitotic indices (P-S10-H3/PI staining) of 
Chk1 S317A and Chk1 S345A phosphorylation mutant cell lines after 16h treatments with the DNA 
polymerase inhibitor aphidicolin or 10Gy of IR in the presence of nocodazole. The percentage of 
total mitotic cells after each treatment is annotated in the mitotic indices profile. 
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After exposure to DNA damage (IR), a high percentage of Chk1 S317A cells entered 
mitosis, however, in comparison to complete G2/M checkpoint failure observed in Chk1-/- 
cells, the Chk1 S317A mutant displayed an intermediate phenotype (Figure 3.5). Taken 
together, these results suggest that phosphorylation of Chk1 on S317 is not essential for the 
S/M checkpoint response; however it appears to be to some extend important for the proper 
establishment of the G2/M arrest in response to DNA damage. 
The second phosphorylation mutant, Chk1 S345A, exhibited a more severe phenotype 
(Figure 3.5). In response to block to DNA replication with aphidicolin a high percentage of 
Chk1 S345A cells (28%) entered mitosis prematurely with 2N DNA content. Also, there 
was no measurable G2 arrest in response to DNA damage after IR exposure in the Chk1 
S345A cells. This observation suggests that phosphorylation of Chk1 on S345 is an 
essential event for the proper functioning of both the S/M and the G2/M checkpoint 
responses.  
To summarise this section, failure of the S/M checkpoint as judged by detection of 
premature 2N mitotic cells was observed in Chk1-/-, Chk1 K38R Kinase Dead, and Chk1 
S345A phosphorylation mutant cell lines (Figure 3.6b). In comparison, G2/M arrest was 
abolished in Chk1-/-, Chk1 K38R, Chk1 S345A, and significantly compromised in the 
Chk1 S317A mutant. The Chk2-/- cell lines showed an intermediate G2/M checkpoint 
response (Figure 3.6c). 
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Figure 3.6: Comparison of S/M and G2/M checkpoint proficiency in DT40 cell lines 
Graphical illustration of representative examples for the flow cytometry data of checkpoint 
proficiency experiments which were each performed several times with reproducible results:  
(a) Percentage of total mitotic cells (i.e. both 2N and 4N) calculated as a percentage of the 
nocodazole treated mitotic control (blue: 100%). Untreated control cells are depicted in black, cells 
treated with aphidicolin are shown in red (S/M checkpoint response), and cells treated with 10Gy IR 
are represented in yellow (G2/M checkpoint response).  
(b) S/M checkpoint response (red) after 16h replication block represented as percentage of 2N 
premature mitosis in each cell line.  
(c) G2/M checkpoint response (yellow) after 16h IR treatment represented as percentage of 4N 
mitotic cells compared to mitotic control (blue: 100%).  Verena Oehler, 2007     Chapter 3, 78 
3.1.3 Analysis of Chk1 activation in response to replication stress 
and DNA damage 
Checkpoint assays with DT40 cells expressing a kinase dead Chk1 mutant demonstrated 
that Chk1 kinase activity is essential for S/M and G2/M checkpoint responses in DT40 
cells. Furthermore, analysis of Chk1 phosphorylation mutants has shown that 
phosphorylation on S317 and S345 of Chk1 is also important for proper functioning of 
these mitotic checkpoints. To complement this analysis it was of interest to document 
Chk1 phosphorylation at these two regulatory sites. Previous studies have shown that the 
phosphorylation of Chk1 by upstream kinase ATR can serve as a read-out of kinase 
activity (Zhao and Piwnica-Worms, 2001). Therefore, the phosphorylation status of Chk1 
on critical residues S317 and S345 was analysed as a surrogate marker to determine Chk1 
activation in response to block to DNA replication or DNA damage.  
DT40 WT, Chk1-/- and Chk2-/- cells were treated either with the DNA polymerase 
inhibitor aphidicolin or 10Gy of IR and returned to culture. Cells were harvested after 1h 
and whole cell extracts analysed on a phosphorylation shift SDS PAGE gel (see materials 
and methods). As shown in Figure 3.7, Western blotting with Chk1 phospho-specific 
antibodies revealed that the level of basal Chk1 phosphorylation was very low under 
untreated control conditions. In response to aphidicolin treatment, Chk1 became very 
strongly phosphorylated on S345 and also modified on S317 in DT40 WT and Chk2-/- 
cells. After exposure to DNA damage induced by IR, both S317 and S345 of Chk1 were 
phosphorylated within one hour of treatment; however the overall extent of S345 
phosphorylation was much lower than after DNA replication block. This result implied a 
difference in Chk1 activation depending on the kind of stress the cells were exposed to. 
Chk1 became more strongly phosphorylated, and thus presumably activated, in response to 
DNA replication block than after DNA damage with 10Gy IR. The levels of S317 and 
S345 Chk1 phosphorylation were comparable in DT40 WT and Chk2-/- cells showing that 
Chk1 activation was not impaired in the absence of Chk2. Interestingly, the total Chk2 
protein level in Chk1-/- cells was much lower than in DT40 WT cells. However, the reason 
and significance of this difference has not yet been determined. 
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Figure 3.7: Chk1 phosphorylation in response to replication stress and DNA damage 
DT40 WT, Chk1-/-, Chk2-/- cells were either untreated (C), aphidicolin treated (A), or irradiated with 
10Gy (IR), returned to culture for 1h and harvested. Whole cell extracts were separated on a 
phosphorylation shift SDS PAGE gel. Chk1 protein levels and phosphorylation status on S317 and 
S345 as well as Chk2 protein levels and Actin protein levels were analysed by Western blotting. 
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3.2  Mitotic checkpoint responses in human BE cells 
The avian Chk1-/- cell line has been established as a very useful experimental system. 
However, to determine whether the requirement for Chk1 in mitotic checkpoint responses 
is general, it was necessary to study Chk1 function in a different background, such as a 
human cell line. Therefore, the colon carcinoma BE cell line was chosen as a second 
vertebrate system to study Chk1 function in addition to the DT40 knock-out cell lines. The 
human BE cells were selected as, like the DT40 cells, they do not express functional p53 
and furthermore they have been established as a cell line that is very suitable for the use of 
small interfering RNA (siRNA). Thus, two approaches were employed to abrogate Chk1 
function in the BE cells: Firstly, using a small molecule inhibitor with a high selectivity for 
Chk1, and secondly, using siRNA in order to down-regulate Chk1 expression levels. 
Initially, the effect of both Chk1 inhibition and Chk1 siRNA were tested in the S/M 
checkpoint assay.  
3.2.1 Requirement of Chk1 for S/M checkpoint proficiency in BE 
cells 
The small molecule inhibitor 7-hydroxy-staurosporine (UCN-01) has been identified as a 
potent anticancer agent and was found to target Chk1 and the Cdc25C pathway (Graves et 
al., 2000). To investigate the effect of pharmacological inhibition of Chk1 on the S/M 
checkpoint response, BE cells were treated with aphidicolin and nocodazole in the 
presence or absence of 300nM UCN-01. Cells were harvested after 16 or 24h and analysed 
by flow cytometry. Control cells treated with nocodazole alone and cells treated with 
UCN-01 and nocodazole progressed through the cell cycle and the majority of cells had 
accumulated in mitosis by 24h (Figure 3.8a). In response to replication block with 
aphidicolin the BE cells were able to delay entry into mitosis. In contrast, in the presence 
of UCN-01 and aphidicolin, there was an increase in the total number of mitotic cells after 
16h and 24h. Furthermore, more than a quarter of UCN-01 treated BE cells had entered 
mitosis prematurely with 2N DNA content after 16h of replication block with aphidicolin. 
The graph in Figure 3.8b illustrates the quantification of the flow cytometry data for the 
16h time point in more detail. These results demonstrated that inhibition of Chk1 with 
UCN-01 in BE cells recapitulated the phenotype of the avian Chk1-/- cells in response to 
replication block.  Verena Oehler, 2007     Chapter 3, 81 
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Figure 3.8: Analysis of effect of Chk1 inhibition with UCN-01 on S/M checkpoint proficiency 
BE cells were treated as required with UCN-01 and/or aphidicolin and grown in the presence of 
nocodazole for 16 or 24h respectively. Data for untreated control cells is not shown. Cells were 
harvested and analysed for DNA content (PI profiles) and mitotic indices (P-S10-H3/PI) and 
analysed by flow cytometry (a). Quantification of flow cytometry data for the 16h time point (b). Verena Oehler, 2007     Chapter 3, 82 
Down-regulation of Chk1 protein expression was achieved using siRNA directed against 
human Chk1. As shown in the Western blot analysis in Figure 3.9a, four individual siRNA 
duplexes as well as a pool of all four in combination successfully ablated Chk1 protein 
expression after 72h of transfection at both 50 and 100nM. A time course experiment was 
performed to establish the best dose and time for siRNA administration and to determine 
any negative effects on cell cycle progression. A concentration of 50nM of Chk1 siRNA 
pool was sufficient to effectively down-regulate Chk1 protein expression after 48h (Figure 
3.9a, right panel). Flow cytometry analysis of BrdU incorporation suggested that after 72h 
of transfection with Chk1 siRNA some cells exhibited perturbation of S phase progression 
as indicated by loss of BrdU incorporation; however this was not seen at 48h (Figure 3.9b). 
From these results it was concluded that a concentration of 50nM of Chk1 siRNA pool for 
48h of transfection was suitable for further experiments. 
To evaluate the effectiveness of Chk1 inhibition versus down-regulation of Chk1 protein 
expression, BE cells were analysed for S/M checkpoint proficiency after exposure to either 
UCN-01 or Chk1 siRNA. As shown in Figure 3.10, after block to DNA replication with 
aphidicolin, cells treated with UCN-01 or Chk1 siRNA entered mitosis prematurely with 
2N DNA content (9% and 15% respectively). The observed impairment of the S/M 
checkpoint response was comparable to previous observations of S/M checkpoint failure 
made in Chk1-/- DT40 cells. In conclusion, both approaches of abrogating Chk1 function, 
either by inhibition with UCN-01 or down-regulation of Chk1 protein levels with siRNA, 
showed that Chk1 is required for the S/M checkpoint in BE cells.  
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Figure 3.9: Analysis of Chk1 down-regulation with siRNA  
(a) Left panel: Western blot analysis of Chk1 protein levels, Actin served as loading control. Cells 
were un-transfected (U) or transfected with either mock (M), negative control siRNA (Neg), positive 
control siRNA (Lam), 50 or 100nM of either individual Chk1 siRNA duplex or Chk1 pool siRNA. 
Right panel: Western blot analysis of Chk1 levels for Chk1 siRNA time and dose response 
experiment, Actin was used as loading control. Cells were un-transfected cells (U), transfected with 
either mock (M), 25 or 50mM of Chk1 siRNA pool. (b) FACS profiles of DNA content (PI) and 
analysis of proliferating cells (BrdU/PI) for Chk1 siRNA time and dose response experiment.   
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Figure 3.10: Comparison of effect of Chk1 siRNA and Chk1 inhibitor UCN-01 on S/M 
checkpoint proficiency 
Chk1 function was abrogated in BE cells by either transfection with Chk1 siRNA (for 48h) or Chk1 
inhibition with UCN-01. Respective drug treatments of nocodazole, aphidicolin or UCN-01 were 
administered 24h before harvesting. Samples were analysed by flow cytometry for DNA content (PI 
profiles) and mitotic indices (P-S10-H3/PI). Verena Oehler, 2007     Chapter 3, 85 
3.2.2 Analysis of Chk1 and Chk2 requirement for mitotic 
checkpoint proficiency in BE cells 
To compare the relative requirement of Chk1 and Chk2 for S/M and G2/M checkpoint 
proficiency in BE cells the expression of one or both proteins was silenced using small 
interfering RNA. The effectiveness of Chk1 siRNA in BE cells has already been described 
(3.2.1). In the case of Chk2, protein expression was also successfully ablated within 48h 
with either of four individual siRNA duplexes as well as a Chk2 siRNA pool. An example 
of Chk2 protein depletion after siRNA treatment can be seen in Figure 3.13b.    
In order to determine the consequences for S/M and G2/M checkpoint proficiency, BE 
cells were transfected with siRNA(s) for 48h and then exposed to either the DNA 
polymerase inhibitor aphidicolin or 10Gy of IR and grown in the presence of nocodazole 
for a further 24h. As shown in Figure 3.12, mock transfected control cells progressed 
through the cell cycle and accumulated efficiently in mitosis in the presence of nocodazole. 
In contrast, mitosis was effectively delayed in response to both DNA replication block with 
aphidicolin and DNA damage induced by IR, as assessed by the appearance of 2N and 4N 
mitotic cells, respectively.  
When Chk1 expression was down-regulated with siRNA, the majority of cells accumulated 
in mitosis in the presence of nocodazole (Figure 3.12). After aphidicolin treatment an 
increase in the total number of mitotic cells was observed and there was also a small but 
significant amount of premature mitotic cells with 2N DNA content, indicating impaired 
S/M checkpoint function. Between individual Chk1 siRNA experiments a certain degree of 
variation in the amount of premature mitosis was seen (compare for example Figures 3.10 
and 3.12), however overall the effect was very reproducible. When Chk1siRNA treated 
cells were exposed to DNA damage induced by IR, they were not able to delay mitosis 
efficiently as most cells progressed through the cell cycle to mitosis at a rate similar to 
cells treated with nocodazole alone (49% and 53% respectively in Figure 3.12). The 
absence of any measurable arrest in response to DNA damage demonstrated that Chk1 
function was essential for the G2/M checkpoint in BE cells.  
In contrast, when BE cells were treated with Chk2 siRNA little effect on S/M or G2/M 
checkpoint proficiency was observed (Figure 3.12). In the presence of Chk2 siRNA, most 
cells arrested in S phase and delayed the onset of mitosis after block to DNA replication. 
Entry to mitosis was also blocked after exposure to DNA damage with 10Gy of IR and Verena Oehler, 2007     Chapter 3, 86 
almost all cells arrested in G2 (Figure 3.12). Thus, both S/M and G2/M checkpoint 
responses were functioning properly even in the absence of Chk2.  
The siRNA approach has also been applied to investigate checkpoint responses in BE cells 
in the absence of both Chk1 and Chk2 function (Figure 3.13a). Western blot analysis was 
performed to confirm efficient down regulation of the protein levels of both kinases 
(Figure 3.13b). In the checkpoint proficiency assays, the S/M checkpoint response was 
impaired as judged by the appearance of a small population of premature mitotic cells with 
2N DNA content after replication block with aphidicolin. In comparison, the G2/M arrest 
in response to DNA damage was essentially abrogated in these cells as the majority of cells 
entered mitosis without any measurable arrest in G2. This phenotype was very similar to 
that of Chk1 down regulation alone as shown in the graphical representation of all siRNA 
experiments in this section as calculated from the flow cytometry data and presented in 
graph form to allow ready comparison (Figure 3.11) This result further emphasises the 
significant function of Chk1 in these two mitotic checkpoint responses in BE cells.   
Taken together, the results from the siRNA experiments in BE cells confirmed several 
observations made in the avian DT40 knock out system: Chk1 function is essential for the 
G2/M arrest in response to DNA damage. However, while Chk2 plays a minor role in the 
proper execution of the G2/M checkpoint in DT40 cells, this does not seem to be the case 
in the BE cells. Furthermore, the proper functioning of the S/M checkpoint is also 
dependent on Chk1 function in DT40 and BE cells, whereas Chk2 is not required for 
mitotic delay after replication block. Taken together, Chk1 emerged as the major effector 
kinase of the S/M and G2/M checkpoint responses in both vertebrate systems that were 
analysed in this study.  Verena Oehler, 2007     Chapter 3, 87 
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Figure 3.11: Analysis of S/M and G2/M checkpoint proficiency in BE cells depleted of Chk1 
or Chk2 function 
BE cells were transfected with siRNA against Chk1 or Chk2 or with a negative control. After 48h of 
transfection, cells were exposed to either block to DNA replication with aphidicolin or DNA damage 
with 10Gy of IR and cultured in the presence of nocodazole. At the experimental end point, 
samples were fixed and analysed by flow cytometry for DNA content (PI profiles) and mitotic 
indices (P-S10-H3/PI). The percentage of total mitotic cells after each treatment is annotated in the 
mitotic indices profile. 
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Figure 3.12: Analysis of S/M and G2/M checkpoint proficiency in BE cells depleted of Chk1 
and Chk2 function 
BE cells were transfected with siRNA against Chk1 and Chk2 or with a negative control. After 48h 
of transfection, cells were exposed to either block to DNA replication with aphidicolin or DNA 
damage with 10Gy of IR and cultured in the presence of nocodazole. At the experimental end 
point, samples were fixed and analysed by flow cytometry for DNA content (PI profiles) and mitotic 
indices (P-S10-H3/PI) as shown in (a). Figure (b) shows the Western blot analysis of Chk1 and 
Chk2 protein levels after siRNA treatment with either Chk1 and Chk2 siRNA together (lanes 2-6) or 
Chk1 siRNA alone (lanes 7-8), Actin was used as loading control. 
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Figure 3.13: Comparison of S/M and G2/M checkpoint proficiency in BE cells depleted of 
Chk1 and/or Chk2 expression 
Graphical illustration of a representative example of the flow cytometry data of experiments that 
have been performed several times with reproducible results:  
(a) Percentage of total mitotic cells (i.e. both 2N and 4N) calculated as a percentage of the 
nocodazole treated mitotic control (blue: 100%). Untreated control cells are depicted in black, cells 
treated with aphidicolin are shown in red (S/M checkpoint response), and cells treated with 10Gy IR 
are represented in yellow (G2/M checkpoint response).  
(b) S/M checkpoint response (red) after replication block represented as percentage of 2N 
premature mitosis in each cell line.  
(c) G2/M checkpoint response (yellow) after IR treatment represented as percentage of 4N mitotic 
cells compared to mitotic control (blue: 100%). Verena Oehler, 2007     Chapter 3, 90 
3.3  Discussion  
The requirement of Chk1 and Chk2 for mitotic checkpoint proficiency in response to DNA 
replication block and DNA damage was analysed in two vertebrate systems: avian B-
lymphoma DT40 cells, where WT and knock-out cell lines for each kinase could be 
compared, and in human colon carcinoma BE cells in which Chk1 and Chk2 function was 
abrogated by siRNA or using a selective Chk1 inhibitor. 
Chk1 emerged as the major effector kinase for the S/M delay in both systems. Flow 
cytometry analysis revealed that avian Chk1-/- cells were not able to delay mitosis when 
DNA replication was blocked. Instead, a significant number of cells entered mitosis 
prematurely with un-replicated DNA. Re-expression of Chk1 in the Chk1-/- cells 
completely rescued the phenotype, demonstrating that the effect on checkpoint proficiency 
was directly dependent on Chk1. Further experiments established that the S/M delay was 
dependent on Chk1 kinase activity as cells expressing a kinase dead version of Chk1 were 
not able to delay the onset of mitosis after DNA replication block and also displayed high 
levels of premature mitosis. These observations were consistent with previous studies 
demonstrating a role for Chk1 in response to replication stress in vertebrate cells (Feijoo et 
al., 2001; Zachos et al., 2003).   
The analysis of Chk1 phosphorylation mutants revealed that phosphorylation of Serine 345 
by upstream kinases ATM/ATR was essential for the S/M checkpoint response whereas 
phosphorylation of Serine 317 was dispensable. This result was in agreement with the 
findings of a recent study using conditional Chk1 knock-out ES cells (Niida et al., 2007). 
This also correlated with the finding that Chk1 became very strongly phosphorylated on 
Serine 345 within one hour of aphidicolin treatment. Serine 317 was found to be 
phosphorylated also, however to a much weaker extent. These observations demonstrated 
that Serine 345 is the major phosphorylation site of Chk1 by upstream kinases after DNA 
replication block and it is essential for Chk1 biological function. Serine 317 is a second site 
that is phosphorylated after replication stress; however this does not appear to be essential 
for the initiation or maintenance of the S/M checkpoint delay.  
Chk1 was also shown to play a significant role for S/M checkpoint proficiency in the 
human BE cells. When DNA replication was blocked in the presence of either the Chk1 
inhibitor UCN-01 or Chk1siRNA, BE cells entered mitosis prematurely. The degree of 
checkpoint failure in BE cells did not seem as severe as in the Chk1-/- cells. Differences 
between the two experimental systems could be due to the fact that the avian system used a Verena Oehler, 2007     Chapter 3, 91 
knock-out approach to study Chk1 function and therefore was void of any Chk1 gene or 
protein expression as shown by Western blot analysis for Chk1 protein levels. In contrast, 
the human system was first investigated using the Chk1 inhibitor UCN-01, which might 
not achieve complete inhibition of Chk1 function. In this situation a residual amount of 
active Chk1 and also the actual presence of the Chk1 protein itself, whether active or not, 
could have been responsible for the residual checkpoint response in the BE cells as the 
actual amount of premature mitosis was lower than during checkpoint failure in the avian 
system. The same could apply to the siRNA approach, as although Chk1 protein levels 
were greatly diminished, some residual protein might have remained and could have had 
an effect on the checkpoint response. Alternatively, it is also possible that the degree of the 
S/M checkpoint response simply varies between the two different vertebrate systems. In 
either case, Chk1 plays a crucial role for the proper execution of this mitotic checkpoint in 
both DT40 and BE cells.  
Chk1 also emerged as the major effector kinase for the G2/M arrest in response to DNA 
damage. This mitotic delay was completely abrogated in avian Chk1-/- cells and human 
BE cells treated with Chk1 siRNA. Cells entered mitosis to same levels as control cells 
without any measurable cell cycle arrest, clearly demonstrating that Chk1 is absolutely 
essential for the G2/M arrest. Furthermore, the checkpoint could also be restored by re-
introducing Chk1 in the Chk1-/- cells. The essential requirement of Chk1 for DNA damage 
checkpoint pathways in vertebrate cells has previously been described in studies of Chk1-/- 
blastocysts and conditional Chk1-/- ES cells (Liu et al., 2000; Takai et al., 2000). 
Furthermore, the analysis of Chk1 phosphorylation mutants revealed that phosphorylation 
of Serine 345 is also a crucial event for the G2/M checkpoint function of Chk1 as was 
previously observed for the S/M checkpoint response. Interestingly however, the Chk1 
Serine 317 phosphorylation mutant displayed an intermediate phenotype, suggesting that 
phosphorylation on this residue is necessary for a full G2/M checkpoint response, albeit 
secondary to Serine 345 phosphorylation. This observation suggests that both Serines 317 
and 345 need to be phosphorylated for maximal G2/M checkpoint response. Analysis of 
Chk1 phosphorylation after exposure to 10Gy of IR by Western blotting revealed that both 
Serine residues become phosphorylated within one hour after DNA damage. Interestingly, 
the amount of phosphorylation on S345 and possibly on S317 of Chk1 was much less after 
the doses of IR used as compared to the levels of phosphorylation after DNA replication 
was blocked with aphidicolin. A possible explanation for this could be that the two types of 
genotoxic stress result in different amounts of checkpoint activating structures. For 
example, when replication is blocked with aphidicolin, this presumably affects all active Verena Oehler, 2007     Chapter 3, 92 
replication forks and results in quite a high number of single-stranded stretches of DNA 
that can be bound by sensory proteins such as RPA. Subsequent binding of the ATR-
ATRIP complexes will result in a strong activation of the signalling cascade including high 
levels of Chk1 phosphorylation. In comparison, exposure to IR will create DNA damage 
such as DNA double-strand breaks which may result in a smaller number of DNA repair 
intermediates and single stranded DNA. In addition, treatment with aphidicolin was 
continuous compared to a brief IR treatment. Thus, it is difficult to compare these two 
different treatment regimens. 
A very different picture emerged for the requirement of Chk2 for mitotic checkpoint 
proficiency. Chk2 does not play a significant role in the S/M checkpoint response at least 
in the presence of functional Chk1. Instead it was found to be dispensable as both avian 
Chk2-/- cells and Chk2 siRNA treated human BE cells were still able to delay mitosis after 
DNA replication was blocked. The S/M checkpoint response was almost certainly executed 
by Chk1 which is still functioning in these cells. In the absence of both Chk1 and Chk2 
function, achieved by down-regulation of their protein expression with siRNA in the BE 
cells, the S/M checkpoint response was noticeably impaired. There was no obvious 
quantitative difference between the S/M checkpoint failures in cells depleted of Chk1 alone 
or Chk1 and Chk2 together, suggesting that Chk2 does not contribute to S/M checkpoint 
proficiency independently of Chk1. The significant function of Chk1 in the S/M 
checkpoint response is also in line with previous studies that have demonstrated a role for 
Chk1 in suppressing futile origin firing and stabilizing stalled replication forks in response 
to replication arrest (Feijoo et al., 2001; Zachos et al., 2003). Taken together these 
observations further confirm that Chk1 is the major effector kinase of the S/M checkpoint 
in vertebrate cells whereas Chk2 is dispensable. 
In contrast, Chk2 does contribute to the G2/M checkpoint response in DT40 cells as it 
plays a role in establishing optimal mitotic delay in G2 cells after DNA damage. 
Previously, a study by Xu et al. described and characterised the G2/M arrest after IR and 
demonstrated that two distinct checkpoint responses become activated depending on the 
cell cycle stage that the cells are in at the time of stress (Xu et al., 2002a).  An important 
observation in the study presented here was that Chk2-/- cells displayed an intermediate 
phenotype after DNA damage as some cells arrested in G2, however almost 50% of cells 
did eventually enter mitosis. This result was in agreement with a recent study that 
established a role for Chk2 in the optimal execution of mitotic delay after DNA damage 
(Rainey et al., 2007). This study found that cells lacking Chk2 that were in G1 or S phase 
at the time of DNA damage with IR were able to arrest properly in G2; however a greater Verena Oehler, 2007     Chapter 3, 93 
proportion of cells that were in G2 at the time of damage did enter mitosis compared to 
wild-type cells. The contribution of Chk2 to the G2/M arrest was suggested to be epistatic 
to Chk1. The intermediate phenotype of the Chk2-/- cells in this study can therefore be 
explained by the mixture of cells in an asynchronous cell population, whereby 
approximately half of the cells were in G1 and S phase at the time of damage and therefore 
arrested in G2, while the other half of the cells was mainly in G2 and thus progressed into 
mitosis with DNA damage.  
Analysis of Chk2 requirement in response to DNA damage in human BE cells did not 
reveal a similar role for Chk2 in this checkpoint response as cells treated with Chk2 siRNA 
displayed a functional G2/M arrest comparable to control cells. This could be a general 
difference between the two vertebrate systems or the fact that siRNA down-regulation of 
Chk2 gene expression might not have been as effective and left some residual amounts of 
protein that preserved a functional response. A more careful analysis using various 
approaches of interfering with Chk2 function could be applied to clarify the situation, 
however from the presented data in this study Chk2 appears dispensable for the G2/M 
arrest in BE cells. Taken together, the role of Chk2 appears to vary between the two 
vertebrate systems that were investigated in this study. Under the experimental conditions 
used, Chk2 plays a minor role for the optimal execution of the G2/M arrest in DT40 cells 
but it is basically dispensable for the G2/M arrest in BE cells. When both Chk1 and Chk2 
expression levels were down-regulated with siRNA in BE cells, the G2/M arrest was 
completely abrogated, further emphasising the key role of Chk1.  
In conclusion, Chk1 emerged as the major effector kinase for the G2/M arrest in response 
to DNA damage and for the S/M checkpoint arrest in response to blocks to DNA 
replication in both the avian and human cell systems that were investigated in this study. A 
more detailed analysis and comparison of the mechanisms of mitotic delay after the two 
types of genotoxic stress including respective downstream targets of Chk1 can reveal more 
aspects of the role of Chk1 in mitotic checkpoint responses in vertebrate cells. 
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4  Results: The G2/M and S/M checkpoints are 
mechanistically distinct 
4.1  Kinetic analysis of mitotic checkpoint proficiency 
The experiments in chapter 3 established Chk1 as the major effector kinase for both S/M 
and G2/M checkpoint proficiency in avian DT40 and human BE cells. As these 
checkpoints are activated by two distinct types of stress, i.e. block to DNA replication on 
one side and DNA damage on the other, their actual response mechanism could be 
different even though the eventual outcome is the same: to delay the onset of mitosis. 
Thus, to determine whether the timing of mitotic entry was the same in the absence of 
Chk1, the mitotic checkpoint responses were analysed kinetically.  
4.1.1 Comparison of mitotic checkpoint responses in 
asynchronous DT40 WT and Chk1-/- cell cultures 
To document and compare the S/M and G2/M checkpoint responses over time in the 
presence or absence of functional Chk1, a kinetic analysis was performed with the DT40 
WT and Chk1-/- cell lines. Cells were either exposed to DNA damage with IR or treated 
with the DNA polymerase inhibitor aphidicolin to block DNA replication. Subsequently 
cells were cultured in the presence of the spindle poison nocodazole and samples taken at 
0, 2, 4, 6, 9, and 12h, and analysed for DNA content and mitotic indices by flow 
cytometry.  
As shown in Figure 4.1, control DT40 WT cells progressed steadily through the cell cycle 
with a majority of cells accumulating in mitosis after 12h. In response to DNA damage 
induced by IR, entry to mitosis was completely blocked, although cells progressed through 
S phase and arrested in G2. An initial increase in sub 2N cells for up to 4h was also noted. 
In comparison, when DNA replication was blocked with aphidicolin, cells were also able 
to delay mitotic entry successfully. However in this case they did not progress through the 
cell cycle and appeared to be arrested predominantly in G1 and S phase. Furthermore, a 
significant number of sub 2N DNA content cells could be detected throughout the time 
course. The quantification of the flow cytometry data for this time course experiment is 
presented in Figure 4.3. By comparing the numbers of either the total mitotic or the 4N 
mitotic cells in the graphs on the left side it is apparent that DNA damage and replication Verena Oehler, 2007     Chapter 4, 95 
arrest were equally effective at delaying the onset of mitosis in DT40 WT cells. The 
percentages of total mitotic cells were very low after both DNA damage with IR (10%) and 
replication block (4%), whereas 62% of the control cells entered mitosis (Figure 4.3).  
A similar analysis was also performed on the Chk1-/- cells. As shown in Figure 4.2, 
control Chk1-/- cells progressed through the cell cycle at a comparable rate to the DT40 
WT cells, with approximately two thirds of the cells accumulating in mitosis after 12h. 
After irradiation with 10Gy, Chk1-/- cells advanced through the cell cycle and 
accumulated in mitosis with 4N DNA content at a rate similar to the control cells and 
without any measurable arrest in G2. Furthermore, the actual number of either total or 4N 
mitotic Chk1-/- cells was found to be basically identical after 12h in both control cells 
(56%) and in cells that had been exposed to DNA damage (58%).  
The response of Chk1-/- cells to DNA replication block with aphidicolin was different. 
Initially, the total rate of cells entering mitosis was the same as in control or IR treated 
cells, however this was entirely due to mitotic cells with a DNA content of 4N. Over time 
however, there was a distinct difference in the actual DNA content of the mitotic cells as 
they were comprised of both 2N and 4N cells. As illustrated in the quantification of the 
flow cytometry data in Figure 4.3, only Chk1-/- cells with 4N DNA content initially 
entered mitosis and after approximately 6h this number reached a plateau level and did not 
increase any further. By contrast, Chk1-/- cells with 2N DNA content, and thus 
unreplicated DNA, started to enter mitosis only after 6h of treatment and this number 
increased progressively until the 12h time point.  
Taken together, these experiments revealed a difference in the actual timing of checkpoint 
failure in the different cell populations after DNA damage or DNA replication arrest in the 
Chk1-/- cells. Whereas cells with damaged DNA entered mitosis at a similar rate to control 
cells in the absence of Chk1, there was a difference in the timing of cell populations 
entering normal 4N or premature 2N mitosis after DNA replication was blocked, as the 
onset of premature mitosis occurred only at later times. 
4.1.2 Comparison of mitotic checkpoint responses in BE cells 
A similar kinetic analysis was performed in human BE cells. Time course experiments 
were performed with asynchronous BE cells and Chk1 function was abrogated using the 
inhibitor UCN-01. Cells were exposed to either DNA damage with IR or replication block 
with aphidicolin and cultured in the presence of nocodazole for up to 16h. Verena Oehler, 2007     Chapter 4, 96 
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Figure 4.1: Kinetic analysis of mitotic checkpoint responses in DT40 WT cells 
Asynchronous DT40 WT cells were treated with either 10Gy of IR or the DNA polymerase inhibitor 
aphidicolin and subsequently cultured in the presence of nocodazole. Cells were grown for 12h and 
harvested at the indicated time points. Samples were fixed and analysed for their DNA content (PI 
profiles) and mitotic indices (P-S10-H3/PI) by flow cytometry.Verena Oehler, 2007     Chapter 4, 97 
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Figure 4.2: Kinetic analysis of mitotic checkpoint responses in Chk1-/- cells 
Asynchronous Chk1-/- cells were treated with either 10Gy of IR or the DNA polymerase inhibitor 
aphidicolin and subsequently cultured in the presence of nocodazole. Cells were grown for 12h and 
harvested at the indicated time points. Samples were fixed and analysed for their DNA content (PI 
profiles) and mitotic indices (P-S10-H3/PI) by flow cytometry. Verena Oehler, 2007     Chapter 4, 98 
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Figure 4.3: Comparison of kinetic analysis of mitotic checkpoint responses in DT40 WT and 
Chk1-/- cells 
Graphical illustration of representative examples of the flow cytometry data for the kinetic analysis 
of mitotic checkpoint responses in DT40 WT (graphs on the left side) and Chk1-/- cells (graphs on 
the right side) which has been performed on several occasions with reproducible results (see also 
Figures 4.13 and 4.15 for statistical analysis) .  
Cells were treated with either 10Gy of IR (green) or the DNA polymerase inhibitor aphidicolin (red) 
and cultured in the presence of nocodazole. Apart from the total number of mitotic cells (i.e. 2N and 
4N), the graphs also depict the percentages of 4N mitotic cells and 2N mitotic cells (only for Chk1-/- 
cells). 
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As shown in Figure 4.4, the majority of control BE cells progressed though the cell cycle 
and accumulated in mitosis after 16h in the presence of nocodazole alone. After irradiation 
however, mitosis was blocked. Cells did advance through S phase but by 16h a very high 
percentage arrested in G2 phase with 4N DNA content. In comparison, after DNA 
replication was blocked with aphidicolin, BE cells also effectively delayed the onset of 
mitosis. The cells appeared to be mainly in G1 and S phase of the cell cycle. Quantification 
of the flow cytometry data revealed that whereas up to 73% of control cells entered 
mitosis, only 11% and 15% of cells entered mitosis after treatment with IR and aphidicolin 
respectively (Figure 4.5). The numbers of total and 4N mitotic cells were basically the 
same as essentially no mitotic cells with less than 4N DNA content were observed.   
To inhibit Chk1 function, BE cells were treated with the inhibitor UCN-01 and 
subsequently analysed for mitotic checkpoint proficiency. As shown in Figure 4.4, UCN-
01 alone did not interfere with cell cycle progression. After DNA damage, UCN-01-treated 
cells progressed through the cell cycle almost as rapidly as controls and accumulated in 
mitosis to a similar extent (84% and 78% respectively). In comparison, when DNA 
replication was blocked with aphidicolin, the rate of cells entering mitosis appeared to 
reach similar levels as control cells; however, when separating the total number of mitotic 
cells according to their DNA content, it became apparent that initially only cells with 4N 
DNA content entered mitosis and that from 8h to 16h their number did not increase much 
further and reached a plateau level. By contrast, mitotic cells with 2N DNA content were 
only observed at the 16h time point when a large percentage (32%) of cells entered mitosis 
with unreplicated DNA. Figure 4.5 shows the quantification of 2N and 4N mitotic cells 
from the flow cytometry data for this experiment.  
In summary, quantification of the time course data indicated that there was a difference in 
the timing of checkpoint failure in different cell populations in response to the two types of 
genotoxic stress. The results from the UCN-01 treated BE cells were very reminiscent of 
observations previously made in the avian Chk1-/- DT40 cells. In both systems, cells 
without Chk1 function were unable to delay mitosis after DNA damage as cells progressed 
through the cell cycle and accumulated in mitosis at the same rate as unstressed control 
cells. In contrast, when DNA replication was blocked with aphidicolin, there was a 
difference in the timing of cell populations entering normal 4N or premature 2N mitosis in 
the absence of functional Chk1. Similar to Chk1-/- cells, the UCN-01 treated BE cells 
entered premature mitosis with un-replicated DNA only at later times.  Verena Oehler, 2007     Chapter 4, 100 
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Figure 4.4: Kinetic analysis of mitotic checkpoint responses in BE cells 
The timing of S/M and G2/M checkpoint responses of BE cells was compared in normal wild-type 
cells (a) or cells that were grown in the presence of the Chk1 inhibitor UCN-01 (b). Cells were 
treated with either the DNA polymerase inhibitor aphidicolin or 10Gy of IR and then cultured in the 
presence of nocodazole. Cells were grown for up to 16h and harvested at the indicated time points. 
Samples were fixed and analysed for their DNA content (PI profiles-not shown) and mitotic indices 
(P-S10-H3/PI) by flow cytometry. Verena Oehler, 2007     Chapter 4, 101 
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Figure 4.5: Quantification of kinetic analysis of mitotic checkpoint responses in BE cells  
Graphical illustration for a representative example of the flow cytometry data for the kinetic analysis 
of mitotic checkpoint responses for BE cells (graphs on the left side) and BE cells treated with the 
Chk1 inhibitor UCN-01 (graphs on the right side). Cells were treated with either 10Gy of IR (green) 
or the DNA polymerase inhibitor aphidicolin (red) and cultured in the presence of nocodazole. Apart 
from the total number of mitotic cells (i.e. 2N and 4N), the graphs also depict the percentages of 4N 
mitotic cells and 2N mitotic cells (only for BE UCN-01). 
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4.1.3 Comparison of mitotic checkpoint responses in 
synchronised DT40 WT and Chk1-/- cells  
The time course analysis of mitotic checkpoint responses in asynchronous DT40 cells and 
BE cells revealed differences in the timing of the checkpoint failure in different cell 
populations in response to either DNA damage or DNA replication block. To document 
and compare these timing differences in more detail, the kinetic analysis of mitotic 
checkpoint responses was performed with synchronised cells. Also, asynchronous cell 
populations are not ideal for a detailed biochemical analysis as the presence of cells in 
various cell cycle phases could obscure biochemical changes occurring in a specific 
subpopulation.  
To obtain a purified cell population, asynchronous DT40 WT or Chk1-/- cultures were 
synchronised by centrifugal elutriation, a method that allows separation of cells based on 
their size (see method section 2.2.4). Populations of cells in the G1/S phase of the cell 
cycle were elutriated and then either exposed to DNA damage with 10Gy of IR or treated 
with the DNA polymerase inhibitor aphidicolin to block DNA replication. Cells were then 
returned to culture and grown in the presence of the spindle poison nocodazole. This 
procedure made it possible to observe the progress of a synchronised cell population 
through the cell cycle to mitosis as well as their actual DNA content in much more detail.  
Figure 4.6 shows synchronised G1/S DT40 WT control cells progressing unperturbed 
through the cell cycle in the presence of nocodazole. Most cells reached S phase 4h after 
release as can be seen clearly in the PI profiles in Figure 4.6. The cells then passed through 
G2 phase and eventually after 12h almost all cells entered mitosis.  
In comparison, when cells were exposed to DNA damage with IR, they did not enter 
mitosis. A small but significant proportion of DT40 WT cells appeared to arrest in S phase 
after IR treatment, indicating the existence of an intra S phase checkpoint in response to 
DNA damage in these cells (Figure 4.6). Aside from this specific population, the vast 
majority of irradiated DT40 WT cells progressed through S phase by 4 to 6h and 
eventually accumulated in G2 phase with 4N DNA content. There was also some level of 
cell death after DNA damage as apparent in the sub 2N population, most notably at the 2h 
time point (Figure 4.6).  
In contrast, when DNA replication was blocked with aphidicolin, accumulation of mitotic 
cells was also completely blocked. However, the purified cell population did not progress  Verena Oehler, 2007     Chapter 4, 103 
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Figure 4.6: Mitotic checkpoint responses in G1/S synchronised DT40 WT cells 
A purified G1/S cell population was isolated from DT40 WT cells by centrifugal elutriation and 
returned to culture. Cells were subsequently treated with either the DNA polymerase inhibitor 
aphidicolin or 10Gy of IR and released into culture in the presence of nocodazole. Cells were 
grown for 12h and harvested at the indicated time points. Samples were fixed and analysed for 
their DNA content (PI profiles) and mitotic indices (P-S10-H3/PI) by flow cytometry. Verena Oehler, 2007     Chapter 4, 104 
through the cell cycle and appeared to still be in G1/S phase, or, most likely early S, after 
12h of aphidicolin treatment. There was some level of cell death, which was greatest after 
4h but still apparent at 12h. Taken together, these results showed that DT40 WT cells were 
blocked from entering mitosis in the presence of either damaged or un-replicated DNA and 
accumulated in G2 phase or G1/S phase, respectively. The results obtained from this kind 
of time course experiment were very reproducible. The average of the flow cytometry data 
of four independent elutriation experiments is shown in Figure 4.8.  
A similar kinetic analysis was also performed with the Chk1-/- cells. Elutriated purified 
G1/S Chk1-/- control cells progressed through the cell cycle in a similar manner to their 
DT40 WT counterparts in the absence of perturbation (Figure 4.7). In response to DNA 
damage with IR, the G1/S cell population of Chk1-/- cells advanced through S phase and 
G2 phase without any measurable arrest and eventually accumulated in natural 4N mitosis 
at levels comparable to control cells. In contrast to DT40 WT cells, the Chk1-/- cells 
displayed no measurable arrest or slowing in S phase or G2 phase in response to DNA 
damage, indicating that Chk1 function is required for an intra S phase checkpoint as well 
as the G2/M checkpoint response in the DT40 cells.  
In marked contrast, when the purified Chk1-/- cells were treated with the DNA polymerase 
inhibitor aphidicolin and then released back into culture, accumulation of mitotic cells was 
almost completely blocked for up to 6h (Figure 4.7). The initial mitotic delay of Chk1-/- 
cells lasted for up to 9h, after which the majority of arrested cells entered mitosis 
prematurely. This was not due to cells progressing through S phase to reach G2 and then 
divide; instead these cells entered mitosis with unreplicated DNA. The quantification of 
the flow cytometry data from four independent experiments demonstrated how 
reproducible these observations were. As shown in the graph in Figure 4.8, there were 
significant differences in the timing of the appearance of mitotic cells after aphidicolin or 
IR treatment. Whereas the amount and rate of progression into mitosis was basically the 
same after DNA damage as in the unstressed control cells, there was absolutely no increase 
in the number of mitotic cells after aphidicolin treatment for up to 9h. However, after this 
prolonged mitotic delay Chk1-/- cells did eventually enter mitosis, although prematurely 
with unreplicated DNA.  
Furthermore, the levels of cell death in the Chk1-/- cells after both IR and aphidicolin 
treatment were practically negligible, as judged by the amount of cells with a DNA content 
of less than 2N (Figure 4.7). This observation could indicate a potential role for Chk1 in 
stress-induced cell death mechanisms, a notion that will require further investigation.  Verena Oehler, 2007     Chapter 4, 105 
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Figure 4.7: Mitotic checkpoint responses in G1/S synchronised Chk1-/- cells 
A purified G1/S cell population was isolated from Chk1-/- cells by centrifugal elutriation and 
returned to culture. Cells were subsequently treated with either the DNA polymerase inhibitor 
aphidicolin or 10Gy of IR and released into culture in the presence of nocodazole. Cells were 
grown for 12h and harvested at the indicated time points. Samples were fixed and analysed for 
their DNA content (PI profiles) and mitotic indices (P-S
10-H3/PI) by flow cytometry. 
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The use of synchronised cells allowed the exact documentation of the behaviour of a 
specific cell population in response to DNA damage or DNA replication arrest and 
revealed significant differences between the two mitotic checkpoint mechanisms. The 
G2/M arrest, as well as the intra S phase arrest, is completely absent in Chk1-/- cells and 
therefore absolutely dependent on Chk1 function. In marked contrast, only the 
maintenance of the S/M checkpoint is dependent on Chk1, whereas the initiation of the 
checkpoint is not. Chk1-/- cells in G1/S phase can initially delay the onset of mitosis for 
more than 9h and only after this extended time period do they enter mitosis with 
unreplicated DNA. This strongly suggests that some timing mechanism other than cell 
cycle position and progression per se is operating and is responsible for the initial S/M 
checkpoint delay in the absence of Chk1. 
 
 
 Verena Oehler, 2007     Chapter 4, 107 
  
DT40 WT
0
10
20
30
40
50
60
70
80
90
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
hours in nocodazole
%
 
t
o
t
a
l
 
m
i
t
o
t
i
c
 
c
e
l
l
s
control
aphidicolin
IR
Chk1-/- DT40
0
10
20
30
40
50
60
70
80
90
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
hours in nocodazole
%
 
t
o
t
a
l
 
m
i
t
o
t
i
c
 
c
e
l
l
s
control
aphidicolin
IR
 
Figure 4.8: Comparison of mitotic checkpoint responses in DT40 WT and Chk1-/- cells 
Quantification of the flow cytometry data from the kinetic analysis of mitotic checkpoint responses 
in synchronised DT40 WT (top) and Chk1-/- cells (bottom): The percentage of total mitotic cells 
was judged by P-S10-H3 staining and the average was calculated from four independent 
experiments, including the standard deviation. Untreated control cells are depicted in black, cells 
treated with 10Gy IR are represented in green (G2/M checkpoint response) and cells treated with 
aphidicolin are shown in red (S/M checkpoint response).  Verena Oehler, 2007     Chapter 4, 108 
4.2   Timing of S/M checkpoint failure in the absence of 
Chk1 and Chk2 activity  
Chk1-/- cells still express functional Chk2, therefore this raises the question of whether the 
initial mitotic delay during aphidicolin treatment could be executed by Chk2. When Chk2-
/- cells were treated with the Chk1-inhibitor UCN-01 they still retained an initial mitotic 
delay after DNA replication block, however whether the kinetics of checkpoint failure 
were altered was not resolved (Zachos et al., 2005). Building on these observations, one 
aim of this study was to investigate checkpoint responses in DT40 cells devoid of both 
Chk1 and Chk2 function. 
4.2.1 Attempts to generate a Chk1/Chk2 double knock-out DT40 
cell line  
To address this issue genetically, a gene knock-out approach was attempted. It was decided 
to try to knock out the Chk2 gene in the Chk1-/- background by homologous 
recombination and thereby obtain a Chk1/Chk2 double knock-out DT40 cell line. DT40 
cells have a high ratio of targeted to random integration after transfection (Buerstedde and 
Takeda, 1991) and have previously been successfully used to establish a wide range of 
knock-out cell lines including the Chk1-/- and Chk2-/- cell lines.    
The design of the Chk2 gene targeting vector was based on the Chk2 targeting vector that 
had been used previously to generate the Chk2-/- cells (Rainey et al., 2007), although a few 
important changes were introduced. In order to knock-out the two chicken Chk2 alleles it 
was necessary to generate a replacement construct containing two regions of homology and 
a selectable marker cassette which would then replace essential regions of the Chk2 gene. 
As the Chk1-/- and the Chk2-/- cell lines are resistant to puromycin and neomycin due to 
the design of their original respective gene targeting vectors, the selectable marker cassette 
of the new Chk2 targeting vector had to be changed. The regions of homology were 
created by amplifying stretches of genomic DNA using PCR with primers based on the 
chicken Chk2 cDNA sequence (Rainey, 2003). Briefly, the left arm of homology was of 
1kb length whereas the right arm of homology was of 2.6kb length and with these regions 
in the targeting vector it would be possible to achieve disruption of the region of the Chk2 
gene that encoded the FHA domain and most of the kinase domain. Figure 4.9 shows a 
schematic diagram of the design of the targeting vectors and the targeting strategy.  Verena Oehler, 2007     Chapter 4, 109 
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Figure 4.9: Schematic overview of Chk2 gene targeting vector and knock-out strategy 
This simplified schematic overview shows the Chk2 genome sequence (blue box) that encodes the 
Chk2 protein. The Chk2 targeting construct has been aligned to show how the two regions of 
homology (LA and RA) relate to the genomic sequence of Chk2. The region of genomic Chk2 that 
would get disrupted by targeted integration is also highlighted (grey box). PCR primers are 
annotated in green (primers BSR2, C, I, RA1, RA2, V) and EcoRI restriction enzymes and the 
probe relevant for Southern blotting are highlighted in red.  Verena Oehler, 2007     Chapter 4, 110 
The newly integrated BSR cassette was flanked by two loxP sites and would confer 
resistance to blasticidin. The presence of loxP sites would allow recycling of the marker 
cassette by excising it with Cre recombinase after the first round of targeting and therefore 
rendering the targeting vector re-usable for disruption of the second Chk2 allele. 
The targeting vector was linearised and transfected into Chk1-/- cells in order to obtain 
clones that had stably integrated the targeting construct (see methods). Over the course of 
several rounds of targeting a large number of blasticidin resistant clones was analysed for 
targeted integration by PCR and Southern blotting. Altogether however, only two targeted 
clones could be identified. An example of the PCR/Southern blot analysis for the targeting 
event is shown in Figure 4.10. To summarise briefly, the PCR products in lanes 3 and 4 
were of the predicted size for amplification of a stretch of DNA from a region within the 
selectable BSR marker cassette of the targeting construct to a region of genomic DNA that 
lay outside of the targeting construct. The presence of these PCR products therefore 
confirmed targeting of at least one of the two Chk2 alleles in this particular clone. As for 
the Southern blotting analysis (see methods), a probe was chosen that would recognize a 
fragment of 3.9kb if the gene was wild-type and a fragment of 6.4kb if the gene was 
targeted as integration of the vector would have destroyed one restriction site of the wild-
type gene and created a new site that was located within the targeting vector (Figure 4.9). 
Figure 4.10 shows a Southern blot analysis with DT40 WT, Chk2-/-, and a targeted Chk1-
/-; Chk2+/- clone. Due to differences in the amount of genomic DNA in each lane, the two 
bands at 6.4kb and 3.9kb are quite faint but still visible and confirmed targeting of one of 
the two Chk2 alleles in this clone.  
Unfortunately, neither clone could be propagated for an extended period of time as they 
died within a few weeks of culturing. Several attempts to grow the cells for a longer time 
period failed and therefore made it impossible to characterise these clones thoroughly. This 
issue remains to be resolved; however there are several reasons why the approach to 
generate Chk1/Chk2 double knock-out cells did not have a positive outcome.  
Over the course of several rounds of targeting, only two targeted clones were identified. 
Reasons for this could have been that the targeting strategy and the design of the targeting 
vector was not optimal and also that the transfection efficiency in general was quite low. It 
was not possible to grow Chk1-/-;Chk2+/- cells in culture for an extended amount of time, 
implying that Chk2 was important for the growth of these cells in the absence of Chk1 and 
that a double knock-out was likely to be lethal. There are several ways to address these 
problems: apart from trouble-shooting the design of the targeting vector, the transfection Verena Oehler, 2007     Chapter 4, 111 
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Figure 4.10: Analysis of Chk2 targeting event by PCR and Southern blotting 
Left: Agarose gel photograph depicting results from a PCR analysis. L: λ/HindIII DNA ladder, PCR 
reactions with primers: for 1: V-C control genomic DNA, 2: BSR2-I control vector, 3: BSR2-RA1 
and 4: BSR2-RA2 targeting event. Right: Southern blot analysis with probe A on genomic DNA 
after digest with EcoRI restriction enzyme. DT40 WT (3.9kb), Chk2-/- (6.4kb), and Chk2+/-;Chk1-/- 
clone (3.9kb and 6.4kb). Verena Oehler, 2007     Chapter 4, 112 
method and the screening process, it would be logical to try a conditional knock-out 
approach where Chk1 and Chk2 gene expression could be switched off for the duration of 
an experiment. This method could also clarify whether the issue of lethality of the cells in 
culture is true.  
4.3  Effect of ATM/ATR inhibition with caffeine on mitotic 
checkpoint responses 
As part of the signalling cascade activated in response to genotoxic stress, the upstream 
kinases ATM/ATR, in particular ATR, can phosphorylate and activate Chk1 kinase (Zhao 
and Piwnica-Worms, 2001). In contrast, Chk2 is phosphorylated and activated mainly by 
ATM (Matsuoka et al., 2000). Interfering with components of this signalling pathway can 
result in checkpoint failure, as has been shown in the case of Chk1 previously in this study. 
When Chk1 function was abrogated in DT40 and BE cells both S/M and G2/M checkpoint 
response were severely compromised. If ATM/ATR and Chk1/Chk2 operate in the same 
signalling cascade, then inhibition of ATM and ATR could potentially mimic the inhibition 
of both Chk1 and Chk2.  
The natural compound caffeine is a widely used reagent that has been shown to inhibit the 
catalytic activity of both ATM and ATR kinases (Sarkaria et al., 1999). Therefore, caffeine 
was used to investigate the role of ATM/ATR in the G2/M and S/M checkpoint responses 
in avian DT40 and human BE cells. The effectiveness of inhibition of ATM/ATR activity 
with caffeine was initially tested in the DT40 WT cells. To achieve this, cells were treated 
with aphidicolin which was known to induce a strong checkpoint response associated with 
Chk1 activation within minutes. The phosphorylation of Chk1 on S345 is not only a read-
out of Chk1 kinase activity but can also serve as a read-out for ATM/ATR kinase activity 
as S345 of Chk1 is a known ATM/ATR phosphorylation site (Zhao and Piwnica-Worms, 
2001). Thus, analysing the levels of Chk1 S345 phosphorylation by Western blotting 
allowed an estimation of ATM/ATR activity. As shown in Figure 4.11, when comparing 
the effect of caffeine in relation to the time of addition to the cells, the strongest inhibitory 
effect on aphidicolin-induced Chk1 phosphorylation at S345 was observed when cells had 
been pre-treated with caffeine. Significantly weaker inhibition was obtained if caffeine was 
added at the same time as aphidicolin, and none at all if it was added afterwards. 
Therefore, for all following experiments ATM/ATR inhibition was accomplished by pre-
treating cells with caffeine for 30min. Verena Oehler, 2007     Chapter 4, 113 
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Figure 4.11: Effect of caffeine treatment on Chk1 phosphorylation 
The effect of caffeine on Chk1 phosphorylation as a read-out of ATM/ATR kinase activity after DNA 
replication block with aphidicolin was analysed in DT40 WT cells. The cells were either untreated 
(1), treated with aphidicolin alone (2), with caffeine alone (3), caffeine was added 15min after 
aphidicolin treatment (4), caffeine and aphidicolin were added at the same time (5), or cells were 
pre-treated with caffeine for 15min before aphidicolin was added (6). Samples were harvested after 
1.5h in the absence or presence of 5mM caffeine and analysed by SDS PAGE and Western 
blotting with antibodies specific for phosphorylation of Chk1 on S345 and total Chk1. 
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4.3.1 Effect of caffeine on S/M and G2/M checkpoint responses in 
BE cells 
To evaluate the role of ATM/ATR in human cells, BE cells were pre-treated with caffeine 
for 30min and subsequently analysed for checkpoint proficiency by flow cytometry. As in 
previous experiments, cells were exposed to DNA damage with IR or DNA replication 
block with aphidicolin and cultured in the presence of nocodazole for 16h.  
As shown in Figure 4.12a, caffeine did not inhibit normal cell cycle progression as seen in 
the nocodazole treated samples. However, in response to DNA damage with IR, caffeine 
severely impaired the G2/M checkpoint as cells entered mitosis without any measurable 
arrest. This is also illustrated in the graphical representation of the flow cytometry data in 
Figure 4.12b. Whereas only 10% of untreated BE cells entered mitosis after DNA damage, 
more than 50% of the cells with caffeine pre-treatment accumulated in mitosis after 
exposure to IR. In comparison, in response to DNA replication block with aphidicolin, 
caffeine also increased the overall number of mitotic cells and led to the appearance of 
cells that entered mitosis prematurely with 2N DNA content, which is a diagnostic feature 
of S/M checkpoint failure (Figure 4.12a). Thus, the effect of ATM/ATR inhibition on the 
S/M and G2/M checkpoint responses in the BE cells was comparable to the effect of Chk1 
inhibition with UCN-01 or Chk1 down-regulation with siRNA. Verena Oehler, 2007     Chapter 4, 115 
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Figure 4.12: Effect of ATM/ATR inhibition with caffeine on mitotic checkpoint responses in 
BE cells 
ATM/ATR function was inhibited by pre-treating the cells for 30min with 5mM caffeine and then 
exposed to appropriate drug treatment. DNA replication was blocked by aphidicolin and DNA 
damage was induced with 10Gy of IR. Cells were grown in the presence of nocodazole and in the 
presence or absence of caffeine and harvested after 16h of treatment and subsequently analysed 
by flow cytometry for DNA content (PI profiles) and mitotic indices (P-S10-H3/PI) as shown in (a). 
Quantification of the percentage of mitotic cells is displayed in (b): total number of mitotic cells in 
the upper panel and number of 2N mitotic cells in the lower panel.    Verena Oehler, 2007     Chapter 4, 116 
4.3.2 Effect of caffeine on mitotic checkpoint proficiency in DT40 
WT and Chk1-/- cells 
To evaluate the role of ATM/ATR in the S/M and G2/M checkpoint responses in the avian 
DT40 cells, the effect of caffeine on checkpoint proficiency was first examined in 
genetically normal cultures of DT40 WT cells and subsequently in the Chk1-/- cells which 
were included for comparison.  
Interesting differences in the behaviour of the DT40 WT cells in the mitotic checkpoint 
assays were observed when ATM/ATR activity was inhibited by a 30 min pre-treatment 
with caffeine prior to the start of 12h time course treatments. As shown in Figure 4.13, the 
majority of cells treated with caffeine alone accumulated in mitosis after 12h in nocodazole 
just as their untreated counterparts, indicating that caffeine did not interfere with normal 
cell cycle progression. In response to DNA damage, almost as many caffeine-treated cells 
entered mitosis as in the control cultures and only relatively few cells were observed to 
arrest in G2. Interestingly however, when DNA replication was blocked in the presence of 
caffeine, accumulation of mitotic cells was suppressed and no mitotic cells with 2N DNA 
content were observed. This indicated that a functional S/M checkpoint response persisted 
in caffeine-treated DT40 WT cells. Furthermore, these results also indicated the potential 
existence of a Chk1-dependent but caffeine-(ATM/ATR)-independent checkpoint in 
response to replication arrest in DT40 WT cells.  
The quantification of three independent time course experiments with asynchronous DT40 
WT cells is presented in Figure 4.14. For comparison, the upper panel shows the response 
of control DT40 WT cells to IR and aphidicolin as previously described in detail in chapter 
4.1.1, and the lower panel presents the response of DT40 WT cells that had been pre-
treated with caffeine (Figure 4.14). Taken together, these results show that ATM/ATR 
inhibition with caffeine in DT40 WT cells had little, if any, effect on the S/M checkpoint 
but strongly compromised the G2/M arrest.  
The Chk1-/- cells were also included in the analysis to investigate any possible additive 
effects of dual ATM/ATR inhibition with caffeine and Chk1 loss. The flow cytometry data 
from a representative example for this analysis is shown in Figure 4.15. The quantification 
of the data from three independent experiments including the response of control Chk1-/- 
cells as previously described in detail in chapter 4.1.1 is illustrated in Figure 4.16.  Verena Oehler, 2007     Chapter 4, 117 
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Figure 4.13: Effect of ATM/ATR inhibition with caffeine on mitotic checkpoint responses in 
DT40 WT cells 
Asynchronous cultures of DT40 WT cells were pre-treated with the ATM/ATR inhibitor caffeine for 
30min and subsequently treated with either 10Gy of IR or the DNA polymerase inhibitor aphidicolin 
and cultured in the presence of nocodazole. Cells were grown for 12h and harvested at the 
indicated time points. Samples were fixed and analysed for their DNA content (PI profiles) and 
mitotic indices (P-S10-H3/PI) by flow cytometry. Verena Oehler, 2007     Chapter 4, 118 
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Figure 4.14: Comparison of the effect of ATM/ATR inhibition with caffeine on mitotic 
checkpoint responses in DT40 WT cells 
Quantification of the flow cytometry data from the kinetic analysis of mitotic checkpoint responses 
in asynchronous cultures of DT40 WT cells: The graphs show control DT40 WT cells (top) versus 
caffeine pre-treated cells (bottom). The percentage of total mitotic cells was judged by P-S10-H3 
staining and the average was calculated from three independent experiments, including the 
standard deviation. Untreated control cells are depicted in black, cells treated with 10Gy IR are 
represented in green (G2/M checkpoint response), and cells treated with aphidicolin are shown in 
red (S/M checkpoint response). Verena Oehler, 2007     Chapter 4, 119 
Several interesting observations were made when analysing the effect of caffeine on the 
Chk1-/- cells. Firstly, the overall number of cells progressing to mitosis was reduced by 
approximately one third compared to cells without caffeine pre-treatment (see graphs in 
Figure 4.16). Also, caffeine blocked some cells in G1/S as can be seen in the flow 
cytometry profiles in Figure 4.15. These observations indicated that ATM/ATR inhibition 
had a negative effect on cell cycle progression in the Chk1-/- cells. In response to DNA 
damage with IR, the majority of caffeine pre-treated Chk1-/- cells progressed into mitosis 
without measurable arrest (Figure 4.15). This result was very similar to the DNA damage 
response of Chk1-/- cells with functional ATM/ATR, albeit the total amount of mitotic 
cells was lower after caffeine pre-treatment. Another interesting observation was made 
when Chk1-/- cells were treated simultaneously with caffeine and the DNA polymerase 
inhibitor aphidicolin. In response to replication block, caffeine pre-treated Chk1-/- cells 
were able to delay mitosis for the duration of the experiment. The amount of mitotic cells 
with 2N DNA content at the 12h time point was extremely low (1%) in comparison to 
Chk1-/- cells with functional ATM/ATR (14%) as illustrated in the graphs in Figure 4.16 
(right panels). 
In summary, the effect of ATM/ATR inhibition with caffeine was found to be of a different 
nature for the mitotic checkpoint responses in the DT40 WT and Chk1-/- cells. The G2/M 
arrest was basically abrogated by caffeine pre-treatment in the DT40 WT cells. As Chk1-/- 
cells display G2/M arrest checkpoint failure in general, it was noted that ATM/ATR 
inhibition with caffeine did not have any additional effect on the extent of this checkpoint 
failure. However, while the S/M checkpoint response appeared to persist in caffeine-
treated DT40 WT cells, caffeine-treated Chk1-/- cells surprisingly appeared to block the 
onset of premature mitosis in response to aphidicolin treatment, suggesting that caffeine 
somehow affected this checkpoint response, an observation that was further explored.  
 Verena Oehler, 2007     Chapter 4, 120 
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Figure 4.15: Effect of ATM/ATR inhibition with caffeine on mitotic checkpoint responses in 
Chk1-/- cells 
Asynchronous cultures of Chk1-/- cells were pre-treated with the ATM/ATR inhibitor caffeine for 
30min and subsequently treated with either 10Gy of IR or the DNA polymerase inhibitor aphidicolin 
and cultured in the presence of nocodazole. Cells were grown for 12h and harvested at the 
indicated time points. Samples were fixed and analysed for their DNA content (PI profiles) and 
mitotic indices (P-S10-H3/PI) by flow cytometry. Verena Oehler, 2007     Chapter 4, 121 
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Figure 4.16: Comparison of the effect of ATM/ATR inhibition with caffeine on mitotic 
checkpoint responses in Chk1-/- cells 
Quantification of the flow cytometry data from the kinetic analysis of mitotic checkpoint responses 
in asynchronous cultures of Chk1-/- cells: The graphs show control Chk1-/- cells (top) versus 
caffeine pre-treated cells (bottom). The percentage of total mitotic cells was judged by P-S10-H3 
staining and the average was calculated from three independent experiments, including the 
standard deviation. Untreated control cells are depicted in black, cells treated with 10Gy IR are 
represented in green (G2/M checkpoint response), and cells treated with aphidicolin are shown in 
red (S/M checkpoint response). 
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4.3.3 Effect of caffeine on the timing of S/M checkpoint failure in 
Chk1-/- cells 
Under the conditions used in this study, the inhibition of ATM/ATR with caffeine 
(including a 30min pre-treatment) did not override the S/M checkpoint in DT40 WT cells, 
which were still able to delay mitosis after replication block in the presence of caffeine. 
However, caffeine treatment changed the behaviour of Chk1-/- cells in response to DNA 
replication block. Caffeine had a negative effect on cell cycle progression specifically in 
the Chk1-/- cells. In addition, virtually no 2N mitotic Chk1-/- cells appeared after 12h of 
DNA replication block in combination with caffeine treatment. Since it seems unlikely that 
caffeine could restore a normal S/M checkpoint response in the absence of Chk1, these 
observations raised the question of whether it was altering the timing of the S/M 
checkpoint failure in the Chk1-/- cells. 
To test the possibility that ATM/ATR inhibition with caffeine could affect the timing of 
the S/M checkpoint failure, the time course analysis was extended for a longer time period. 
Figure 4.17 shows that when Chk1-/- cells were treated with aphidicolin alone in the 
presence of nocodazole, approximately 20% of the cells entered premature mitosis by 12h 
and this number did not increase much further until up to 19.5h. By contrast, caffeine pre-
treated Chk1-/- cells displayed very low amounts of 2N mitotic cells after 12h of 
replication arrest. Interestingly however, after 14 and 16h more and more of these caffeine 
treated Chk1-/- cells entered mitosis prematurely, reaching more than 10% at the 19.5h 
time point as depicted in the graphical representation in Figure 4.17b.  
These observations suggested that caffeine does not only have an effect on the timing of 
cell cycle progression in Chk1-/- cells in general, but also on the timing of the mitotic 
checkpoint in response to DNA replication arrest. Caffeine was able to delay the onset of 
S/M checkpoint failure in Chk1-/- cells for many hours. However, caffeine treatment did 
not have any effect on the timing of the G2/M checkpoint failure in response to DNA 
damage in Chk1-/- cells. Thus, these two mitotic checkpoint responses can be further 
distinguished by their sensitivity to caffeine.      Verena Oehler, 2007     Chapter 4, 123 
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Figure 4.17: Effect of ATM/ATR inhibition with caffeine on the timing of S/M checkpoint 
failure in Chk1-/- cells  
Extended kinetic analysis of the effect of ATM/ATR inhibition on the onset of premature mitosis in 
Chk1-/- cells: Inhibition of ATM/ATR was achieved by a 30min pre-treatment with caffeine. 
Subsequently, cells were treated with aphidicolin and nocodazole for up to 19.5h before being 
analysed by flow cytometry for DNA content (PI profiles) and mitotic indices (P-S10-H3/PI) as 
shown in (a). Quantification of the amount of total, 4N, and 2N mitotic cells is presented in the 
graphs in (b). (Aph: Aphidicolin and Caff: Caffeine) 
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4.3.4 Timing of S/M checkpoint failure in Chk1 mutant cells is not 
affected by expression of catalytically inactive or S345A Chk1 
The analysis of the effect of ATM/ATR inhibition during replication block in Chk1-/- cells 
showed that the onset of S/M checkpoint failure was delayed in the presence of caffeine. 
This observation raised the question of whether mutants of Chk1 that for example can not 
be activated by ATM/ATR would exhibit similar changes in the timing of the onset of 
premature mitosis after DNA replication block with aphidicolin. 
To further investigate this issue, time course experiments were performed with Chk1-/-, 
Chk1 S345A, and Chk1 K38R cells. The Chk1 S345A mutant can not be phosphorylated 
by upstream kinases ATM/ATR. The K38R mutant is a catalytically inactive version of 
Chk1 and was included to test any dominant-negative effects. The cells were treated with 
the DNA polymerase inhibitor aphidicolin and grown in the presence of nocodazole for up 
to 12h. As in previous experiments, the analysis of mitotic indices by flow cytometry 
revealed that the Chk1-/- cells initially delayed mitosis, but after 9h cells started to enter 
mitosis prematurely with 2N DNA content (Figure 4.18a). Quantification of the flow 
cytometry data showed that the rate of entry into mitosis of the 2N cells was basically the 
same in all three cell lines (Figure 4.18b). Although the Chk1 S345A mutant did 
accumulate more 4N mitotic cells by 5h compared to the Chk1-/- and Chk1 K38R cells, 
overall the timing of S/M checkpoint failure was very similar in all three cell lines.  
Taken together, these observations indicated that cells expressing these mutants of Chk1, 
which are either catalytically inactive or can not be phosphorylated by upstream kinases 
ATM/ATR, display very similar phenotypes to Chk1-/- cells in response to replication 
block. The timing of S/M checkpoint failure was not affected in these cells, in contrast to 
the effect of ATM/ATR inhibition with caffeine which delayed the onset of premature 
mitosis.    Verena Oehler, 2007     Chapter 4, 125 
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Figure 4.18: Timing of S/M checkpoint failure in Chk1 mutants 
To compare the timing of S/M checkpoint failure, Chk1-/-, Chk1 S345A, and Chk1 K38R cells were 
treated with aphidicolin and nocodazole for up to 12h. Samples were analysed for mitotic indices by 
flow cytometry. Figure (a) shows the P-S10-His H3/PI profiles and (b) illustrates the quantification 
of the flow cytometry data.   
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4.4  Discussion 
One of the aims of this study was to characterise and compare the G2/M and S/M 
checkpoint mechanisms and their requirement for Chk1, which was established as the 
major effector kinase for mitotic checkpoint proficiency in both avian DT40 and human 
BE cells. Remarkably, kinetic analysis revealed that the G2/M and S/M checkpoint 
mechanisms can be distinguished in terms of the rate at which cells enter mitosis aberrantly 
in the absence of Chk1 function and they can furthermore be distinguished according to 
their sensitivity to the ATM/ATR inhibitor caffeine.   
In response to DNA damage with IR, checkpoint proficient cells accumulate in G2 and can 
delay entry to mitosis in the presence of damaged DNA. Chk1 is absolutely essential for 
this G2/M arrest as Chk1-/- cells displayed immediate checkpoint failure with cells 
progressing through the cell cycle and entering mitosis without any measurable arrest in 
G2. The same was true for BE cells treated with the Chk1 inhibitor UCN-01 where the 
G2/M arrest in response to DNA damage was completely absent. These observations 
demonstrate a direct role for Chk1 in the G2/M arrest in vertebrate cells which is consistent 
with several previous studies analysing Chk1 requirement in response to DNA damage 
(Busby et al., 2000; Graves et al., 2000; Zachos et al., 2003).  
In contrast, in response to DNA replication block with the DNA polymerase inhibitor 
aphidicolin, cells with a functional S/M checkpoint can delay mitosis in the presence of un-
replicated DNA. This checkpoint response is also dependent on Chk1 function, but 
importantly, whereas Chk1 is essential for the maintenance of this mitotic delay, it is not 
essential for its initiation. This was initially documented in Chk1-/- cells where in response 
to replication block the cells behaved differently according to their position in the cell 
cycle at the time of arrest. Chk1-/- cells that were in G2 phase when aphidicolin was added 
initially entered mitosis at a rate similar to control cells until the respective G2-population 
had been depleted. This observation suggested that the DNA polymerase inhibitor 
aphidicolin can affect G2 phase cells and is able to induce a mitotic delay specifically in 
this cell population. This observation could suggest that the DNA polymerase might still be 
required after DNA synthesis has been completed, for example in post-replication DNA 
repair or recombination.    
On the other hand, Chk1-/- cells that were in G1/S phase at the time of aphidicolin 
treatment behaved differently. Notably, cells with clearly un-replicated DNA (with only 
2N DNA content) were only observed to enter mitosis after a significant delay. This delay Verena Oehler, 2007     Chapter 4, 127 
was not solely due to cell cycle position, as revealed by experiments with synchronised 
cells. Centrifugal elutriation was used to purify G1/S cells and then monitor the progress of 
these cells very carefully, obtaining information about the DNA content and progress into 
mitosis from a pure G1/S starting population without interference from cells in other cell 
cycle phases. The G1/S Chk1-/- cells were able to delay entry to mitosis for more than 9h 
after replication was blocked with aphidicolin. Only after this prolonged mitotic delay did 
cells enter mitosis abruptly with un-replicated DNA. This distinctive phenotype with 
prolonged mitotic delay in response to replication arrest was also observed in BE cells 
treated with the Chk1 inhibitor UCN-01, indicating that it is a fundamental property of 
vertebrate cells. Taken together, these results suggest that some other factors contribute to 
the timing of premature mitosis in the absence of Chk1.  
The maintenance of the S/M checkpoint is dependent on Chk1, which is consistent with the 
fact that Chk1 is responsible for the replication recovery functions, such as suppression of 
origin firing and the stabilisation of stalled replication forks (Feijoo et al., 2001; Zachos et 
al., 2003). Thus, it has been suggested that Chk1-/- cells can only enter mitosis prematurely 
once all stalled replication structures have collapsed, and that the signal for mitotic delay 
might originate from these replication structures (Zachos et al., 2005).        
ATM and ATR are known upstream kinases of Chk1 and Chk2 in the same signalling 
pathways that become activated in response to genotoxic stress. The ATR kinase has been 
shown to be able to phosphorylate and thereby activate Chk1 in response to replication 
blocks and certain types of genotoxic stress (Zhao and Piwnica-Worms, 2001). Chk1 can 
then phosphorylate and inhibit the activity of downstream targets such as Cdc25, which in 
turn will lead to inhibition of Cdc2 and block of the onset of mitosis.  
It is possible to make predictions from this scheme, as interfering with components of this 
signalling pathway can result in checkpoint failure as was shown when Chk1 function was 
abrogated. Accordingly, the inhibition of ATM/ATR should mimic the effects of dual 
Chk1 and Chk2 inhibition. Interestingly, experiments with the ATM/ATR inhibitor 
caffeine revealed that the mitotic checkpoint mechanisms were regulated differently in the 
two vertebrate systems. In the BE cells, ATM/ATR and Chk1 do indeed appear to operate 
in the same pathway, as inhibition of ATM/ATR resulted in the same phenotype as Chk1 
inhibition with UCN-01 or Chk1 down-regulation with siRNA: in either case, cells without 
functional Chk1 or caffeine-inhibited ATM/ATR were unable to effectively delay mitosis 
in response to either DNA damage or replication block.  Verena Oehler, 2007     Chapter 4, 128 
The situation turned out to be more complex in avian DT40 cells. Here, caffeine was able 
to largely override the G2/M arrest in DT40 WT cells, but it had no noticeable effect on the 
S/M checkpoint that appeared to be still intact in these cells. The differential requirement 
for ATM/ATR in the two checkpoint mechanisms in DT40 cells suggested that ATM/ATR 
is essential for the G2/M arrest in response to DNA damage but dispensable for the S/M 
checkpoint response when DNA replication is blocked in the DT40 WT cells. These 
differences between the avian and the human cells were not too surprising as it is known 
from the literature that the effects of caffeine can differ in various cell types: some 
checkpoint responses are dependent on ATM/ATR, others are independent. For example, 
while caffeine was able to override the S/M checkpoint in fission yeast and hamster cells, 
this was not the case in some of the human and mouse cells tested in earlier studies 
(Schlegel and Pardee, 1986; Steinmann et al., 1991; Wang et al., 1999). Furthermore, a 
study by Brown and Baltimore was able to show the existence of an ATR-independent S/M 
checkpoint in mouse embryo fibroblasts as ATM/ATR knock out cells were still able to 
block mitosis in response to replication block (Brown and Baltimore, 2003). This 
observation was further supported by the differential response of non-transformed and 
transformed mammalian cell lines indicating that most tumour cell lines might have lost 
the ATR-independent checkpoint response (Florensa et al., 2003). 
The persistence of a functional S/M checkpoint in the caffeine pre-treated DT40 WT cells 
also indicated the possible existence of a Chk1-dependent but ATM/ATR-independent 
checkpoint response. A similar observation has previously been made in HeLa cells which 
are able to delay mitosis in response to DNA synthesis inhibition in a Chk1- and Claspin-
dependent but Rad17- and ATM/ATR-independent checkpoint mechanism (Rodriguez-
Bravo et al., 2006). The requirement for ATM/ATR for the checkpoint response in this 
particular study was assessed using caffeine, similar to the results presented here. It would 
be interesting to further confirm the existence of this Chk1-dependent but ATM/ATR-
independent checkpoint mechanism by using additional approaches, such as for example 
studying the activation of Chk1 in ATM/ATR knock-out cells. 
Interestingly, in the absence of Chk1, inhibition of ATM/ATR activity with caffeine affects 
the rate of cell cycle progression. After caffeine treatment the cell cycle progression of 
Chk1-/- cells was slowed down with only approximately two thirds of the cells entering 
mitosis compared to control cells at the same 12h time point. This observation suggests 
that ATM/ATR function is important for the normal rate of cell cycle progression in the 
Chk1-/- cells, although the exact details of this mechanism remain to be elucidated.  Verena Oehler, 2007     Chapter 4, 129 
Surprisingly, under the conditions used, the inhibition of ATM/ATR with caffeine had an 
unexpected effect on the S/M checkpoint response in the Chk1-/- cells. The onset of 
premature mitosis in response to replication block with aphidicolin was delayed for many 
hours in the Chk1-/- cells. It is known that ATM and ATR function during the normal 
unperturbed cell cycle by regulating the timing of origin firing during DNA replication 
(Shechter et al., 2004). Also, it has been shown that Chk1-/- cells have a higher origin 
density in combination with reduced replication fork rates compared to their wild-type 
counterparts (Maya-Mendoza et al., 2007; Petermann et al., 2006). Perhaps, if ATM/ATR 
activity normally suppresses excessive origin firing in Chk1-/- cells, then caffeine 
treatment could interfere with this control mechanism and more origins would be able to 
fire. This could extend the time needed for complete collapse of all replication structures. 
However, it is unclear whether this would account for the general slowing of cell cycle 
progression. Another speculation could be that the reduced replication fork rate of Chk1-/- 
cells can somehow compensate for higher rates of origin firing in the presence of caffeine 
and actually slow down general cell cycle progression. This in turn could also affect the 
rate at which stalled replication structures eventually collapse.   
Generally, caffeine is widely used to inhibit ATM/ATR activity and to study checkpoint 
signalling in many experimental systems. In this study, caffeine appeared to reduce the 
kinase activity of ATM/ATR in the DT40 cells as judged by the reduction of Chk1 
phosphorylation on S345 alone (Figure 4.11). However, previously it has also been 
reported that under some circumstances caffeine can actually abrogate checkpoint 
responses while at the same time promoting increases in the phosphorylation of ATM/ATR 
substrates as well as increased auto-phosphorylation of ATM (Cortez, 2003). Furthermore, 
caffeine has been shown to inhibit many other protein kinases besides ATM/ATR, for 
example DNA-PK, Chk1, Akt, and mTOR (Bode and Dong, 2007). Based on these 
observations it is possible that some effects of caffeine on cell cycle progression might not 
be due to direct inhibition of the kinase activity of ATM/ATR. Therefore, additional 
approaches would be helpful to more satisfactorily address this issue in future experiments, 
such as for example the direct measurement of ATM/ATR kinase activity in the presence 
and absence of caffeine.         
From this study it has emerged that the S/M and G2/M checkpoint responses can be 
distinguished by two factors, the timing of checkpoint failure in Chk1-/- cells and the 
sensitivity to caffeine. Also, it indicates that the initial mitotic delay in response to 
replication block must be due to other factors that contribute to the timing of premature 
mitosis. Nevertheless, both mitotic checkpoints presumably achieve inhibition of mitosis Verena Oehler, 2007     Chapter 4, 130 
by regulation of downstream effectors leading to the inhibition of Cdc2. Therefore, 
investigation of the regulation of Cdc2 in response to the two types of genotoxic stress 
could reveal the mechanism of mitotic delay. Moreover, the analysis of Cdc2 regulation in 
Chk1-/- cells could reveal how the initial Chk1-independent mitotic delay in response to 
DNA replication arrest is accomplished.   131 
5  Results: Biochemical analysis of potential S/M 
and G2/M checkpoint control mechanisms 
The general idea of mitotic checkpoint control mechanisms is that they target Cdc2, the 
cyclin dependent kinase that initiates mitosis. Conventional models postulate that mitotic 
delay in higher eukaryotes is imposed through inhibitory phosphorylation of two residues on 
Cdc2, Threonine 14 and Tyrosine 15. The kinases Wee1 and Myt1 catalyze this 
phosphorylation whereas the phosphatase Cdc25 is able to reverse it (Kumagai and Dunphy, 
1991; Mueller et al., 1995). Human Chk1 has been shown to be able to phosphorylate and 
inhibit Cdc25, by creating a binding site for 14-3-3 proteins and thereby inhibiting Cdc25 
activity and de-phosphorylation of Cdc2 (Peng et al., 1997; Sanchez et al., 1997). Similarly, 
Chk2 was found to be able to inhibit Cdc25 and therefore Cdc2 activity and the onset of 
mitosis after DNA damage (Chaturvedi et al., 1999). 
For this study, it was important to establish whether the S/M and G2/M checkpoint 
responses were accomplished via the conventional control mechanisms in the DT40 and BE 
cells. Furthermore, it was of interest to determine how cells deficient for Chk1 can execute 
mitotic checkpoint responses, such as the initial S/M delay after replication block.  
5.1  Analysis of Cdc2 kinase activity during mitotic 
checkpoint responses in DT40 WT and Chk1-/- cells 
In order to investigate the effect of both DNA replication block and DNA damage on Cdc2 
kinase activity during checkpoint responses, DT40 WT and Chk1-/- cells were subjected to 
Cdc2-Immunoprecipitation (IP) kinase assays using histone H1 as a substrate. 
The assays were performed on synchronised cells which enabled optimal comparison of the 
changes in Cdc2 kinase activity. Purified G1/S cells were obtained from DT40 WT and 
Chk1-/- cells by centrifugal elutriation. Cells were subsequently returned to culture and 
treated either with the DNA polymerase inhibitor aphidicolin or they were exposed to DNA 
damage by IR and cultured in the presence of the spindle poison nocodazole for 14h. 
Samples were harvested and divided into two parts: one for the analysis of mitotic indices 
and DNA content by flow cytometry (Figure 5.1a), the other part for analysis of Cdc2 
kinase activity (Figure 5.1b). Kinase assay reactions were performed with histone H1 as a 
substrate and Cdc2 that had been immunoprecipitated from cell lysates. Verena Oehler, 2007     Chapter 5, 132 
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Figure 5.1: Cdc2 kinase activity in checkpoint assays in synchronised DT40 cells 
Purified G1/S cell populations of DT40 WT and Chk1-/- cells were treated with aphidicolin (Aph) or 
irradiated with 10Gy (IR) and then cultured for 14h in the presence of nocodazole (Noc).              (a) 
Samples were analysed for DNA content and mitotic indices (P-S10-H3/PI profiles) by flow 
cytometry as shown in. The percentage of P-S10-H3-positive cells for each sample is included in the 
profiles. (b) Cdc2 kinase activity was measured by immunoprecipitating Cdc2 from cells and 
performing kinase assays using Histone 1 (H1) as substrate. Samples were resolved by SDS PAGE 
and transferred to a membrane for autoradiography.  Verena Oehler, 2007     Chapter 5, 133 
Figure 5.1b shows a representative example of the results obtained from the kinase assays, 
which were performed on three independent occasions with similar results. 
The DT40 WT purified G1/S cells had very low Cdc2 kinase activity at the 0h time point 
directly after the elutriation. Control DT40 WT displayed a substantial increase in Cdc2 
kinase activity after 14h in nocodazole when the majority of cells had entered mitosis 
(Figure 5.1b). In response to DNA replication block, cells did not progress through the cell 
cycle and the onset of mitosis was delayed. This was associated with a strong suppression of 
Cdc2 kinase activity compared to the mitotic control. However, when DT40 WT cells were 
exposed to DNA damage with IR, the majority of cells progressed into G2 but were still 
able to delay entry to mitosis. This was also associated with some degree of Cdc2 kinase 
activity suppression; however in this case the measured kinase activity was much higher 
than in the aphidicolin treated sample.  
Thus, in DT40 WT cells, both DNA replication block and DNA damage lead to mitotic 
delay associated with suppression of Cdc2 kinase activity when compared to mitotic control 
cells. The actual amount of suppression of Cdc2 activity varied considerably between the 
two types of genotoxic stress. Whereas cells arrested in S phase displayed relatively low 
levels, cells arrested in G2 had relatively high levels of Cdc2 kinase activity, but mitosis 
was still effectively delayed in either case. The differences in kinase activity could be 
attributed to a number of facts. Firstly, Cdc2 kinase activity might increase throughout the 
cell cycle and only once a certain threshold level is reached will cells enter mitosis. 
Secondly, Cdc2 can associate with other cyclins such as cyclinA and this could enable a 
putative Cdc2/cyclinA complex to be catalytically active but not induce the onset of mitosis.  
The Chk1-/- cells also showed barely detectable amounts of Cdc2 kinase activity in the 
G1/S starting population but exhibited very high levels after nocodazole treatment when 
they had mostly accumulated in mitosis (Figure 5.1b). In response to DNA replication block 
and DNA damage, Chk1-/- cells had entered either premature 2N mitosis or 4N mitosis after 
14h, respectively. In each case, the S/M and G2/M checkpoint failure in Chk1-/- cells was 
associated with increased levels of Cdc2 kinase activity, although in neither case was the 
level as high as in nocodazole treated cells.  Verena Oehler, 2007     Chapter 5, 134 
5.2  Biochemical analysis of Cdc2/CyclinB2 regulation 
during an unperturbed cell cycle in DT40 WT and Chk1-/- 
cells   
Prior to investigating any potential control mechanisms of mitotic checkpoint responses in 
DT40 WT and Chk1-/- cells, it was important to characterize the regulatory mechanisms 
affecting Cdc2 during an unperturbed cell cycle in the presence or absence of Chk1. As 
introduced earlier, Cdc2 activity is regulated by inhibitory and activatory phosphorylation 
on specific residues as well as its association with cyclins. In avian cells the major mitotic 
B-type cyclin that is associated with Cdc2 is cyclinB2. In order to study the regulation of 
Cdc2 and cyclinB2 throughout the phases of a normal cell cycle, the method of centrifugal 
elutriation was applied to separate an asynchronous cell population into fractions enriched 
in G1, S, G2, and mitotic cells. The analysis was performed in DT40 WT cells and 
importantly also in Chk1-/- cells to investigate whether the absence of Chk1 had any impact 
on the regulation of Cdc2 during a normal unperturbed cell cycle.  
Asynchronous cultures of DT40 WT and Chk1-/- cells were separated into fractions by 
centrifugal elutriation (as described in methods). A typical elutriation experiment and the 
flow cytometry results are demonstrated using DT40 WT cells as an example. The actual 
speed at which each fraction was eluted is presented in Figure 5.2a. Each eluted fraction 
was divided into two parts and further processed for analysis by flow cytometry and 
Western blotting. The flow cytometry analysis was used to measure several parameters of 
each fraction: Samples were stained with PI for their DNA content, while staining for the 
mitotic marker P-S10-H3 revealed the amount of mitotic cells in each fraction. Prior to the 
elutriation, cells were pulse labelled for 30min with BrdU which is incorporated into newly 
synthesised DNA. Staining with a specific antibody for BrdU then allowed an assessment of 
the number of replicating cells in each sample. 
As shown in Figure 5.2b (upper panel), the flow cytometry analysis demonstrated that the 
asynchronous culture starting population displayed a typical healthy cell cycle profile with 
two peaks in the PI profile. Fractions 1 to 7 that were obtained from the asynchronous load 
were of increasing DNA content as shown by their PI profiles, starting with only 2N cells in 
fraction 1 through to mainly intermediate 2-4N cells in fraction 4, and the last eluted 
fraction 7 contained mainly 4N cells. The number of replicating cells was analysed by 
studying BrdU incorporation (Figure 5.2b middle panel). The asynchronous starting 
population stained BrdU positive for approximately half of the cells, indicating that these Verena Oehler, 2007     Chapter 5, 135 
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Figure 5.2: Centrifugal Elutriation of DT40 WT cells 
Centrifugal elutriation was applied to separate an asynchronous cell population into fractions 
enriched in specific phases of the cell cycle. (a) Speed at which each fraction was eluted. (b) Data 
from DT40 WT elutriation showing the DNA content (PI profiles), analysis of replicating cells 
(BrdU/PI profiles) and mitotic cells (P-S10-H3/PI profiles) as analysed by flow cytometry. (c) Graph 
representing the percentage of cells in each cell cycle phase for the individual fractions.  Verena Oehler, 2007     Chapter 5, 136 
cells were in S phase. The degree of BrdU incorporation varied from fraction 1 to fraction 7, 
starting with low amounts of positive stained cells with 2N DNA content, reaching a 
maximum (86%) in fraction number 4, and in the last two eluted fractions again low levels 
of BrdU positive cells with 4N DNA content. Analysis of P-S10-H3 staining allowed the 
detection of mitotic cells in each fraction, which was found to be approximately 3-4% in the 
asynchronous starting population (Figure 5.2b lower panel). The first three eluted fractions 
1 to 3 did not contain any mitotic cells and thereafter positive staining was detected from 
fraction 4 on and reached a maximum number of around 10% in fraction 7.  
The percentage of cells in each cell cycle phase was calculated from the quantification of 
the flow cytometry data for each individual fraction (Figure 5.2c). Data obtained from the 
BrdU staining as well as the mitotic indices analysis was taken into account. For example, 
cells with 2N DNA content that were predominantly BrdU negative were judged as G1 
cells, and cells with 4N DNA content that stained predominantly negative for BrdU were 
judged as mainly G2 cells.   
The biochemical analysis of Cdc2 and cyclinB2 in the DT40 WT and Chk1-/- cells was 
performed by Western blotting. For each cell type, whole cell extracts from the starting 
population and from the seven elutriated fractions were compared. An additional sample 
was also included in the analysis. As the maximum number of mitotic cells in the elutriation 
experiment did not exceed 10%, a sample enriched in mitotic cells was prepared by treating 
cells with nocodazole for 16h. These cells were at least 60-80% mitotic as judged by flow 
cytometry for mitotic indices (data not shown) and therefore suitable for the analysis of 
Cdc2/cyclinB2 regulation during mitosis.  
As shown in Figure 5.3a, the Western blot analysis of the DT40 WT samples showed that 
the protein levels of cyclinB2 were very low in the G1 fraction, then increased progressively 
and reached a maximum in the G2/M fraction. In addition, in fractions 4 and 5 which 
contained mainly S and S/G2 cells, a slower migrating form of cyclinB2 appeared. This 
became more pronounced in the later G2 and G2/M fractions, with a maximum level being 
seen in the nocodazole treated mitotic sample. This slower migrating form has previously 
been identified as a phosphorylated isoform of cyclinB2 which has been shown to 
accumulate during mitosis and to be associated with the translocation of the cyclin to the 
nucleus in avian fibroblast cells (Gallant and Nigg, 1992). From both the flow cytometry 
data and the Western blot analysis of the elutriation experiment, it emerged that the amount 
of phosphorylated cyclinB2 isoform correlated closely with the percentage of mitotic cells 
in each sample. Verena Oehler, 2007     Chapter 5, 137 
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Figure 5.3: Cdc2/CyclinB2 regulation during unperturbed cell cycle in DT40 WT and Chk1-/- 
Comparison of cell cycle specific protein levels and phosphorylation status of Cdc2 and cyclinB2 in 
DT40 WT (a) and Chk1-/- (b) cells: Whole cell extract lysates were subjected to SDS PAGE and 
Western blotting analysis. Asynchronous cell cultures (Load) were separated into several fractions 
(G1-earlyS-S-G2-M) by centrifugal elutriation; to obtain a sample highly enriched in mitotic cells a 
lysate from 16h nocodazole treated DT40 WT or Chk1-/- cells respectively (mitotic) was included in 
the analysis. Actin served as loading control. Verena Oehler, 2007     Chapter 5, 138 
In contrast to cyclinB2, the total protein levels of Cdc2 were found to be the same in each 
sample (Figure 5.3a). However, various changes in the phosphorylation status of Cdc2 were 
observed. The activatory phosphorylation of Cdc2 on Threonine 161 was detectable from 
fraction 4 on and progressively increased in each following fraction. The highest levels of 
this activatory phosphorylation were observed in the nocodazole treated mitotic sample. 
Two different antibodies were used for the detection of inhibitory Cdc2 phosphorylation, 
one recognizing both Threonine 14 and Tyrosine 15 phosphorylation of Cdc2 and the other 
recognizing phospho-Y15-Cdc2 only. The results were almost identical with both 
antibodies. The levels of inhibitory phosphorylation of Cdc2 were very low in the G1 and 
G1/early S fractions and steadily increased until reaching maximum levels in the fraction 
with mainly G2 cells.  
When the same analysis was performed in Chk1-/- cells, very similar results were obtained. 
As shown in Figure 5.3b, the total cyclinB2 protein levels were very low in G1 and then 
progressively increased in the subsequent fractions. The phosphorylated cyclinB2 isoform 
was detected from fraction 5 onwards and maximum levels were seen in the mitotic sample. 
The total protein levels of Cdc2 were constant throughout the cell cycle and the periodic 
changes in phosphorylation status were observed just as in the DT40 WT cells. The amount 
of activatory phosphorylation on T161 increased from fraction to fraction with highest 
levels in the mitotic sample, whereas the inhibitory phosphorylation on T14 and Y15 
progressively increased until maximum levels were reached in G2. These observations 
demonstrated that the regulation of Cdc2 and cyclinB2 during an unperturbed cell cycle is 
not compromised by the absence of Chk1 in these avian cells. 
5.3  Biochemical analysis of Cdc2/CyclinB2 regulation 
during mitotic checkpoint responses  
The regulation of Cdc2/cyclinB2 during an unperturbed cell cycle was essentially the same 
in DT40 WT and Chk1-/- cells. To investigate the checkpoint mechanisms responsible for 
mitotic delay during functional S/M and G2/M arrest, the regulation of Cdc2/cyclinB2 in the 
DT40 WT cells was analysed by Western blotting. In addition, the Chk1-/- cells were 
analysed in the same manner in order to assess the regulation of Cdc2/cyclinB2 during 
checkpoint failure and crucially also during the initial mitotic delay after replication block. 
To enable optimal analysis of the exact regulation of Cdc2 and cyclinB2, Western blotting 
was performed on samples obtained from the time course analyses with synchronised DT40 
WT and Chk1-/- cells. By using samples from synchronised cells, the biochemical analysis Verena Oehler, 2007     Chapter 5, 139 
should not be compromised by the simultaneous presence of cell populations from multiple 
phases of the cell cycle. 
Figure 5.4b shows two representative examples for the Western blot analysis of cyclinB2 
regulation in the time course experiments. In DT40 WT cells, the G1/S starting population 
displayed very low levels of cyclinB2 which progressively increased with time. The 
phosphorylated cyclinB2 isoform was detectable from about 6h onwards and progressively 
increased and reached maximum levels at the 12h time point. As noted earlier, the amount 
of phosphorylated cyclinB2 isoform correlated with the percentage of mitotic cells in each 
sample. When the DT40 WT cells were exposed to DNA damage, they very effectively 
delayed entry into mitosis. For purpose of comparison, the graphs in Figure 5.4a illustrate 
again the results of the flow cytometry analyses of synchronised time course experiments 
(as previously shown in Figure 4.8). Interestingly, the mitotic delay in response to IR was 
associated with the suppression of cyclinB2 phosphorylation. The same observation was 
made when DT40 WT cells were treated with the DNA polymerase inhibitor aphidicolin. 
The cells were able to delay mitosis and this was associated with the suppression of 
cyclinB2 phosphorylation.  
In comparison, control Chk1-/- cells also initially displayed very low levels of cyclinB2 at 
the 0h time point but the protein levels increased over time and the phosphorylated isoform 
of cyclinB2 was detectable from around 6h onwards with maximum amounts at the 12h 
time point (Figure 5.4b).  
In marked contrast to DT40 WT cells, Chk1-/- cells failed to arrest after exposure to DNA 
damage and entered mitosis at a rate similar to control Chk1-/- cells as illustrated in the 
graph in Figure 5.4a. Strikingly, G2/M checkpoint failure was associated with a 
corresponding failure to suppress cyclinB2 phosphorylation. Thus, the onset and degree of 
cyclinB2 phosphorylation was basically identical in control cells and in cells that had been 
irradiated. In comparison, after replication block with aphidicolin, the Chk1-/- cells initially 
delayed mitosis for up to 9h prior to entering premature mitosis with unreplicated DNA. 
Western blot analysis established that cyclinB2 was regulated just as in the control cells, 
with increases in both total protein level and phosphorylated cyclinB2 isoform. 
Interestingly, in this case cyclinB2 phosphorylation did not strictly correlate with the 
percentage of mitotic cells, since the phosphorylated isoform was already detectable at 6h, 
when the onset of premature mitosis had not yet started.         Verena Oehler, 2007     Chapter 5, 140 
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Figure 5.4: Analysis of CyclinB2 regulation and during mitotic checkpoint responses in DT40 
WT and Chk1-/- cells 
(a) Graphs illustrating flow cytometry analysis results from the time course experiments with 
synchronised DT40 WT and Chk1-/- cells. (b) Whole cell extracts from the time course samples 
were separated on SDS PAGE gels and analysed by Western blotting with antibodies specific for 
CyclinB2. Actin served as loading control. Shown are two examples of the Western blot analysis. Verena Oehler, 2007     Chapter 5, 141 
Total Cdc2 protein levels were found to be constant throughout the duration of the 
experiment, whereas the phosphorylation status of Cdc2 changed in response to genotoxic 
stress in the DT40 WT cells (Figure 5.5b). The nocodazole treated control cells displayed a 
progressive decrease in inhibitory T14/Y15-Cdc2 phosphorylation with lowest amounts at 
12h when the majority of cells had accumulated in mitosis. In contrast, both DNA damage 
and DNA replication block affected the levels of inhibitory Cdc2 phosphorylation. In 
response to DNA damage, the phosphorylation of Cdc2 on T14/Y15 was maintained 
whereas the levels of inhibitory phosphorylation increased slightly over time in response to 
replication block. Very similar results were obtained with the anti-phospho-Y15-Cdc2 
antibody (data not shown). 
Total Cdc2 protein levels were also found to be constant throughout the time course 
experiments in Chk1-/- cells (Figure 5.5b). Furthermore, the Chk1-/- cells did not exhibit 
any significant changes in the amount of inhibitory phosphorylation on Cdc2 in response to 
either DNA replication block or DNA damage. In some experiments lower levels of P-
T14/Y15-Cdc2 were observed at the 12h time point in IR or aphidicolin treated samples, 
however overall the inhibitory Cdc2 phosphorylation levels in the Chk1-/- cells were very 
similar. Taken together, the inhibitory phosphorylation of Cdc2 was not notably regulated in 
response to genotoxic stress in the absence of Chk1.  
In summary, the mitotic delay in DT40 WT cells was presumably imposed through the 
conventional mechanism as mitotic delay in response to DNA damage and DNA replication 
block was associated with maintenance of inhibitory Cdc2 phosphorylation on T14 and 
Y15. In addition, the mitotic delay was also associated with the suppression of cyclinB2 
phosphorylation. In contrast, the Chk1-/- cells did not show any significant regulatory 
changes to either cyclinB2 or Cdc2 phosphorylation in response to the two types of 
genotoxic stress, suggesting that proper functioning of these regulatory checkpoint 
mechanisms is dependent on Chk1. Interestingly, the accumulation of total cyclinB2 and 
especially the appearance of the phosphorylated isoform preceded the onset of premature 
mitosis when DNA replication was blocked with aphidicolin in the Chk1-/- cells.  
The human BE cell line was also analysed for the regulation of Cdc2/cyclinB during 
checkpoint responses in the time course experiments with asynchronous cultures of BE cells 
that have been discussed earlier in chapter 4. The flow cytometry analysis showed that in 
response to either DNA damage by IR or replication block with aphidicolin, the BE cells 
efficiently delayed mitosis. Similar to DT40 WT cells, the mitotic delay in BE cells was 
associated with maintenance of inhibitory Cdc2 phosphorylation on T14 and Y15 (data not  Verena Oehler, 2007     Chapter 5, 142 
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Figure 5.5: Analysis of Cdc2 regulation and inhibitory phosphorylation on T14/Y15 during 
mitotic checkpoint responses in DT40 WT and Chk1-/- cells 
(a) Graph illustrating flow cytometry analysis results from the time course experiments with 
synchronised DT40 WT and Chk1-/- cells. (b) Whole cell extracts from the time course samples 
were separated on SDS PAGE gels and analysed by Western blotting with antibodies specific for 
total Cdc2 levels and Cdc2 inhibitory phosphorylation on T14/Y15. Shown are two examples of the 
Western blot analysis. Verena Oehler, 2007     Chapter 5, 143 
shown). The regulation of human cyclinB1 was also analysed by Western blotting with an 
antibody recognizing the total protein, but the phospho-isoform of cyclinB1 was not 
detected and no significant regulatory changes associated with checkpoint activation could 
be observed (data not shown).  
5.4  CyclinB2 phosphorylation is a target of mitotic 
checkpoints in DT40 cells 
The biochemical analysis of synchronised DT40 WT cells revealed that the phosphorylation 
of cyclinB2 was suppressed in response to both DNA replication block and DNA damage. 
This regulatory mechanism was completely absent in Chk1-/- cells, suggesting that the 
suppression of cyclinB2 phosphorylation is Chk1 dependent.  
To explore this hypothesis further, a variety of DT40 cell lines were analysed in the S/M 
checkpoint assay. Apart from the DT40 WT and Chk1-/- cells, the Chk1 Revertant (Rev) as 
well as the Chk1 kinase dead (K38R) mutant cells were included in the analysis. 
Furthermore, Chk2-/- cells in which Chk1 function was inhibited with UCN-01 were also 
investigated. All samples were analysed by flow cytometry and Western blotting.  
As shown in the flow cytometry analysis in Figure 5.6a, the DT40 WT, Chk2-/-, and Chk1 
Revertant cell lines were able to delay mitosis effectively when replication was blocked, 
whereas all cell lines without functional Chk1 (Chk1-/-, Chk1 K38R, Chk2-/- plus UCN-01) 
were unable to delay entry to mitosis. The results from the Western blot analysis showed 
that the mitotic delay observed in cells with functional Chk1, was in each case associated 
with the suppression of cyclinB2 phosphorylation (Figure 5.6b). In marked contrast, 
Western blotting analysis of samples from Chk1-/-, Chk1 K38R Kinase Dead mutant, and 
Chk2-/- cells treated with the Chk1 inhibitor UCN-01 revealed no differences in the total 
cyclinB2 levels or the phosphorylation status of cyclinB2 in these cells.  
The total protein levels of Cdc2 were more or less the same in each sample, whereas a 
functional S/M checkpoint response was associated with high levels of inhibitory T14/Y15 
phosphorylation of Cdc2. Actin served as a loading control. 
In conclusion, mitotic delay in response to DNA replication block was associated with the 
suppression of cyclinB2 phosphorylation and this was dependent on functional Chk1. Thus, 
the data suggested that the phosphorylation of cyclinB2 is a target of mitotic checkpoints.   Verena Oehler, 2007     Chapter 5, 144 
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Figure 5.6: CyclinB2 phosphorylation is a checkpoint target in cells with functional Chk1  
To investigate cyclinB2 modification in response to DNA replication block, cells were treated with the 
DNA polymerase inhibitor aphidicolin and cultured in the presence of nocodazole for 16h. Samples 
were analysed by flow cytometry for DNA content and mitotic indices (P-S10-H3/PI profiles) as 
shown in (a). Whole cell extracts were prepared and analysed by SDS PAGE and Western blotting 
with antibodies specific for cyclinB2, Cdc2, P-T14/Y15-Cdc2, and Actin served as loading control (b).   
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5.5  CyclinB2 phosphorylation is a target of Cdks in the 
DT40 cells 
Avian cyclinB2 isoform accomplishes basically the same functions as human cyclinB1; 
however its regulation is not exactly the same. Both cyclins are able to bind to Cdc2 and the 
active state of this complex can bring about the onset of mitosis. CyclinB1 has been show to 
be phosphorylated by Plk1 and this was associated with its nuclear translocation 
(Toyoshima-Morimoto et al., 2001). Studies on the starfish oocyte model system have 
shown that Cdc2 is the cyclinB-kinase and there has also been some speculation about a 
possible role for MAP kinase in the regulation of Cdc2/cyclinB1 (Borgne et al., 1999).  
In order to clarify the issue of which kinase might be responsible for mitotic 
phosphorylation of cyclinB2 in DT40 cells, an inhibitor approach was taken. The 
phosphoinositide 3-kinase inhibitor wortmannin was used at concentrations that were shown 
to potently inhibit Plk1 activity (Liu et al., 2005). The MEK inhibitor U0126 was used to 
inhibit MAP kinase activity and in order to inhibit Cdc2 a panel of three different Cdk 
inhibitors was used: allsterpaullone, purvalanol A, and roscovitine. Although none is 
completely specific, all three inhibitors were used at concentrations which should be 
selective for Cdc2. DT40 WT and Chk1-/- cells were treated with the respective inhibitors 
and grown for 16h in the presence of the spindle poison nocodazole. Whole cell extracts 
were analysed by SDS PAGE and Western blotting with specific antibodies.  
As shown in Figure 5.7, untreated DT40 WT and Chk1-/- cells displayed very low levels of 
the phosphorylated cyclinB2 isoform, whereas in cells that had been treated with 
nocodazole high levels of the phosphorylated isoform of cyclinB2 were detected. When the 
cells were treated with two different concentrations of wortmannin which should inhibit 
Plk1 activity, the phosphorylation of cyclinB2 was not affected compared to nocodazole 
treated control cells. However, whether these concentrations of wortmannin indeed potently 
inhibit Plk1 activity was not tested in this particular experiment. This issue could be 
clarified for example by performing a Plk1 kinase assay. The phosphorylation of cyclinB2 
was slightly affected by MAP kinase inhibition with U0126 in the DT40 WT but not in the 
Chk1-/- cells. However, inhibition of Cdc2 with any of the three Cdk inhibitors abrogated 
cyclinB2 phosphorylation in the DT40 WT as well as the Chk1-/- cells. It was also noted 
that the cdk inhibitors, especially roscovitine, had a negative effect on total cyclinB2 protein 
levels in both cell types. The inhibition of cyclinB2 phosphorylation was also associated 
with inhibition of mitosis as was detected by flow cytometry (data not shown).  Verena Oehler, 2007     Chapter 5, 146 
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Figure 5.7: Analysis of cyclinB2 phosphorylation in DT40 WT and Chk1-/- cells treated with 
various protein kinase inhibitors 
DT40 WT and Chk1-/- cells were treated with a panel of kinase inhibitors (C: DMSO control, 
WM1/WM2: 100mM/500mM of wortmannin, U0: 50mM of U0126, Ros: 100mM of roscovitine, Pur: 
15mM of purvalanol A, All: 100mM of allsterpaullone) and grown in the presence of nocodazole for 
16h (apart from U: untreated control). Whole cells extracts were analysed by SDS PAGE and 
Western blotting with antibodies specific for cyclinB2, Cdc2, and P-T14/Y15-Cdc2. Actin was used 
as a loading control. Verena Oehler, 2007     Chapter 5, 147 
The Western blot analysis was also used to study the regulation of Cdc2 in these samples. In 
general, total Cdc2 protein levels were similar in most samples, apart from the samples 
treated with roscovitine which displayed lower levels of Cdc2, indicating that roscovitine 
might have a negative effect on transcription. This property of roscovitine has also been 
described in a study in human cells (Ljungman and Paulsen, 2001). As for the 
phosphorylation status of Cdc2, suppression of cyclinB2 phosphorylation was associated 
with higher levels of inhibitory T14/Y15 phosphorylation in the samples treated with 
purvalanol A and allsterpaullone. The inhibitory phosphorylation was also to some extent 
increased in the U0126 treated DT40 WT cells, indicating that MAP kinase might be 
involved in the regulation of Cdc2/cyclinB2 in the DT40 WT cells, however this issue has 
so far not been addressed any further.  
In summary, these observations suggest that the phosphorylation of cyclinB2 in avian cells 
is executed by Cdks. From the present data there is a strong implication for Cdc2 as the 
kinase responsible for cyclinB2 phosphorylation in these cells; however other cdks can not 
be excluded at this stage.   
5.6  Discussion 
Cell cycle arrest in response to checkpoint activation is generally believed to result from 
inhibition of cyclin dependent kinases. Cdc2 is the major Cdk responsible for triggering 
entry into mitosis and therefore the main target of the G2/M and S/M checkpoint responses. 
One aim of this study was to evaluate the mitotic checkpoint control mechanisms associated 
with mitotic delay in response to genotoxic stress in the DT40 WT and BE cells. Another 
focus was to determine how cells deficient for Chk1 can execute mitotic checkpoint 
responses, such as the initial S/M delay after replication block.  
Avian DT40 cells are evidently able to regulate Cdc2 and cyclinB2 normally during an 
unperturbed cell cycle even in the absence of functional Chk1. Both in the presence and 
absence of Chk1, cyclinB2 protein levels accumulated progressively throughout the cell 
cycle and a phosphorylated isoform was observed which correlated with the proportion of 
mitotic cells as determined by flow cytometry. Furthermore, typical fluctuations in 
activatory and inhibitory Cdc2 phosphorylation status were observed in both cell types. 
These results demonstrated that normal Cdc2 regulation is not affected by loss of Chk1 in 
these cells, which was somewhat surprising as Chk1 has previously been implicated in the 
regulation of cell cycle progression in the absence of genotoxic stress, for example by Verena Oehler, 2007     Chapter 5, 148 
phosphorylation and negative regulation of Cdc25B on the centrosome (Kramer et al., 2004; 
Schmitt et al., 2006). 
The mitotic delay in response to DNA damage or replication block in DT40 WT and BE 
cells was associated with Cdc2 inhibition via maintenance of inhibitory phosphorylation on 
T14 and Y15, which is broadly consistent with the proposed conventional checkpoint 
model. In contrast, the phosphorylation of Cdc2 did not appear to be significantly affected 
in response to DNA damage or replication block in Chk1-/- cells. These observations 
suggested that Chk1 is involved in the regulation of Cdc2 in response to genotoxic stress. 
This is in line with the fact that Chk1 is known to be able to phosphorylate Cdc25 in 
response to stress, thereby creating a binding site for 14-3-3 proteins, which will then export 
Cdc25 out of the nucleus and thus prevent de-phosphorylation of Cdc2 (Peng et al., 1997; 
Sanchez et al., 1997). In addition, it has been shown that Chk1 can phosphorylate and 
activate Wee1 kinase in response to DNA damage, thereby inducing inhibitory 
phosphorylation and inactivation of Cdc2 (O'Connell et al., 1997).    
Apart from the conventional checkpoint regulation of Cdc2 by activatory and inhibitory 
phosphorylation, another potential checkpoint target was identified in the DT40 cells. The 
mitotic delay in response to either DNA damage or replication block was associated with 
the suppression of cyclinB2 phosphorylation. This regulatory mechanism was further shown 
to be dependent on functional Chk1 as cells with compromised Chk1 function (Chk1-/-, 
Chk1 K38R, and also Chk2-/- cells with Chk1 inhibitor UCN-01) were unable to suppress 
cyclinB2 phosphorylation in response to genotoxic stress.  
Avian cyclinB2 has been shown to undergo rapid translocation to the nucleus at the onset of 
prophase and this process might be associated with the phosphorylated cyclinB2 isoform 
(Gallant and Nigg, 1992). This idea is also supported by the approximate correlation of the 
amount of phosphorylated isoform with the percentage of mitotic DT40 WT cells. 
Interestingly, this does not account for the fact that cyclinB2 is able to undergo 
phosphorylation and nuclear translocation in the Chk1-/- cells even during the initial 
prolonged mitotic delay in response to replication block. The onset of premature mitosis in 
the Chk1-/- cells is dependent on Cdk activity as it could be blocked by inhibition of Cdc2 
(Cdks) with either of three different Cdk inhibitors at concentrations selective for Cdc2 
(data not shown). This indicates that the presence of the mitotic phosphorylated cyclinB2 
isoform is necessary but not sufficient to induce mitosis and that some other factors are able 
to restrain Cdc2 activity. This notion could also explain why DT40 WT cells displayed 
relatively high levels of Cdc2 kinase activity while mitosis was effectively delayed in Verena Oehler, 2007     Chapter 5, 149 
response to DNA damage (Figure 5.1). Thus, apart from the conventional mitotic delay 
mechanism via maintenance of inhibitory Cdc2 phosphorylation, other factors can restrain 
Cdc2 activity and an obvious candidate involved in this regulation is the replication 
machinery itself.  
It is known that Chk1 plays an important role for the suppression of origin firing and for the 
stabilisation of stalled replication forks and is therefore responsible for the maintenance of 
viable replication structures in response to DNA replication stress (Zachos et al., 2003; 
Zachos et al., 2005). However, the initial mitotic delay in response to DNA replication 
block in Chk1-/- cells was independent of Chk1 function, further emphasizing that some 
other intrinsic mechanism is responsible for mitotic delay in the presence of unreplicated 
DNA even in the absence of Chk1. This idea is further supported by the observation that 
DT40 WT cells displayed a functional S/M checkpoint response in the presence of the 
ATM/ATR inhibitor caffeine which severely compromised Chk1 activation, while their 
ability to delay mitosis in response to DNA damage was abrogated in the presence of 
caffeine (Figure 4.13).  
Thus, in response to replication arrest, cells appear to be able to initially delay mitosis 
independently of ATM/ATR and Chk1 function. The replication machinery itself emerges 
as the most likely candidate for the origin of the checkpoint signal. Investigation of the 
properties of the stalled replication machinery could reveal the origin of the checkpoint 
signal for mitotic delay. Eventual checkpoint failure in Chk1-/- cells suggests that in the 
long term, Chk1 function does become important for maintaining the mitotic delay, 
probably due to its function in stabilising the stalled replication structures (Zachos et al., 
2005). Maybe preventing the stalled replication structures from collapsing could hence 
extend the mitotic delay in the absence of Chk1, a hypothesis that remains to be tested.  
To investigate the mechanism of mitotic delay in response to replication arrest in Chk1-/- 
cells, further characterisation of the relationship between the timing of DNA replication and 
the onset of normal as well as premature mitosis is required.  150 
6  Results: DNA replication and checkpoint control 
The experiments in the previous chapters have established that the initiation of the S/M 
checkpoint is independent of Chk1. When DNA replication is blocked with aphidicolin, 
Chk1-/- cells can delay the onset of mitosis for many hours even in the presence of 
potentially active Cdc2/cyclinB2. Furthermore, from observations both in this study as 
well as earlier studies it has been suggested that there is an intrinsic checkpoint mechanism 
that ensures that cells block entry to mitosis either while normal DNA replication is 
ongoing but also when the replication machinery is stalled (Rao and Johnson, 1970; 
Zachos et al., 2005). To further investigate this hypothesis is was important to document 
the relationship between the process of DNA replication and the onset of normal as well as 
premature mitosis.  
6.1  Documentation of the relationship between DNA 
replication and entry to mitosis  
Proliferating cell nuclear antigen (PCNA) is a clamp protein associated with DNA 
polymerase δ during DNA synthesis, thus it is found at replication foci during S-phase and 
can therefore be used as a marker for DNA replication (Celis and Celis, 1985). Previously 
it has been suggested that loss of PCNA staining precedes the onset of premature mitosis in 
Chk1-/- cells (Zachos et al., 2005). Although this previous study described the staining 
pattern of PCNA and P-S10-H3 in cell populations, it did not document the exact timing of 
PCNA loss and onset of premature mitosis in individual cells. 
6.1.1 Analysis of the timing of PCNA loss and the onset of mitosis  
One approach to document the timing of PCNA loss and the onset of normal or premature 
mitosis was by flow cytometry analysis. DT40 WT and Chk1-/- cells were treated with the 
DNA polymerase inhibitor aphidicolin and grown in the presence of nocodazole for 16h. 
Cells were stained for the DNA replication marker PCNA with a FITC-labelled secondary 
antibody and for the mitotic marker P-S10-H3 with a PE-labelled secondary antibody and 
subsequently analysed by flow cytometry. The anticipated objective was to follow the 
progress of PCNA positive cells as they presumably first become PCNA negative and then 
eventually P-S10-H3 positive when they enter mitosis prematurely.  Verena Oehler, 2007    Chapter 6, 151 
As shown in Figure 6.1, untreated cultures of DT40 WT and Chk1-/- cells displayed 
predominantly positive PCNA staining and approximately 5% mitotic cells that stained for 
P-S10-H3. The appropriate negative and positive controls were included in the analysis 
and verified that the staining was indeed specific (data not shown). In the presence of 
nocodazole, the number of mitotic cells rose to about 50% in the DT40 WT and Chk1-/- 
cells as judged by staining for P-S10-H3, whereas the PCNA staining appeared over a 
somewhat broader intensity range compared to untreated controls (Figure 6.1).  
In comparison, while only about 5% of DT40 WT cells entered mitosis in the presence of 
aphidicolin, a high percentage (33%) of Chk1-/- cells stained positive for P-S10-H3 
(Figure 6.1). The levels of intensity for PCNA seemed to vary slightly, however overall it 
was not possible to detect any significant changes in the PCNA staining in response to the 
different treatments. Moreover, the majority of nocodazole-treated DT40 WT and Chk1-/- 
cells stained positive for both PCNA and P-S10-H3. The same was true for Chk1-/- cells 
that had entered mitosis in the presence of aphidicolin and nocodazole.  
This was somewhat unexpected as a previous study by Zachos et al. had shown that PCNA 
and P-S10-H3 staining was mutually exclusive and suggested that loss of PCNA staining 
preceded the onset of premature mitosis in the Chk1-/- cells (Zachos et al., 2005). 
However, the flow cytometry results presented here in this study indicated that DT40 WT 
and Chk1-/- cells in fact enter both normal and premature mitosis without loss of PCNA 
staining.   
6.1.2 PCNA distribution during an unperturbed cell cycle 
The flow cytometry analysis of DT40 WT and Chk1-/- cells suggested that both natural 
and premature mitotic cells retained PCNA staining. To further investigate this 
observation, the expression patterns of PCNA were first analysed during an unperturbed 
cell cycle.  
To achieve this, the protein levels of PCNA were analysed during the phases of the cell 
cycle and mitosis in whole cell extracts obtained by centrifugal elutriation of DT40 WT 
and Chk1-/- cells (as described in chapter 5.2). Interestingly, the total protein levels of 
PCNA were found to be constant in all fractions as shown in the Western blot analysis in 
Figure 6.2. This observation suggested that while PCNA protein levels remain the same 
throughout the cell cycle they might possibly undergo changes in sub-cellular localisation.  
To investigate changes in the sub-cellular localisation of PCNA, DT40 WT cells were Verena Oehler, 2007    Chapter 6, 152 
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Figure 6.1: Flow cytometry analysis of PCNA expression in DT40 WT and Chk1-/- cells  
DT40 WT and Chk1-/- cells were treated with/out the DNA polymerase inhibitor aphidicolin and 
grown in the presence of nocodazole (Noc.) for 16h. Samples were stained with antibodies specific 
for PCNA and P-S10-H3 and analysed by flow cytometry (P-S10-H3/PCNA profiles). Verena Oehler, 2007    Chapter 6, 153 
established that stably expressed PCNA as a marker for DNA replication. RFP-tagged 
PCNA was introduced into a DT40 WT cell line expressing GFP-tagged Histone H2B 
which can be used as a marker to visualize chromatin condensation.   
The RFP-PCNA/GFP-H2B/DT40 WT cells were separated into several fractions by 
centrifugal elutriation, a method that has been introduced previously in chapter 5. The cells 
were then analysed by confocal microscopy to study the expression pattern and localisation 
of RFP-PCNA and GFP-H2B throughout the phases of a normal unperturbed cell cycle. As 
shown in the first and second picture row in Figure 6.2b, G1 and G1/S phase cells 
displayed relatively low levels of PCNA expression in the nucleus. The third picture row in 
Figure 6.2b shows a typical example for cells in S phase with strong nuclear staining of 
PCNA with typical speckled structures in the nucleus, indicative of ongoing DNA 
synthesis. Whereas cells in G2 phase still contained mainly nuclear PCNA, cells 
undergoing mitosis displayed a dramatic change in PCNA localisation, as it appeared 
dispersed into the cytoplasm while the chromatin was condensed (Figure 6.2b). Overall, 
PCNA was found diffusely dispersed in the cytosol of all mitotic cells observed. These 
observations confirmed that while total PCNA protein levels remain constant, the sub-
cellular localisation of the protein changes throughout the cell cycle.  
To study these regulatory patterns of PCNA in real time, GFP-H2B/RFP-PCNA DT40 WT 
cells were analysed by time-lapse microscopy. Overall the results confirmed the 
observations made in fixed cells with PCNA appearing diffusely distributed in the cytosol 
in G1 and accumulating in the nucleus during S phase forming bright speckles in places of 
DNA synthesis (data not shown). Importantly, the time-lapse movies made it possible to 
document the changes in sub-cellular localisation of PCNA in individual cells as they 
entered mitosis.  
Although the resolution was not very good, the pictures in Figure 6.3 show three individual 
cells as they entered mitosis and each divided into two daughter cells. Firstly, the 
chromatin in cell no.1 started to condense as shown from picture 1 onwards. Then, PCNA 
started to appear in the cytosol from picture 2 on and is clearly visible in the cytoplasm of 
the metaphase cell in picture 4. The two daughter cells then presumably entered G1 and a 
new S phase. Cells no.2 and no.3 also underwent mitosis in this time frame. They 
displayed the same change in sub-cellular localisation of PCNA which dispersed into the 
cytosol at the same time as the chromatin condensed. This analysis showed that normal 
scheduled mitosis in the DT40 WT cells is associated with chromatin dissociation and 
cytosolic dispersion of PCNA. Verena Oehler, 2007    Chapter 6, 154 
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Figure 6.2: Expression and localisation of PCNA during an unperturbed cell cycle  
(a) Asynchronous DT40 WT and Chk1-/- cell cultures (Load) were separated into several fractions 
(G1-earlyS-S-G2-M) by centrifugal elutriation and samples analysed by SDS PAGE and Western 
blotting (including load and mitotic control) with antibodies specific for PCNA and Actin (upper 
panel). (b) GFP-H2B/RFP-PCNA DT40 WT cells were separated into several fractions (G1-S-G2-
M) by centrifugal elutriation and analysed by confocal microscopy. Shown are five representative 
examples for the pattern of PCNA during G1, S, G2 phase, and in mitosis (lower panels).    Verena Oehler, 2007    Chapter 6, 155 
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Figure 6.3: Time-lapse analysis of PCNA distribution during an unperturbed cell cycle 
Time-lapse microscopy of GFP-H2B RFP-PCNA DT40 WT cells: Shown is a selection of pictures 
(from 1 to 12) taken every 10 frames/20min corresponding to a total time frame of 3h 40min. Three 
cells (no.1, 2 and 3) are highlighted in selective pictures as they successively undergo mitosis. 
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6.1.3 PCNA distribution during normal and premature mitosis 
To study the timing of changes in PCNA sub-cellular distribution and the onset of normal 
or premature mitosis, the response of cells to DNA replication block was analysed over a 
time course. DT40 WT and Chk1-/- cells were treated with aphidicolin and grown for up to 
12h in nocodazole. Samples were taken at several time points and analysed by confocal 
microscopy. Cells were stained for PCNA with a FITC-labelled secondary antibody 
(green) and for P-S10-H3 with a TRITC-labelled secondary antibody (red). Subsequently, 
cover slips were mounted on Vectashield mounting medium containing DAPI to enable 
staining of the DNA of the cells (blue).  
As shown in Figure 6.4, untreated DT40 WT cells stained mainly positive for PCNA in the 
nucleus, consistent with the fact that the majority of cells in an unperturbed cell population 
are either in S phase or just before or after DNA replication with PCNA located mainly in 
the nucleus. When DT40 WT cells were grown in the presence of nocodazole for 12h, they 
accumulated in mitosis as demonstrated by the high percentage of cells staining positive 
for P-S10-H3. These mitotic cells showed PCNA staining excluded from the nucleus. By 
contrast, when DNA replication was blocked with aphidicolin in the presence of 
nocodazole, DT40 WT cells retained nuclear PCNA staining and the vast majority of cells 
did not enter mitosis as judged by P-S10-H3 staining. Taken together, checkpoint 
proficient DT40 WT cells were able to delay entry to mitosis in response to replication 
block and this was associated with maintenance of nuclear PCNA staining in arrested cells, 
suggesting that these cells retained the capability to synthesise DNA. 
In comparison, untreated Chk1-/- cells showed very similar staining as untreated DT40 
WT cells with the majority of cells exhibiting strong mainly nuclear PCNA staining 
(Figure 6.4). When Chk1-/- cells were grown in the presence of nocodazole, they 
accumulated in mitosis and by 12h the vast majority of cells were P-S10-H3-positive and 
PCNA was excluded from the nucleus. Thus, in both DT40 WT and Chk1-/- cells the onset 
of normal 4N mitosis was associated with cytosolic dispersed PCNA and on no occasion 
was double staining of PCNA and P-S10-H3 on the chromatin observed. 
In marked contrast, when Chk1-/- cells were treated with the DNA polymerase inhibitor 
aphidicolin and grown in the presence of nocodazole for 12h, most of the cells stained 
positive for P-S10-H3 as shown in Figure 6.5. Interestingly, approximately a third of these 
mitotic cells exhibited strong co-staining of both P-S10-H3 and PCNA on the condensed  Verena Oehler, 2007    Chapter 6, 157 
PCNA-FITC             P-S10-H3-TRITC                 Dapi Merge
Nocod.
Control
Aph.+
Nocod.
DT40 WT
PCNA-FITC             P-S10-H3-TRITC                 Dapi Merge 
Chk1-/-
Nocod.
Control
 
Figure 6.4: Analysis of PCNA distribution in DT40 WT and Chk1-/- cells  
DT40 WT and Chk1-/- cells were treated with/out aphidicolin and nocodazole and grown for up to 
12h on poly-L-lysine coated cover slips. The cover slips were stained with antibodies specific for 
PCNA (FITC) and P-S10-H3 (TRITC) and with Dapi and analysed by confocal microscopy. The 
displayed pictures represent the 12h time point for each respective treatment.  
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Figure 6.5: Analysis of PCNA distribution during S/M checkpoint failure in Chk1-/- cells  
Chk1-/- cells were grown for up to 12h on poly-L-lysine coated cover slips. Cells were treated with 
aphidicolin and nocodazole. Cover slips were stained with antibodies specific for PCNA (FITC) and 
P-S10-H3 (TRITC) and with Dapi and analysed by confocal microscopy. The three displayed 
pictures represent examples for the typical staining pattern of aphidicolin and nocodazole treated 
Chk1-/- cells at the 12h time point.  
The graph illustrates quantification of PCNA and P-S10-H3 staining throughout the time course 
experiment with Chk1-/- cells treated with aphidicolin and nocodazole. Verena Oehler, 2007    Chapter 6, 159 
chromatin, whereas the other two thirds were positive for P-S10-H3 but displayed diffuse 
PCNA staining in the cytosol as shown in several examples in Figure 6.5. 
The failure of the S/M checkpoint is characterised by a general increase in the number of 
mitotic cells and more specifically by the appearance of premature mitotic cells with a 2N 
DNA content as has been documented previously in several experiments in this study. The 
percentage of mitotic Chk1-/- cells with strong PCNA staining was analysed over a time 
course after 0, 5, 9, and 12h and was found to correlate very closely with the percentage of 
2N mitotic cells as estimated from quantification of previous flow cytometry analyses 
(Figure 6.5 graph). This observation suggested that those cells with dual P-S10-H3 and 
PCNA staining could actually be premature mitotic cells with unreplicated DNA. It also 
raised the question whether all premature mitotic cells stain simultaneously for nuclear 
PCNA or whether the dual staining can only be observed at certain times and PCNA will 
eventually disperse in the cytoplasm of the mitotic cell. However, unfortunately it was not 
possible to follow Chk1-/- cells in real-time which would be useful to distinguish between 
the two possibilities. Although GFP-H2B/RFP-PCNA Chk1-/- cells were generated during 
this study, the cells were unsuitable for analysis due to difficulties with stable RFP-PCNA 
expression and extreme variability in the fluorescence intensity. As both untreated as well 
as nocodazole-treated mitotic Chk1-/- cells never showed any dual PCNA/P-S10-H3 
staining, it seems most likely that it really is a characteristic of premature mitosis 
associated with S/M checkpoint failure.       
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6.2  Checkpoint regulation of Cdc6  
The observations in this and previous studies (Zachos et al., 2005) led to the hypothesis 
that the signal for mitotic delay in response to replication arrest might originate from the 
replication machinery itself. Potential candidates would presumably be involved in the 
process of DNA replication but also interact with mitotic controls and checkpoint 
signalling. One protein potentially fulfilling these criteria is the cell division cycle protein 
6 (Cdc6), an important component of the pre-replication complex and essential for the 
initiation of DNA replication in yeast and vertebrate cells (Cocker et al., 1996; Coleman et 
al., 1996). Studies on the Cdc6 fission yeast homologue Cdc18 have shown that mitosis 
can be delayed or prevented through the production of large amounts of Cdc18 (Nishitani 
and Nurse, 1995). More recent studies have implicated a role for Cdc6 in checkpoint 
function as over-expression of human Cdc6 in G2 phase prevents Hela cells from entering 
mitosis and it has been suggested that this control mechanism is Chk1-dependent (Clay-
Farrace et al., 2003). It has also been suggested that the presence of Cdc6 during S phase is 
essential for Chk1 activation in response to replication inhibition in Xenopus (Oehlmann et 
al., 2004). Most of these observations however were made using ectopic expression of 
Cdc6. Thus, to evaluate any potential checkpoint function, it was of interest to determine 
whether the amount of endogenous Cdc6 protein might vary in a Chk1-dependent manner 
in response to DNA replication arrest. 
6.2.1 Role for Cdc6 in the S/M checkpoint response in BE cells  
To investigate whether Cdc6 levels change during the S/M checkpoint in response to block 
to DNA replication, endogenous Cdc6 protein levels were analyzed in the mitotic 
checkpoint assay. Experiments were performed using the human BE colon carcinoma cell 
line and not the avian DT40 cells due to difficulties in obtaining an antibody specific for 
the avian Cdc6 protein. The cells were treated with the DNA polymerase inhibitor 
aphidicolin and grown in the presence of nocodazole for 16h. Samples were analyzed for 
mitotic indices by flow cytometry and also by Western blotting with an antibody specific 
for human Cdc6. Aphidicolin treated BE cells delayed the entry to mitosis and arrested 
mainly in G1 and S phase as previously described in detail in chapter 3. This was 
associated with a substantial increase of endogenous Cdc6 protein levels as shown in the 
Western blot analysis in Figure 6.6a (left panel). The protein levels of Cdc6 were increased 
in response to DNA replication block as compared to the levels in nocodazole treated cells 
that had mainly accumulated in mitosis. Interestingly, when cells were treated with  Verena Oehler, 2007    Chapter 6, 161 
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Figure 6.6: Accumulation of endogenous Cdc6 during replication arrest in BE cells 
(a) BE cells were treated with the DNA polymerase inhibitor aphidicolin (A) and grown in the 
presence of nocodazole (N) for up to 16h. Chk1 inhibition was achieved by addition of UCN-01 (U). 
(b) BE cells were transfected with Chk1 siRNA for 48h and then treated with aphidicolin and 
nocodazole for a further 24h. Whole cell extracts were analysed by SDS PAGE and Western 
blotting with antibodies specific for Cdc6, cyclinB1, Chk1, Actin.   
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aphidicolin while Chk1 was inhibited with UCN-01, Cdc6 levels did not increase. Also, 
under these conditions S/M checkpoint failure was detected by flow cytometry (data not 
shown). 
Furthermore, analysis of a time course experiment of the response of BE cells to DNA 
replication arrest with aphidicolin revealed that Cdc6 protein levels appeared to 
accumulate throughout the experiment and reached highest levels at 16h (Figure 6.6a right 
panel). This was in stark contrast to UCN-01-treated BE cells which entered mitosis 
prematurely after 16h of aphidicolin treatment as detected by flow cytometry (data not 
shown) and displayed reduced Cdc6 levels at this time point.  
A similar analysis was also performed in BE cells in which Chk1 protein expression was 
down-regulated with Chk1 siRNA. The analysis by both flow cytometry (not shown) and 
Western blotting (Figure 6.6b) revealed that a functional S/M checkpoint response in 
control BE cells was associated with a substantial accumulation of Cdc6 protein levels, 
whereas S/M checkpoint failure induced by either Chk1 siRNA or UCN-01 was associated 
with very low Cdc6 protein levels. These results suggested that the accumulation of 
endogenous Cdc6 during replication arrest was dependent on Chk1 function. 
6.2.2 Regulation of Cdc6 during an unperturbed cell cycle in BE 
cells 
The functional S/M checkpoint in response to replication arrest in BE cells was associated 
with an accumulation of Cdc6 protein levels. This could be due to either an increase in the 
levels of Cdc6 in cells specifically arrested in S phase, or because Cdc6 levels are in 
general higher in cells in S phase. To test this, BE cells were subjected to centrifugal 
elutriation and separated in several fractions according to cells size and then analysed by 
Western blotting with antibodies specific for Cdc6.  
As shown in the DNA content histograms in Figure 6.7a, the asynchronous load was 
separated into four fractions with increasing DNA content. Separation of BE cells was not 
as efficient as compared to DT40 cells, which might be due to their greater variability in 
size and shape. However, each of the four fractions was enriched in G1, S, or G2/M cells 
and subsequently used for Western blot analysis.  
As shown in Figure 6.7b, the protein levels of Cdc6 were lowest in G1 and increased 
slightly throughout the cell cycle in contrast to Actin levels that remained constant in each  Verena Oehler, 2007    Chapter 6, 163 
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Figure 6.7: Analysis of Cdc6 protein levels throughout an unperturbed cell cycle in BE cells  
BE cells (L) were separated in several fractions (1 to 4) by centrifugal elutriation. Samples were 
analysed for DNA content (PI profiles) as shown in (a) and samples were also analysed by SDS 
PAGE and Western blotting with antibodies specific for Cdc6, cyclinB1, Chk1, Cdc2, P-Cdc2, and 
Actin served as loading control as shown in (b).   
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fraction. Samples were further analysed by Western blotting and cell cycle specific 
fluctuations were observed in cyclinB1 levels and in the phosphorylation status of Cdc2, 
with highest activatory T161-Cdc2 phosphorylation in fraction 4 with mainly G2/M cells. 
The inhibitory T14/Y15-Cdc2 phosphorylation levels reached a maximum in fraction 3 and 
then decreased again in fraction 4. These changes were observed while total Cdc2 and 
Chk1 protein levels were constant.  
In summary, the data from the elutriation experiment showed that Cdc6 levels were low in 
G1 and increased throughout the cell cycle, very similar to cyclinB1 which is regulated by 
proteolysis by the APC. These observations were in accordance with previous studies in 
Hela cells that demonstrated that Cdc6 is a target of the APC in G1 (Petersen et al., 2000). 
Thus, this suggests that the Cdc6 protein levels in the BE cells are also regulated by 
proteasomal degradation.  
6.2.3 Regulation of Cdc6 stability by Chk1 in BE cells   
The observations made in the chapters above as well as previous studies in Hela cells 
(Clay-Farrace et al., 2003) have suggested a role for Cdc6 in the S/M checkpoint response. 
In BE cells, endogenous protein levels of Cdc6 accumulated in a Chk1-dependent manner 
in response to replication arrest with aphidicolin. As Cdc6 protein levels have previously 
been shown to be regulated via the proteasome (Petersen et al., 2000), this raised the 
question of whether Cdc6 accumulation during replication arrest was due to inhibition of 
the proteasome.  
To address this issue, BE cells were treated with aphidicolin and grown in the presence of 
nocodazole for 16h. Chk1 inhibition was achieved using UCN-01 and the proteasome 
inhibitor MG 132 was included to study the involvement of the proteasome. Samples were 
harvested and analysed by SDS PAGE and Western blotting with antibodies specific for 
Cdc6 and Actin was used as a loading control. As shown in Figure 6.8, the protein levels of 
Cdc6 were relatively high in response to replication arrest with aphidicolin and in contrast 
much lower when Chk1 was inhibited with UCN-01 and cells exhibited S/M checkpoint 
failure (upper panels). Interestingly, addition of the proteasome inhibitor MG 132 was able 
to rescue the S/M checkpoint response in the absence of functional Chk1 as shown in the 
flow cytometry profiles in Figure 6.8. The restored checkpoint response was associated 
with an increase in Cdc6 protein levels. However, it was also noticed that MG 132 alone 
was able to block entry to mitosis along with an increase in Cdc6 protein levels (flow        Verena Oehler, 2007    Chapter 6, 165 
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Figure 6.8: Inhibition of the proteasome with MG 132 stabilises Cdc6 protein levels  
BE cells were grown in the presence of nocodazole for 16h. Cells were treated with the DNA 
polymerase inhibitor aphidicolin (A or Aph.), Chk1 inhibitor UCN-01 (U), cdk inhibitor roscovitine 
(R), or the proteasome inhibitor MG 132 (M) respectively. Samples were analysed for mitotic 
indices (P-S10-H3/PI) by flow cytometry and also by SDS PAGE and Western blotting with 
antibodies specific for Cdc6. Actin served as a loading control.   Verena Oehler, 2007    Chapter 6, 166 
cytometry data not shown). Nevertheless, these results suggested that Chk1 might be able 
to stabilise Cdc6 during replication arrest via inhibition of the proteasome.    
Another interesting observation was that while the Cdk inhibitor roscovitine was able to 
inhibit the onset of premature mitosis, it did not restore Cdc6 protein levels, as shown in 
lane 4 in the Western blot analysis in Figure 6.8. Moreover, roscovitine alone had a strong 
effect on Cdc6 levels. This could be due to the aforementioned negative effect of 
roscovitine on transcription (Ljungman and Paulsen, 2001). Aside from that, in budding 
yeast, the activation of S phase Cdks is associated with de-stabilization of Cdc6 and the 
fission yeast homologue of Cdc6 has been shown to be regulated by Cdk-dependent 
phosphorylation and proteolysis (Jallepalli et al., 1997; Piatti et al., 1996). However, the 
stability of Cdc6 in human Hela cells has been found to be independent of cdk 
phosphorylation (Petersen et al., 2000). Nevertheless, the observations presented here 
could suggest that Cdc6 stability or accumulation in response to replication arrest is not 
due to low levels of Cdk activity as inhibition of Cdks with roscovitine did not restore 
Cdc6 protein levels. On the other side, results from another study showed that within a 
limited time window prior to S phase Cdc6 can also be stabilized by Cdk2/cyclinE-
dependent phosphorylation which prevents its association with the APC (Mailand and 
Diffley, 2005). It is therefore possible that Cdk inhibition with roscovitine could have 
affected this step of initial Cdc6 stabilisation; however a more detailed analysis would be 
required to clarify this issue. 
The replication protein Cdc6 is a target of proteasomal degradation in BE cells and Chk1 
appears to play a role in the accumulation of Cdc6 during replication arrest. To test 
whether Chk1 has any effect on proteasomal degradation of Cdc6 in general and during 
replication arrest, the half life of Cdc6 was analysed in both checkpoint proficient BE cells 
and cells in which Chk1 protein levels were down-regulated with siRNA. 
The half life of Cdc6 was analysed by performing a time course experiment with cells that 
were treated with the protein synthesis inhibitor cycloheximide which inhibits de novo 
synthesis of Cdc6 and therefore allows the rate at which the protein is degraded to be 
estimated. Samples were taken at 0, 1, 2, 4, and 6h time points and analysed by SDS PAGE 
and Western blotting. As shown in Figure 6.9a, control BE cells exhibited decreases in the 
total Cdc6 protein levels after cycloheximide treatment, which led to an estimation of an 
approximate Cdc6 half life of about 2h. In the presence of both cycloheximide and the 
proteasome inhibitor MG 132 the protein levels of Cdc6 did not decrease. Actin levels  Verena Oehler, 2007    Chapter 6, 167 
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Figure 6.9: Analysis of Cdc6 half life in BE cells  
Cells were treated with cycloheximide (C or CHX) for up to 6h. Analysis was performed with control 
cells in (a) and in (b) Chk1 function was abrogated with Chk1 siRNA transfection for 48h. Where 
required, DNA replication was blocked with aphidicolin for 12h prior to start of the time course. MG 
132 (M) was used for inhibition of the proteasome. Cells were analysed by SDS PAGE and 
Western blotting with antibodies specific for Cdc6, Chk1, and Actin which served as loading control.  Verena Oehler, 2007    Chapter 6, 168 
were not affected by cycloheximide treatment, while total Chk1 protein levels appeared to 
be decreasing after 6h of treatment.  
The cycloheximide time course analysis was also performed on BE cells that had been pre-
treated with the DNA polymerase inhibitor aphidicolin for 12h. These cells displayed high 
levels of Cdc6 after 12h and still after an additional 6h of replication arrest (Figure 6.9a). 
At the beginning of the cycloheximide treatment Cdc6 levels were high but subsequently 
decreased over time at a rate similar to untreated control cells. The Cdc6 protein levels did 
not decrease when the proteasome inhibitor MG 132 was included. These observations 
suggested that the accumulation of Cdc6 protein in response to replication arrest was not 
primarily due to a longer half life of the protein.  
A similar analysis was then performed on BE cells that had been transfected with Chk1 
siRNA for 48h prior to starting the cycloheximide time course. As shown in Figure 6.9b, 
Chk1 protein levels were almost completely abrogated by siRNA treatment whereas Actin 
levels were constant throughout the duration of the experiment. When Chk1 siRNA 
transfected BE cells were treated with cycloheximide, total Cdc6 protein levels decreased 
over time with an estimated half life of about 2h as judged by density quantification of the 
Western blots. Overall, the half life of Cdc6 was very similar in both control cells and 
Chk1-depleted cells.  
When Chk1 siRNA transfected BE cells were exposed to aphidicolin for 12h prior to the 
start of the cycloheximide time course, the Western blot analysis revealed that a certain 
amount of Cdc6 was detectable at the 0h time point (Figure 6.9b). In the presence of 
cycloheximide the Cdc6 protein levels in the Chk1-depleted cells decreased over time at a 
rate similar to control cells. When the proteasome inhibitor MG 132 was added, the levels 
of Cdc6 protein were restored to some extent.  
These observations showed that the half life of Cdc6 is approximately 2h and does not 
appear to be affected by Chk1 status or aphidicolin treatment in BE cells. Taken together, 
although Chk1 appears to be important for promoting accumulation of Cdc6 in response to 
replication arrest, this is not obviously associated with an increased half life of the protein. 
Thus, other factors, such as for example transcriptional activation, might contribute to the 
accumulation of Cdc6 in response to replication block with aphidicolin. Verena Oehler, 2007    Chapter 6, 169 
6.2.4 Role of Cdc6 during S/M checkpoint - Intervention 
experiments  
The functional S/M checkpoint response in BE cells was characterized by the ability of 
arrested cells to efficiently delay mitosis and this was also associated with an accumulation 
of endogenous Cdc6 protein levels. Previously it has been shown that ectopic expression of 
Cdc6 can block the entry to mitosis in checkpoint-proficient cells (Clay-Farrace et al., 
2003). As S/M checkpoint failure in the absence of functional Chk1 was associated with 
very low levels of Cdc6, this raised the question of whether introduction of exogenous 
Cdc6 could restore the mitotic checkpoint response in checkpoint-deficient cells.   
To test this, Cdc6 was ectopically expressed in checkpoint-proficient as well as Chk1-
depleted checkpoint-deficient BE cells. The experimental procedure involved the co-
transfection of cells with plasmids expressing Cdc6 and GFP for 24h. These cells were 
then treated with aphidicolin and nocodazole as required for a further 24h. Samples were 
analysed by flow cytometry for DNA content and mitotic indices in combination with GFP 
staining as shown in Figure 6.10.  
Un-transfected BE cells accumulated in mitosis in the presence of nocodazole (44%) but 
delayed mitosis effectively when replication was blocked with aphidicolin as only a small 
percentage of cells (7%) stained positive for the mitotic marker P-S10-H3 (Figure 6.10a). 
Transfection efficiency for Cdc6 was estimated by the amount of cells displaying positive 
GFP-staining. Although the levels of GFP staining varied in intensity, overall a high 
percentage of cells (~90%) were successfully transfected. Of the transfected cells only 
23% were able to accumulate in mitosis in the presence of nocodazole. As the progression 
into mitosis was not compromised in GFP-only transfected control cells (data not shown), 
this suggested a negative effect of Cdc6 transfection on cell cycle progression. In response 
to aphidicolin treatment, the transfected cells were able to effectively delay mitosis (7% P-
S10-H3-positive) similar to un-transfected cells under the same treatment.   
To study the effect of Cdc6 over-expression on checkpoint-deficient cells, BE cells were 
first treated with Chk1 siRNA (48h), then transfected with Cdc6/GFP plasmids after 24h 
and finally treated with aphidicolin and nocodazole for the last 24h of the experiment. As 
shown in Figure 6.10b, un-transfected Chk1-depleted cells progressed into mitosis in the 
presence of nocodazole (34%), but not as effectively as Chk1-proficient cells. There was 
an increase in the amount of mitotic cells after aphidicolin treatment, indicative of S/M 
checkpoint failure; however, the overall increase in mitotic cells was rather small (7%), Verena Oehler, 2007    Chapter 6, 170 
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Figure 6.10: Effect of Cdc6 over-expression on S/M checkpoint response in BE cells  
The effect of Cdc6 over-expression was analysed in control cells (a) or cells transfected with Chk1 
siRNA for 48h prior to plasmid transfection (b). Cells were co-transfected with Cdc6 and GFP 
expression vectors for 24h and treated for a further 24h with aphidicolin and/or nocodazole. 
Samples were analysed by flow cytometry for DNA content (PI profiles), GFP/PI staining, and 
mitotic indices by GFP/PS10-H3 staining by flow cytometry. Gate R2 served as approximate 
quantification of P-S10-H3 positive cells for each sample.  Verena Oehler, 2007    Chapter 6, 171 
which might be due to variability in the extent of S/M checkpoint failure as has been 
previously mentioned (chapter 3.2.2). Interestingly, the number of mitotic cells in response 
to aphidicolin treatment was decreased in the Cdc6-transfected cells (2%). Furthermore, 
only 16% of the Chk1-depleted and Cdc6-transfected cells accumulated in mitosis after 
nocodazole treatment.  
Taken together, the ectopic expression of Cdc6 resulted in a decrease in the number of 
cells entering mitosis in the presence of nocodazole in both checkpoint-proficient as well 
as checkpoint-deficient BE cells. Moreover, the amount of checkpoint-deficient cells 
entering mitosis in response to replication block was to some extent reduced. However, 
overall it was not yet possible to judge whether this effect of ectopic Cdc6 expression on 
the S/M checkpoint failure in Chk1-depleted BE cells was significant. 
6.3  Discussion 
The relationship between the process of DNA replication and the onset of mitosis was 
analyzed in order to gain insight into the S/M checkpoint mechanism as well as mitotic 
delay in response to replication block in the absence of functional Chk1.   
The localization and distribution pattern of a marker for DNA replication, PCNA, was first 
analyzed during normal unperturbed cell cycle regulation in DT40 WT cells. Cell cycle 
specific distribution patterns of PCNA were identified. Whereas PCNA staining appears 
weak and cytosolic in G1, it accumulates in S phase cells in the nucleus forming foci with 
strong staining and thereafter the staining becomes weaker and diffuse again similar to 
descriptions in earlier studies (Celis and Celis, 1985). In DT40 WT and Chk1-/- cells the 
chromatin bound PCNA dispersed into the cytosol when cells started to enter natural 
mitosis associated with condensation of the chromatin. Interestingly, PCNA was found to 
be bound to chromatin in some of the Chk1-/- cells that entered mitosis prematurely after 
12h of replication arrest with aphidicolin. This observation suggested that premature 
mitosis of cells with un-replicated DNA is associated with the continued presence of 
PCNA on the chromatin of these cells. 
However, the experiments in this study did not address the question whether the dual 
PCNA and P-S10-H3 staining of Chk1-/- cells was a general feature of premature mitotic 
cells or a transient step until completion of mitosis. This issue could be further addressed 
using time-lapse microscopy on Chk1-/- cells stably expressing GFP-H2B and RFP-
PCNA. Although respective DT40 WT counterparts have been generated successfully, it Verena Oehler, 2007    Chapter 6, 172 
was not yet possible to obtain Chk1-/- cells with the same properties. This was due to 
extreme variability in fluorescence intensity which made further characterization of these 
cells difficult.  
The results from these experiments suggest that premature and normal mitosis can be 
distinguished by the difference in PCNA distribution, which appears still bound to the 
chromatin during the onset of premature mitosis whereas it is dispersed into the cytosol 
during chromatin condensation associated with normal scheduled mitosis.  
While Chk1 function is dispensable for the initiation of mitotic delay, it appears to be 
important at later stages as a major factor for maintenance of the delay (Zachos et al., 
2005). This notion is supported by the fact that Chk1 is responsible for the replication 
recovery functions, such as suppression of new origin firing and the stabilization of stalled 
replication forks (Feijoo et al., 2001; Zachos et al., 2003). Thus, the model is that the 
replication machinery itself is able to signal either the process of normal properly executed 
DNA replication or the presence of disrupted stalled replication machinery. This signal can 
initiate a mitotic delay independently of Chk1. However, in general the stabilization of 
stalled replication forks and the suppression of origin firing are dependent on Chk1 
function, which could explain why Chk1-deficient cells eventually fail to maintain the 
mitotic delay. Intriguingly, this model also implies that as long as stalled replication 
structures are stabilized, the intrinsic mitotic delay mechanism will persist.   
Accordingly, one prediction would be that Chk1-/- cells could block the onset of premature 
mitosis as long as the collapse of stalled replication structures is prevented. In this study, 
replication was routinely blocked with the DNA polymerase inhibitor aphidicolin. This 
drug inhibits the DNA polymerase activity and thereby stalls DNA replication. However, 
aphidicolin can also cause uncoupling of the MCM helicase from the replication fork and 
this can eventually result in the collapse of previously stalled replication structures  (Byun 
et al., 2005; Walter and Newport, 2000). Thus, one could imagine that aphidicolin 
treatment will aid the collapse of stalled replication structures over time and this could be 
responsible for the premature mitotic entry of Chk1-/- cells. This scenario could suggest 
that the intrinsic checkpoint signal might persist for a longer time if the uncoupling of the 
polymerase and helicase activities during aphidicolin treatment could be prevented and the 
stalled replication structures would be kept stable. This is a concept that could be easily 
tested, for example with an inhibitor of MCM helicase, such as the Rb-400 fragment used 
in a recent study (Byun et al., 2005).   Verena Oehler, 2007    Chapter 6, 173 
One component of the replication machinery, the replication protein Cdc6, has been 
identified as a potential candidate involved in checkpoint regulation. Interestingly, during 
replication arrest in human BE cells, the mitotic delay was associated with an accumulation 
of endogenous Cdc6 protein. Furthermore, the accumulation of Cdc6 stability is dependent 
on Chk1 function, as cells in which Chk1 was inhibited with UCN-01 or in which Chk1 
levels were depleted with siRNA did not accumulate Cdc6 and also exhibited S/M 
checkpoint failure after several hours in aphidicolin. This observation is probably the first 
evidence for checkpoint regulation of endogenous Cdc6, as most previous studies have 
used ectopic expression of the protein and there has been some discrepancy in results 
obtained with endogenous and ectopically expressed Cdc6 protein which related to the 
degradation of the protein (Clay-Farrace et al., 2003; Coverley et al., 2000). An interesting 
experiment to confirm whether Cdc6 accumulation is only associated with arrested cells 
would be to separate mitotic and non-mitotic Chk1- depleted cells after replication block. 
The prediction would be that only the non-mitotic arrested cells would display high Cdc6 
protein levels and only cells with low Cdc6 levels enter mitosis prematurely. Aside from 
that, the presented results further confirm that Cdc6 plays a role in replication checkpoint 
control in accordance with several recent studies in both human and yeast cells (Clay-
Farrace et al., 2003; Fersht et al., 2007; Hermand and Nurse, 2007; Oehlmann et al., 2004). 
The potential role of Chk1 in the accumulation of Cdc6 in response to replication arrest 
might be the stabilization of Cdc6 protein by inhibiting its proteasomal degradation, as the 
proteasome inhibitor MG 132 was able to maintain or even increase cdc6 levels. However, 
analysis of the half life of Cdc6 revealed no significant differences between cells with or 
without functional Chk1 in untreated or aphidicolin treated cells. Moreover, it appears that 
de novo Cdc6 protein synthesis contributes to some extent to the increase in Cdc6 protein 
levels after replication block. It would be interesting to analyze whether Cdc6 mRNA 
levels might be affected in response to replication block. Taken together, there are several 
factors determining the checkpoint regulation of Cdc6 and while Chk1 function appears to 
be important, the exact mechanism has not been elucidated yet.  
One proposed model for mitotic delay in response to replication block is that the presence 
of replication proteins such as Cdc6 generates the signal for mitotic delay. This model 
would predict that intervention experiments using ectopic expression of the protein could 
presumably restore the checkpoint response in Chk1-depleted cells. Intervention 
experiments performed in this study gave some indication that this might be true as Chk1-
depleted BE cells displayed lower levels of mitosis when replication was blocked while 
Cdc6 was ectopically expressed. However, further experiments are required to sufficiently Verena Oehler, 2007    Chapter 6, 174 
address this issue, for example, the use of an inducible Tet-On system for Cdc6 or other 
potential candidates in DT40 WT and Chk1-/- cells. Unfortunately, due to difficulties in 
obtaining an antibody specific for the avian protein, it was not yet possible to study Cdc6 
in the DT40 cells. Apart from that, adherent BE cells could also be microinjected with 
plasmids of interest and then analyzed using UCN-01 or Chk1 siRNA to test the hypothesis 
of checkpoint restoration. Although this approach has been attempted during this study, it 
could not be pursued further due to low injection efficiency and low survival rates of the 
microinjected cells. 
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7  Conclusions and Future Perspectives 
Vertebrate cells have evolved checkpoint control mechanisms that prevent the onset of 
mitosis in the presence of DNA damage or if DNA replication is blocked. Most of these 
control mechanisms have originally been identified in yeast but were later found to be 
similar in many aspects in vertebrate cells. The signaling pathway that was identified to be 
responsible for the establishment of mitotic delay can be summarized in the ‘conventional’ 
checkpoint model.  
This conventional model states that the onset of mitosis is always blocked through 
inhibition of the cyclin dependent kinase Cdc2. Initially, sensor proteins can detect any 
DNA lesions or stalled replication structures and subsequently lead to the activation of a 
signalling cascade that involves Chk1/Chk2-activation via ATM/ATR and consequently 
results in the modulation of several downstream targets. Phosphorylation of the Cdc25C 
phosphatase by Chk1 and Chk2 on the N-terminus creates a binding site for 14-3-3 
proteins and results in the nuclear export and degradation of Cdc25C (Chaturvedi et al., 
1999; Peng et al., 1997; Sanchez et al., 1997). In addition, this N-terminal phosphorylation 
of Cdc25C can also directly inhibit Cdc25 phosphatase activity (Blasina et al., 1999). 
Apart from this, Chk1 has also been shown to phosphorylate several Cdc25 family 
members on C-terminal sites which as a result inhibits their interaction with their 
cdk/cyclin substrates (Uto et al., 2004). As a consequence of these inhibitory mechanisms, 
the Cdc25C phosphatase cannot de-phosphorylate Cdc2 on residues T14 and Y15 and the 
Cdk is kept in an inactive state. In addition, Chk1 can phosphorylate and activate Wee1 
and thus promote inhibitory phosphorylation of Cdc2. In Xenopus, Chk1-mediated 
phosphorylation of Wee1 can promote 14-3-3 binding and further enhance the inhibitory 
Wee1 kinase activity (Lee et al., 2001a; O'Connell et al., 1997). 
These two conventional checkpoint mechanisms, the inhibition of Cdc25 phosphatase and 
the promotion of Wee1 kinase activity, ensure the maintenance of inhibitory Cdc2 
phosphorylation, keeping the Cdc2/cyclinB complex inactive and hence preventing the 
onset of mitosis. Both checkpoint kinases Chk1 and Chk2 have the potential to operate in 
the conventional checkpoint model. Therefore, the initial aim of this study was to 
investigate the relative requirement of Chk1 and Chk2 function for mitotic checkpoint 
responses in vertebrate cells. Using two different vertebrate cell systems, it was shown that 
Chk1 is the major effector kinase for mitotic delay in response to DNA damage. In the 
absence of Chk1, cells with damaged DNA entered mitosis at a similar rate to control cells. Verena Oehler, 2007    Chapter 7, 176 
The biochemical analysis of Cdc2 regulation showed that the inhibitory phosphorylation of 
Cdc2 was maintained in checkpoint proficient cells in response to DNA damage but not in 
untreated control cells or checkpoint-deficient cells. Furthermore, the suppression of 
cyclinB2 phosphorylation was identified as a checkpoint target in the avian DT40 cells. 
Overall, the results suggest that IR-induced DNA damage leads to the activation of a 
signalling cascade involving ATM/ATR and Chk1 and subsequent phosphorylation of 
downstream targets then results in the inhibition of mitosis via maintenance of inhibitory 
Cdc2 phosphorylation in a fashion that is in many aspects consistent with the conventional 
model as illustrated in Figure 7.1.  
However, although the regulatory changes in Cdc2/cyclinB2 correlated with the 
conventional model of mitotic checkpoint delay, the actual Cdc2 kinase activity of IR-
treated DT40 WT G2 cells was relatively high even though mitosis was effectively 
delayed. This observation seems initially counterintuitive, but could be attributed to a 
number of facts as discussed earlier. For example, Cdc2 kinase activity might increase 
progressively throughout the cell cycle and only once a certain threshold level is reached 
will cells enter mitosis. If this was the case, then the levels of Cdc2 kinase activity in the 
G2 arrested DT40 WT cells would have been greater than in the starting G1/S population 
but nevertheless below that threshold. Alternatively, Cdc2 could have been associated with 
another cyclin such as cyclinA, which could enable a putative Cdc2/cyclinA complex to be 
catalytically active but either not be in the appropriate location or below the threshold to 
induce the onset of mitosis. 
As described in chapter 5, further studies of the Cdc2/cyclinB2 complex in the DT40 cells 
revealed that the phosphorylation of cyclinB2 is accomplished by Cdks and from 
experiments using a variety of kinase inhibitors it could be suggested that maybe Cdc2 
itself can auto-phosphorylate the cyclinB2 subunit in these cells. Interestingly, this concept 
of Cdc2/cyclinB2 auto-phosphorylation has previously been proposed on the basis of 
earlier studies in starfish oocytes, which demonstrated that the phosphorylation of cyclinB 
requires Cdc2 activity both in vivo and in vitro (Borgne et al., 1999). In this particular 
system, it was shown that the Cdc2-mediated cyclinB phosphorylation is an intra-
molecular mechanism that occurs at the prophase/metaphase transition. It has also been 
suggested that Cdc2/cyclinB becomes activated in the cytoplasm prior to the transition to 
the nucleus in these starfish oocytes (Ookata et al., 1992). Interestingly, the Cdc2 kinase 
activity of purified de-phosphorylated Cdc2 complexed to the de-phosphorylated cyclinB 
subunit was almost identical to the kinase activity of the mitotic complex of de- 
phosphorylated Cdc2 complexed to the phosphorylated cyclinB (Borgne et al., 1999). Verena Oehler, 2007    Chapter 7, 177 
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Figure 7.1: Model for mitotic delay mechanisms in response to DNA damage 
DNA damage, such as DNA double strand breaks induced by IR, lead to the activation of a 
signalling cascade that involves ATM/ATR and Chk1. Subsequent phosphorylation of Chk1 
downstream targets results in nuclear exclusion of the Cdc25C phosphatase by binding of 14-3-3 
proteins and activation of the Wee1 kinase. Both events help to maintain inhibitory phosphorylation 
of Cdc2 on T14 and Y15 according to the conventional model of mitotic checkpoint delay 
mechanisms. In addition in DT40 cells, the phosphorylation of cyclinB2 is suppressed as part of the 
signalling cascade. Consequently, the Cdc2/cyclinB(2) complex is kept in an inactive state and the 
onset of mitosis is inhibited.    
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The fact that Cdc2 in combination with de-phosphorylated cyclinB appears to be 
catalytically active in the cytoplasm without inducing mitosis could therefore possibly 
account for the observation that IR-treated DT40 WT cells, which were mainly arrested in 
G2, displayed such high Cdc2 kinase activity levels although they blocked the entry to 
mitosis. This could also relate to the threshold model for Cdc2 activity which might 
increase progressively throughout the cell cycle but needs to exceed a certain level in order 
to induce mitosis. In the Cdc2-IP kinase assays, the relatively high Cdc2 kinase activity in 
response to IR was accompanied by the un-phosphorylated form of cyclinB2. As the 
phosphorylated isoform of cyclinB2 has been associated with Cdc2 nuclear translocation at 
the onset of prophase (Gallant and Nigg, 1992), this would further support the idea that 
mitosis is only initiated once Cdc2 has phosphorylated its cyclinB2 subunit and the 
complex has translocated to the nucleus.  
In order to thoroughly investigate theses issues, it would be interesting to repeat these 
experiments in the Cdk2 knock out cell line that has been generated recently in DT40 cells 
(Hochegger et al., 2007). In these cells it is thought that Cdc2 regulates not only entry to 
mitosis but also regulates G1 and S phase cell cycle transitions and DNA replication, 
functions previously assigned to Cdk2. In this context it would be interesting to assess the 
Cdc2 kinase activity throughout the cell cycle as it appears that the Cdc2 activity that is 
necessary for the S phase functions in these cells is below the threshold for the induction of 
mitosis and therefore appears to be regulated according to the threshold model of Cdc2 
kinase activity.  
The investigation of mitotic checkpoint proficiency in response to replication arrest with 
the DNA polymerase inhibitor aphidicolin revealed a more complex situation. The timing 
of checkpoint failure in Chk1-deficient DT40 cells differed according to their position in 
the cell cycle: Those cells that were in G2 phase with 4N DNA content at the time of 
aphidicolin treatment did initially enter mitosis similar to control cells until the respective 
G2 cell population was depleted. This observation indicates that aphidicolin can actually 
induce a mitotic delay specifically in G2 cells. This delay is dependent on Chk1 function as 
demonstrated by the fact that G2 phase Chk1-/- cells enter mitosis without any delay 
comparable to untreated control cells. The exact mechanism of this aphidicolin-induced G2 
delay remains to be determined; it appears however that the activity of the DNA 
polymerase might still be required even after DNA replication has been completed, for 
example it could be involved in post-replication DNA repair or recombination. This would 
distinguish the aphidicolin-induced G2-delay from the DNA damage IR-induced G2/M 
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In marked contrast to the Chk1-/- G2 phase cells, those cells that were in G1/S phase at the 
time of aphidicolin treatment did not enter mitosis for an extended period of time and only 
after this prolonged mitotic delay did cells start to enter mitosis with 2N DNA content. 
This difference in the timing of cells entering normal 4N or premature 2N mitosis was not 
simply due to their position in the cell cycle as was shown using purified G1/S cell 
populations. Compared to elutriated Chk1-/- cells that progressed into mitosis with 
damaged DNA at the same rate as control cells, the aphidicolin-treated Chk1-/- cells 
entered mitosis only at much later times after many hours of delay. The entry to mitosis 
was premature as cells had not completed the replication of their DNA. This distinctive 
phenotype with prolonged mitotic delay in response to replication arrest was also observed 
in BE cells treated with the Chk1 inhibitor UCN-01, indicating that it is a fundamental 
property of vertebrate cells. Taken together, these results suggest that some other factors 
contribute to the timing of premature mitosis in the absence of Chk1.  
The biochemical analysis of regulatory changes on Cdc2 and cyclinB2 revealed that the 
phosphorylation of cyclinB2 accumulated during the initial mitotic delay of the 
aphidicolin-treated Chk1-/- cells similar to control cells and was not suppressed as during 
the mitotic delay in checkpoint-proficient cells. As the phosphorylated isoform of cyclinB2 
has been associated with Cdc2 nuclear translocation at the onset of prophase (Gallant and 
Nigg, 1992), this observation indicated that although the presence of the mitotic 
phosphorylated cyclinB2 isoform might be necessary it is not sufficient to induce mitosis. 
Hence, the mitotic delay in the presence of a potentially active Cdc2/cyclinB2 complex 
might be attributed to other additional factors responsible for restraining Cdc2 activity. The 
obvious question that therefore arises is: what mechanism times the onset of premature 
mitosis in the G1/S phase Chk1-/- cells?  
There are several possibilities that could account for restricting Cdc2 activity, for example 
the sequestration of the protein into the cytoplasm which has been mentioned above when 
discussing the Cdc2 kinase activity in checkpoint proficient cells in response to DNA 
damage. Also, Cdc2 could be associated with another cyclin, such as cyclinA. 
Alternatively, binding of Cdc2 to another protein for example could restrain the mitotic 
kinase activity. In order to identify the mechanism of Chk1-independent mitotic delay the 
characteristics of premature and normal mitosis were compared.   
A previous study by Zachos et al. suggested an approximate correlation between the 
collapse of replication structures and the onset of premature mitosis (Zachos et al., 2005). 
However, results presented here indicate that the timing of premature mitosis does not Verena Oehler, 2007    Chapter 7, 180 
strictly correlate with the loss of chromatin-bound PCNA, which is a DNA polymerase 
processivity factor and was therefore used as a marker for DNA synthesis and viable 
replication structures. While PCNA was found to dissociate from the chromatin and 
disperse into the cytosol before chromatin condensation of any normal mitosis, this was not 
the case for cells that entered mitosis prematurely. Instead, it appears that Chk1-/- cells 
eventually enter mitosis in the presence of chromatin-bound PCNA. The discrepancies 
between the PCNA staining patterns between the two studies, by Zachos et al. and here, 
might be due to different staining protocols, for example, a more stringent buffer could 
have displaced chromatin-bound PCNA from the nucleus in the earlier study. Nevertheless, 
the question is raised of whether PCNA staining can be used as a reliable marker for viable 
replication structures or whether it might also persist on collapsed replication structures, as 
was seen in the Chk1-/- cells that entered mitosis prematurely. 
It seems likely that although the initial prolonged mitotic delay in response to replication 
arrest is Chk1-independent and due to some other checkpoint signal, Chk1 function is still 
indirectly required for the long-term maintenance of the mitotic delay. So far one cannot 
exclude the possibility that mitosis with chromatin-bound PCNA is only a transient 
phenomenon in these cells, also it is unclear whether DNA replication could resume in 
these cells once the drug is removed or whether these cells have lost all viable replication 
structures although PCNA is still associated with them. As Chk1 function is generally 
required for the stabilisation of stalled replication structures (Zachos et al., 2005), it seems 
probably most likely that the stalled replication structures eventually collapse and that 
these cells enter mitosis even in the continued presence of PCNA, however to clarify this 
question further investigation is required.  
Taking all these observations into account, the hypothesis was made that the onset of 
mitosis might be dependent on the completion of DNA synthesis and that the replication 
machinery itself might initiate a checkpoint signal either while normal DNA replication is 
ongoing but also when the replication machinery is stalled.  
The idea of a connection between DNA replication and mitosis is not completely new. The 
existence of an intrinsic relationship between the process of DNA replication and the onset 
of mitosis has previously been introduced based on observations from cell fusion 
experiments performed by Rao and Johnson (Rao and Johnson, 1970). These experiments 
demonstrated that when a nucleus from an S phase cell was fused with a nucleus of a G2 
phase cell, the progression of the heterokaryon to mitosis was dependent on the completion 
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checkpoint-proficient, but as Chk1 should hardly be activated under these conditions, it 
seems likely that these observations indicate the functioning of an intrinsic link between 
DNA replication and mitosis.  
Further evidence for a potential intrinsic mitotic delay mechanism comes from studies in 
ATR and ATM/ATR knock-out cell lines that are able to effectively delay mitosis in 
response to replication block although Chk1 activation was severely compromised (Brown 
and Baltimore, 2003). This study suggested that the ATR knock-out cells can block entry 
to mitosis by inhibiting Cdc2/cyclinB by some other mechanism than the maintenance of 
inhibitory Cdc2 phosphorylation. This idea of an ATR-independent replication checkpoint 
is also supported here because DT40 WT cells were able to sustain a functional S/M-delay 
even in the presence of the ATM/ATR-inhibitor caffeine. Another study revealed how 
many, though not all, cell lines differ in their sensitivity to the ATM/ATR-inhibitor 
caffeine with an indication that most untransformed cell lines can delay mitosis after DNA 
synthesis inhibition independently of ATM/ATR (Florensa et al., 2003). All these 
observations strongly suggest that cells can delay mitosis in response to replication arrest 
in more ways than the conventionally known mechanisms via ATM/ATR.  
A potential candidate for the link between DNA replication and mitosis would ideally be a 
protein that is involved in DNA replication as well as checkpoint signalling and maybe 
even linked to mitotic control mechanisms. As previously mentioned, several replication 
proteins, such as fission yeast Cdc18/Cdc6 and Orp1 have been implicated to some extent 
in Cds1 activation during replication checkpoint responses and they can also interact with 
cyclin dependent kinases (Lopez-Girona et al., 1998; Murakami et al., 2002). Especially 
Cdc6, which is an essential factor for the initiation of DNA synthesis, has emerged as a 
prime candidate to be involved in replication checkpoint signalling. So far, a number of 
studies have addressed potential Cdc6 checkpoint function: For example, one study 
showed that the over-expression of human Cdc6 in G2 phase cells resulted in a mitotic 
delay associated with Chk1 phosphorylation (Clay-Farrace et al., 2003). Another study 
demonstrated that the actual presence of Cdc6 during S phase is required for Chk1 
activation in response to replication block in Xenopus (Oehlmann et al., 2004). And only 
very recently Rad26 has been shown to bind directly to Cdc18 and that this interaction can 
aid the recruitment of Rad3 to the chromatin when DNA replication is stalled (Hermand 
and Nurse, 2007). In conclusion, these studies have implicated Cdc6 upstream of Chk1 in 
the replication checkpoint response as the over-expression of Cdc6 was associated with 
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However, there is also the potential for Cdc6 to interact directly with Cdc2 as several 
studies have shown that Cdks can bind to Cdc6/Cdc18 in a cyclin-dependent manner 
(Lopez-Girona et al., 1998; Mimura et al., 2004). This scenario could possibly put Cdc6 
downstream of Chk1 in the replication checkpoint response, as Chk1 is involved in the 
stabilisation of replication structures and thus might affect replication components. 
Overall, most of the cited studies on Cdc6 have used ectopically expressed and tagged 
Cdc6 proteins. The results from the study presented here further confirm a checkpoint 
function for Cdc6; however, unlike previous studies the results here show that the 
accumulation of endogenous Cdc6 protein is promoted in a Chk1-dependent manner 
during DNA replication arrest. To further test whether Cdc6 functions upstream or 
downstream of Chk1 in the replication checkpoint response, Cdc6 was over-expressed in 
control BE cells and Chk1-depleted cells. The results from these intervention experiments 
give preliminary evidence that ectopic expression of Cdc6 can block or at least greatly 
reduce the mitotic entry of cells in both checkpoint-proficient as well as checkpoint-
deficient BE cells. If it is true that Cdc6-overexpression can block mitosis in the Chk1-
depleted cells, than this suggest that Cdc6 functions downstream of Chk1 in the S/M 
checkpoint response. 
Obviously, further experiments are required to sufficiently address this issue, such as for 
example the use of an inducible Tet-On system for Cdc6 in the DT40 WT and the Chk1-/- 
cells which would enable the controlled expression of Cdc6 in the checkpoint-proficient as 
well as the checkpoint-deficient background. Also, the exact mechanistical details of Cdc6-
involvement in mitotic delay are still unclear, but one question to be addressed is the 
potential sequestration of Cdc2 by Cdc6 bound to the replication machinery. 
Taken results from this study into account, Figure 7.2 shows a model including both 
conventional and other potential mitotic delay mechanisms in response to DNA replication 
block in vertebrate cells. On one side, stalled replication structures can lead to the 
activation of Chk1, presumably through ATR via ATRIP-bound single-stranded DNA or 
other sensor proteins. Activated Chk1 can then contribute to the inhibition of mitosis via 
the conventional mechanisms of Cdc25C inhibition and Wee1 activation as described 
above for the DNA damage checkpoint response. On the other side, the replication 
machinery itself might generate a checkpoint signal leading to mitotic delay which is 
especially important in the absence of Chk1 or ATM/ATR. Verena Oehler, 2007    Chapter 7, 183 
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Figure 7.2: Model for mitotic delay mechanisms in response to DNA replication block 
Replication arrest, such as induced by DNA polymerase inhibition with aphidicolin, results in stalled 
replication structures. These presence of these structures can result in the activation of a signalling 
cascade involving ATM/ATR and Chk1 and lead to the inhibition of mitosis by the conventional 
mechanisms of maintaining the inhibitory phosphorylation of Cdc2 on T14 and Y15. In addition, 
alternative mitotic delay mechanisms might originate from the replication machinery and block the 
onset of mitosis independently of ATM/ATR and Chk1. The replication protein Cdc6 appears to 
accumulate in response to replication arrest in a Chk1-dependent manner and functions in the 
signalling pathway responsible for blocking the onset of mitosis. 
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It is likely that these potential pathways generally interact and overlap, for example Chk1 
activation might promote Cdc6 accumulation which could block the onset of mitosis 
maybe directly but most likely by inhibiting Cdc2.   
Further studies will be required to address the exact mechanistical details of checkpoint 
regulation of Cdc6. Many more potential regulatory proteins involved in checkpoint 
control still remain to be identified. Overall, the investigation of both intrinsic control 
mechanisms as well as the checkpoint-regulated processes will further improve our 
understanding of cell cycle control. 
In view of cancer therapy, many components of the cell cycle checkpoint machinery have 
been identified as potential drug targets. Especially in recent years, much attention has 
been focused on the development of small molecule inhibitors targeting specific proteins of 
the cell signalling machinery, for example Chk1. It is thought that by inhibiting specific 
components of the checkpoint pathways in combination with conventional therapeutic 
approaches it should be possible to further enhance cell death and therefore improve the 
success rate of the treatment. From recent studies as well as observations made in this 
study, it appears that under some circumstances Chk1 might indeed be a suitable drug 
target, as for example Chk1-deficient DT40 tumour cells which do not express functional 
p53 are more sensitive to killing by IR (Zachos et al., 2003). However, in order to 
successfully apply the knowledge gained from these studies it will be important to consider 
both the complexity and interplay between checkpoint mechanisms as well as individual 
characteristics of each therapeutic case.  185 
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